
<html lang="en"     class="pb-page"  data-request-id="a4b54e59-f24b-45c9-af8a-c320945568bc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2017.60.issue-16;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b01441;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold" /></meta><meta name="dc.Creator" content="Elena  Sandoval" /></meta><meta name="dc.Creator" content="María José  Lafuente-Monasterio" /></meta><meta name="dc.Creator" content="María J.  Almela" /></meta><meta name="dc.Creator" content="Pablo  Castañeda" /></meta><meta name="dc.Creator" content="María Belén  Jiménez Díaz" /></meta><meta name="dc.Creator" content="María S.  Martínez-Martínez" /></meta><meta name="dc.Creator" content="Jaume  Vidal" /></meta><meta name="dc.Creator" content="Íñigo  Angulo-Barturen" /></meta><meta name="dc.Creator" content="Paul  Bamborough" /></meta><meta name="dc.Creator" content="Jeremy  Burrows" /></meta><meta name="dc.Creator" content="Nicholas  Cammack" /></meta><meta name="dc.Creator" content="María J.  Chaparro" /></meta><meta name="dc.Creator" content="José M.  Coterón" /></meta><meta name="dc.Creator" content="Cristina  de Cozar" /></meta><meta name="dc.Creator" content="Benigno  Crespo" /></meta><meta name="dc.Creator" content="Beatriz  Díaz" /></meta><meta name="dc.Creator" content="Gerard  Drewes" /></meta><meta name="dc.Creator" content="Esther  Fernández" /></meta><meta name="dc.Creator" content="Santiago  Ferrer-Bazaga" /></meta><meta name="dc.Creator" content="María Teresa  Fraile" /></meta><meta name="dc.Creator" content="Francisco J.  Gamo" /></meta><meta name="dc.Creator" content="Sonja  Ghidelli-Disse" /></meta><meta name="dc.Creator" content="Rubén  Gómez" /></meta><meta name="dc.Creator" content="John  Haselden" /></meta><meta name="dc.Creator" content="Sophie  Huss" /></meta><meta name="dc.Creator" content="María Luisa  León" /></meta><meta name="dc.Creator" content="Jaime  de Mercado" /></meta><meta name="dc.Creator" content="Simon J. F.  Macdonald" /></meta><meta name="dc.Creator" content="José Ignacio  Martín Hernando" /></meta><meta name="dc.Creator" content="Sara  Prats" /></meta><meta name="dc.Creator" content="Margarita  Puente" /></meta><meta name="dc.Creator" content="Anne  Rodríguez" /></meta><meta name="dc.Creator" content="Juan C.  de la Rosa" /></meta><meta name="dc.Creator" content="Lourdes  Rueda" /></meta><meta name="dc.Creator" content="Carolyn  Selenski" /></meta><meta name="dc.Creator" content="Paul  Willis" /></meta><meta name="dc.Creator" content="David M.  Wilson" /></meta><meta name="dc.Creator" content="Michael  Witty" /></meta><meta name="dc.Creator" content="Félix  Calderón" /></meta><meta name="dc.Description" content="Since the appearance of resistance to the current front-line antimalarial treatments, ACTs (artemisinin combination therapies), the discovery of novel chemical entities to treat the disease is reco..." /></meta><meta name="Description" content="Since the appearance of resistance to the current front-line antimalarial treatments, ACTs (artemisinin combination therapies), the discovery of novel chemical entities to treat the disease is reco..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 14, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01441" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01441" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01441" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01441" /></link>
        
    
    

<title>The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01441" /></meta><meta property="og:title" content="The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0019.jpeg" /></meta><meta property="og:description" content="Since the appearance of resistance to the current front-line antimalarial treatments, ACTs (artemisinin combination therapies), the discovery of novel chemical entities to treat the disease is recognized as a major global health priority. From the GSK antimalarial set, we identified an aminoxadiazole with an antiparasitic profile comparable with artemisinin (1), with no cross-resistance in a resistant strains panel and a potential new mode of action. A medicinal chemistry program allowed delivery of compounds such as 19 with high solubility in aqueous media, an acceptable toxicological profile, and oral efficacy. Further evaluation of the lead compounds showed that in vivo genotoxic degradants might be generated. The compounds generated during this medicinal chemistry program and others from the GSK collection were used to build a pharmacophore model which could be used in the virtual screening of compound collections and potentially identify new chemotypes that could deliver the same antiparasitic profile." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01441"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01441">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01441&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01441&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01441&amp;href=/doi/10.1021/acs.jmedchem.6b01441" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 6880-6896</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00205" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00396" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.7b01491"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Sandoval">Elena Sandoval</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Jos%C3%A9++Lafuente-Monasterio">María José Lafuente-Monasterio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+J.++Almela">María J. Almela</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pablo++Casta%C3%B1eda">Pablo Castañeda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Bel%C3%A9n++Jim%C3%A9nez+D%C3%ADaz">María Belén Jiménez Díaz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+S.++Mart%C3%ADnez-Mart%C3%ADnez">María S. Martínez-Martínez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jaume++Vidal">Jaume Vidal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=%C3%8D%C3%B1igo++Angulo-Barturen">Íñigo Angulo-Barturen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Bamborough">Paul Bamborough</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy++Burrows">Jeremy Burrows</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas++Cammack">Nicholas Cammack</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+J.++Chaparro">María J. Chaparro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+M.++Coter%C3%B3n">José M. Coterón</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++de+Cozar">Cristina de Cozar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benigno++Crespo">Benigno Crespo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beatriz++D%C3%ADaz">Beatriz Díaz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerard++Drewes">Gerard Drewes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Esther++Fern%C3%A1ndez">Esther Fernández</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Santiago++Ferrer-Bazaga">Santiago Ferrer-Bazaga</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Teresa++Fraile">María Teresa Fraile</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco+J.++Gamo">Francisco J. Gamo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sonja++Ghidelli-Disse">Sonja Ghidelli-Disse</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rub%C3%A9n++G%C3%B3mez">Rubén Gómez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Haselden">John Haselden</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sophie++Huss">Sophie Huss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Luisa++Le%C3%B3n">María Luisa León</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jaime++de+Mercado">Jaime de Mercado</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+J.+F.++Macdonald">Simon J. F. Macdonald</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4859-8246" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+Ignacio++Mart%C3%ADn+Hernando">José Ignacio Martín Hernando</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sara++Prats">Sara Prats</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Margarita++Puente">Margarita Puente</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne++Rodr%C3%ADguez">Anne Rodríguez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan+C.++de+la+Rosa">Juan C. de la Rosa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lourdes++Rueda">Lourdes Rueda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carolyn++Selenski">Carolyn Selenski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Willis">Paul Willis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+M.++Wilson">David M. Wilson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Witty">Michael Witty</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F%C3%A9lix++Calder%C3%B3n">Félix Calderón</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-0486-6883" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Medicines Research Center, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Cellzome GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Medicines for Malaria Venture (MMV), 21 route de Pré-Bois, PO Box 1826, 1215 Geneva 15, Switzerland</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#452320292c3d6b376b2624292120372a2b68372a282a0522362e6b262a28"><span class="__cf_email__" data-cfemail="b2d4d7dedbca9cc09cd1d3ded6d7c0dddc9fc0dddfddf2d5c1d99cd1dddf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01441&amp;href=/doi/10.1021%2Facs.jmedchem.6b01441" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 6880–6896</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 14, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 February 2017</li><li><span class="item_label"><b>Published</b> online</span>14 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 August 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01441" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01441</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6880%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DElena%2BSandoval%252C%2BMar%25C3%25ADa%2BJos%25C3%25A9%2BLafuente-Monasterio%252C%2BMar%25C3%25ADa%2BJ.%2BAlmela%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D16%26contentID%3Dacs.jmedchem.6b01441%26title%3DThe%2BDiscovery%2Bof%2BNovel%2BAntimalarial%2BAminoxadiazoles%2Bas%2Ba%2BPromising%2BNonendoperoxide%2BScaffold%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6896%26publicationDate%3DAugust%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01441"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2090</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01441" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Sandoval&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;José Lafuente-Monasterio&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;J. Almela&quot;},{&quot;first_name&quot;:&quot;Pablo&quot;,&quot;last_name&quot;:&quot;Castañeda&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Belén Jiménez Díaz&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;S. Martínez-Martínez&quot;},{&quot;first_name&quot;:&quot;Jaume&quot;,&quot;last_name&quot;:&quot;Vidal&quot;},{&quot;first_name&quot;:&quot;Íñigo&quot;,&quot;last_name&quot;:&quot;Angulo-Barturen&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Bamborough&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;Burrows&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;Cammack&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;J. Chaparro&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;M. Coterón&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;de Cozar&quot;},{&quot;first_name&quot;:&quot;Benigno&quot;,&quot;last_name&quot;:&quot;Crespo&quot;},{&quot;first_name&quot;:&quot;Beatriz&quot;,&quot;last_name&quot;:&quot;Díaz&quot;},{&quot;first_name&quot;:&quot;Gerard&quot;,&quot;last_name&quot;:&quot;Drewes&quot;},{&quot;first_name&quot;:&quot;Esther&quot;,&quot;last_name&quot;:&quot;Fernández&quot;},{&quot;first_name&quot;:&quot;Santiago&quot;,&quot;last_name&quot;:&quot;Ferrer-Bazaga&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Teresa Fraile&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;J. Gamo&quot;},{&quot;first_name&quot;:&quot;Sonja&quot;,&quot;last_name&quot;:&quot;Ghidelli-Disse&quot;},{&quot;first_name&quot;:&quot;Rubén&quot;,&quot;last_name&quot;:&quot;Gómez&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Haselden&quot;},{&quot;first_name&quot;:&quot;Sophie&quot;,&quot;last_name&quot;:&quot;Huss&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Luisa León&quot;},{&quot;first_name&quot;:&quot;Jaime&quot;,&quot;last_name&quot;:&quot;de Mercado&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;J. F. Macdonald&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Ignacio Martín Hernando&quot;},{&quot;first_name&quot;:&quot;Sara&quot;,&quot;last_name&quot;:&quot;Prats&quot;},{&quot;first_name&quot;:&quot;Margarita&quot;,&quot;last_name&quot;:&quot;Puente&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;Rodríguez&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;C. de la Rosa&quot;},{&quot;first_name&quot;:&quot;Lourdes&quot;,&quot;last_name&quot;:&quot;Rueda&quot;},{&quot;first_name&quot;:&quot;Carolyn&quot;,&quot;last_name&quot;:&quot;Selenski&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Willis&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;M. Wilson&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Witty&quot;},{&quot;first_name&quot;:&quot;Félix&quot;,&quot;last_name&quot;:&quot;Calderón&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;6880-6896&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01441&quot;},&quot;abstract&quot;:&quot;Since the appearance of resistance to the current front-line antimalarial treatments, ACTs (artemisinin combination therapies), the discovery of novel chemical entities to treat the disease is recognized as a major global health priority. From the GSK antimalarial set, we identified an aminoxadiazole with an antiparasitic profile comparable with artemisinin (1), with no cross-resistance in a resistant strains panel and a potential new mode of action. A medicinal chemistry program allowed delivery of compounds such as 19 with high solubility in aqueous media, an acceptable toxicological profile, and oral efficacy. Further evaluation of the lead compounds showed that in vivo genotoxic degradants might be generated. The compounds generated during this medicinal chemistry program and others from the GSK collection were used to build a pharmacophore model which could be used in the virtual screening of compound collections and potentially identify new chemotypes that could deliver the same antiparasitic profile.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01441&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01441" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01441&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01441" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01441&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01441" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01441&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01441&amp;href=/doi/10.1021/acs.jmedchem.6b01441" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01441" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01441" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01441%26sid%3Dliteratum%253Aachs%26pmid%3D28806082%26genre%3Darticle%26aulast%3DSandoval%26date%3D2017%26atitle%3DThe%2BDiscovery%2Bof%2BNovel%2BAntimalarial%2BAminoxadiazoles%2Bas%2Ba%2BPromising%2BNonendoperoxide%2BScaffold%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D16%26spage%3D6880%26epage%3D6896%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290663" title="Pharmacophores">Pharmacophores</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/jmcmar.2017.60.issue-16/20170824/jmcmar.2017.60.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0019.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Since the appearance of resistance to the current front-line antimalarial treatments, ACTs (artemisinin combination therapies), the discovery of novel chemical entities to treat the disease is recognized as a major global health priority. From the GSK antimalarial set, we identified an aminoxadiazole with an antiparasitic profile comparable with artemisinin (<b>1</b>), with no cross-resistance in a resistant strains panel and a potential new mode of action. A medicinal chemistry program allowed delivery of compounds such as <b>19</b> with high solubility in aqueous media, an acceptable toxicological profile, and oral efficacy. Further evaluation of the lead compounds showed that in vivo genotoxic degradants might be generated. The compounds generated during this medicinal chemistry program and others from the GSK collection were used to build a pharmacophore model which could be used in the virtual screening of compound collections and potentially identify new chemotypes that could deliver the same antiparasitic profile.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria is a parasitic disease caused by parasites of the genus <i>Plasmodium</i>, which are transmitted to people during the blood meal of a female Anopheles mosquito. From the different species of <i>Plasmodium</i> (<i>Plasmodium falciparum</i>, <i>Plasmodium ovale</i>, <i>Plasmodium vivax</i>, <i>Plasmodium Knowlesi</i>, and <i>Plasmodium malariae</i>) <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i> are responsible for most of the disease cases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">According to the 2015 World Health Organization (WHO) global malaria report, 3.3 billion people are at risk of being infected with malaria. In 2015, 214 new million cases were reported, and the disease led to ca. 438000 deaths. Although these data includes the six WHO regions, the reality is that 90% of deaths occurred in the WHO African region with 78% being children aged under five.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Fatal cases still remain directly linked to poverty as the highest malaria mortality rates are being reported in countries where the population is living on less than US$1.25 per day. Moreover, malaria is also hampering economic development in affected countries due to expenditures on prevention and treatments.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Great progress has been made in the last 15 years due to increased funding, new diagnostics and chemotherapies as well as vector control strategies. In fact, a 29% decrease in deaths has been reported in 2015 comparing to 2010.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The world’s first malaria vaccine (RTS,S/As01) will be rolled out in pilot projects in sub-Saharan Africa, WHO confirmed on 17th November 2016. Funding is now secured for the initial phase of the program, and vaccinations are due to begin in 2018.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, today, resistance to the insecticides<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> and antimalarials currently in use have been reported (including resistance to the current front-line treatment, artemisin (<b>1</b>) based therapies (ACTs)).<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a></div><div class="NLM_p">As a consequence, there is still an urgent requirement for new antimalarial drugs that can be added to or substitute the current therapies. The criteria for new antimalarial drugs are demanding; the new molecule must be safe, efficacious against strains displaying clinical resistance to current antimalarials, have pharmacokinetics compatible with oral dosing, be affordable, and be able to relieve symptoms as fast as the artemisinins. Responding to the urgency of the situation, the antimalarial community has adopted a pragmatic strategy by focusing on compounds active in a whole cell assay although the mode of action may be unknown.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> This does not mean that identifying the target is not a matter of interest. In fact, the sequencing of the <i>Plasmodium falciparum</i> genome has revealed more than 5000 genes.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, the number of antimalarial targets these days is still very restricted. The structures of around 15000 antimalarial hits from different screening collections (St. Jude’s Hospital,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Novartis,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and GlaxoSmithKline<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a>) can be downloaded free from the Chembl-NTD database and provide a rich resource for selecting leads.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Optimization efforts on several series from the GSK screening, the Tres Cantos Antimalarial Set (TCAMS) have already been published.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22">(17-22)</a></div><div class="NLM_p">Recently, we published data from <i>Plasmodium berghei</i> in vivo screening aimed at reducing attrition by selecting potential in vivo active scaffolds.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> By using this approach, we identified the peroxide-free TCAMS compound TCMDC-134278 (<b>2</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), a basic tetra-aromatic compound containing a central amino-1,3,4-oxadiazole moiety surrounded by a phenyl ring and bicyclic aromatic system (phenyl-pyridine).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Artemisinin (<b>1</b>), <b>2</b> (antimalarial containing oxadiazole scaffolds discovered by GSK), and the one described by Zareef et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Oxadiazole containing leads have become widely used by both pharma and academia as judged by their presence in numerous publications, patents, and late stage clinical trials. Most studied have been the 1,3,4- and 1,2,4-isomers. Both are present in compounds having a broad spectrum of biological activities, are easy to prepare (efficient syntheses have been described) and they can act as bioisosteres of carboxylic acids, esters, and carboxamides.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Although structurally very similar, their different charge distribution makes the 1,3,4 more suitable for drug discovery as, for instance, it shows a better profile in terms of lipophilicity, metabolic stability, lack of hERG inhibition, and aqueous solubility. As an example, raltegravir contains a 1,3,4-oxadizole and is an antiretroviral approved by the FDA for HIV treatment.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">Although oxadiazole containing compounds are frequently found in the TCAMS, there were no close analogues to <b>2</b>. This explains why this compound was not one of the 47 starting points identified in our first mining of the TCAMS, where clusters containing numerous compounds were prioritized over those containing very few or consisted of only one compound (singletons). In that exercise, TCAMS compound were allocated points from 0 to 30 using different parameters and compounds with >14 points were selected for further profiling. <b>2</b> scored 14.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In reviewing the literature, the only other compounds containing the 1,3,4-oxadiazole motif described as antimalarials are the benzenesulfonamides reported by Zareef et al. (<b>3</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p"><b>2</b> is an antimalarial chemotype with activity against the sensitive 3D7 strain and a panel of multidrug strains including clinical isolates resistant to chloroquine, pyrimethamine, and atovaquone. The compound is not cytotoxic at 25 μM when tested against a mammalian cell line (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and its in vitro speed-of-action is comparable with artemisinin (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of Key Data for <b>2</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">result</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pf (3D7A) IC<sub>50</sub> μM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ratio HB3, Dd2, TC08, T9/94, V1/S, FCR3, Tm90C2A, Tm90C2B/3D7<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">∼1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ED<sub>90</sub> (mg/kg)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (mL/min/kg)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>LBF</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">%<i>F</i><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">26.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tox<sub>50</sub><a class="ref internalNav" href="#t1fn6" aria-label="f">f</a>/<i>Pf</i> (3D7) IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">In vitro antimalarial activities of test drugs against sensitive strain 3D7A by [<sup>3</sup>H]hypoxanthine incorporation assay. Standard deviations (included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>) were extracted from two/three independent biological replicates.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">3D7, wild type; HB3, moderately resistant to pyrimethamine; Dd2, chloroquine and pyrimethamine resistant; TC08, pyrimethamine resistant; T9/94, chloroquine resistant; V1/S, chloroquine and pyrimethamine resistant; FCR3, chloroquine, atovaquone, and cycloguanil resistant; Tm90C2A, chloroquine and pyrimethamine resistant; Tm90C2B, chloroquine, pyrimethamine, and atovaquone resistant.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Reference <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">29</a>.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Clearance (Cl) and volume of distribution (<i>V</i><sub>ss</sub>), mouse, iv, 1 mg/kg.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Oral bioavailability, mouse, po, 10 mg/kg.</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last">HepG2 cells.</p></div></div></div><div class="NLM_p">The weakness of <b>2</b> is its high in vivo clearance (Cl > liver blood flow (LBF), <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) (which may be due to the vulnerability of the biaryl left-hand side of the molecule to oxidation),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> which translates into only moderate efficacy in vivo in a severe combined immunodeficiency (SCID) mouse model infected with the human parasite (81% reduction of parasitemia with respect to controls at the high dose tested, 120 mg/kg). In this experiment mice were infected at day 0 with the human parasite (<i>P. falciparum</i><i>Pf</i> 3D7<sup>0087/N9</sup>), and 3 days after infection, the compound was dosed once a day for four consecutive days.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p last">The promising antiparasitological profile of <b>2</b> led to studies evaluating the potential of this novel antimalarial template aimed at delivering a clinical candidate. These studies are described in the rest of this article.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We first focused our efforts on finding an analogue of <b>2</b> that would enable us to understand the potential of the series to deliver antimalarial efficacy in an in vivo model. Upon the basis of the early profiling of <b>2</b>, the chemistry strategy was focused on finding an analogue that would have a better potency/metabolic stability profile.</div><div class="NLM_p">Several preparative methods of oxadiazoles have been published.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> shows the general methods used for the preparation of oxadiazoles <b>4</b>–<b>17</b>. In route A, the corresponding aromatic amine was reacted with thiophosgene in DCM in the presence of a base to give the isothiocyanate. This isothiocyanate was subsequently reacted with the aromatic carboxamide to give a crude material that was then reacted in the presence of DCC to give the corresponding aminoxadiazole (<b>Int-A</b>). This intermediate reacted with 3-pyridinyl boronic acid using Suzuki reaction conditions to give the compounds <b>2</b>, <b>4</b>, <b>7</b>, <b>10</b>, <b>11</b>, <b>12</b>, <b>13</b>, and <b>14</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Routes Used for Preparation of Compounds <b>2</b>–<b>17</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For route B the corresponding hydrazide was reacted with CNBr and a base to give 5-(3-bromophenyl)-1,3,4-oxadiazol-2-amine. This bromide was then reacted using Suzuki reaction conditions with 3-pyridinylboronic acid to give <b>Int-B</b>. The reaction of <b>Int-B</b> with copper(II) bromide and <i>tert</i>-butylnitrite gave the bromide <b>Int-C.</b></div><div class="NLM_p"><b>Int-B</b> was reacted with the corresponding chlorine derivative using Buchwald reaction conditions to give the compound <b>15a</b>. Similar conditions were used to obtain the compounds <b>6</b> and <b>15b</b> using Int-C and the corresponding amine. Compound <b>8</b>, <b>9</b>, and <b>16a</b> were obtained by nucleophilic aromatic substitution between <b>Int-C</b> and the corresponding amines.</div><div class="NLM_p">Finally, in route C, the reaction between the corresponding bromide intermediate and 3-pyridinylboronic acid using Suzuki reaction conditions gave the desired products. The ester moiety then reacted with hydrazine hydrate in ethanol to give the hydrazide intermediates D and E. Those intermediates were respectively reacted with the corresponding isothiocyanates to give a crude material that reacted with DCC or EDCI to give the compounds <b>5</b>, <b>15c</b>, <b>16b</b>, <b>17a</b>, and <b>17b</b></div><div class="NLM_p">Initial lead optimization iterations demonstrated that changes to both the right-hand side (RHS) and left-hand side (LHS) were able to increase metabolic stability while maintaining good whole cell potency (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of <b>2</b>: Right-Hand Side</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">In vitro antimalarial activities of test drugs against sensitive strain 3D7A by [<sup>3</sup>H]hypoxanthine incorporation assay. Standard deviations (included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>) were extracted from two/three independent biological replicates.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">In vitro clearance (microsomes fraction).</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of <b>5</b>: Upper-Left-Hand Side</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0011.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>Pf</i> (3D7) IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><sub>i</sub>Cl<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> human (mL·min/g)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">1-H</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char="."><0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">3-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char="."><0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">In vitro antimalarial activities of test drugs against sensitive strain 3D7A by [<sup>3</sup>H]hypoxanthine incorporation assay. Standard deviations (included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>) were extracted from two/three independent biological replicates.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">In vitro clearance (microsomes fraction).</p></div></div></div><div class="NLM_p">We started to explore the RHS by studying the role of the oxygen in the oxazepine ring by synthesizing the corresponding azepine (<b>4</b>). Although the in vitro stability did not improve comparing to <b>2</b> (in vitro clearance of <b>2</b> is 13.7 mL/min·g), the result was encouraging as <b>4</b> presented submicromolar antiplasmodial activity and opened-up the options to develop SAR through the more tractable heterocycles such as tetrahydroisoquinoline (THiQ) (<b>5</b>) and the isoindoline (<b>6</b>). Nonbasic derivatives (<b>7</b>–<b>9</b>) also presented low clearance but all were less active than <b>5</b> or <b>6</b>. The <i>N</i>-methylated THiQ (<b>5</b>) provided the best balanced profile in terms of potency and clearance and was selected for SAR studies on the left-hand side.</div><div class="NLM_p">With the objective of improving clearance, the options to block potential labile positions of the phenyl ring were studied (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) by synthesizing the three fluorine isomers (<b>10</b>–<b>12</b>). The 4-F derivative (<b>12</b>) caused a drop in potency of 1 order of magnitude, while the 2-F (<b>10</b>) and 3-F derivatives (<b>11</b>) showed potencies in the same range as <b>5</b>. However, <b>11</b> had the lower clearance data. Further exploration of this position with other groups (<b>13</b> and <b>14</b>) delivered the 3-trifluoromethyl analogue <b>14</b> as a promising compound due to its balanced ADME/potency (LE = 0.3, <i>Pf</i> IC<sub>50</sub> 20 nM) profile and low in vitro and in vivo clearance (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>), thus selected as a representative compound for the series for further characterization.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Summary of Key Data for <b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center" char=".">result</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Pf</i> IC<sub>50</sub> μM (3D7A)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left" char=".">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ratio TC08, HB3, T9/94, Dd2, V1/S, FCR3, Tm90C2A, Tm90C2B/3D7<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left" char=".">∼1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ED<sub>90</sub> (mg/kg)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left" char=".">9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC (μg·h/mL/day)</td><td class="colsep0 rowsep0" align="left" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (mL/min/kg)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left" char=".">43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left" char=".">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">%<i>F</i><a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left" char=".">90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FASSIF (μg/mL)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left" char=".">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">In vitro antimalarial activities of test drugs against sensitive strain 3D7A by [<sup>3</sup>H]hypoxanthine incorporation assay. Standard deviations (included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>) were extracted from two/three independent biological replicates.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">See <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> footnote.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Reference <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">29</a>.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Clearance (Cl) and volume of distribution (<i>V</i><sub>ss</sub>), mouse, iv, 1 mg/kg.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Oral bioavailability, mouse, po, 10 mg/kg.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Fasted state simulated intestinal fluid (pH 6.5).</p></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Characterization of <b>14</b></h3><div class="NLM_p">Four key experiments were carried out to understand the potential of <b>14</b> to deliver a novel antimalarial drug according to the desired profile, namely parasite reduction rate (see figure in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> activities versus a panel of resistant strains, in vivo efficacy, and propensity to generate resistant mutants. <b>14</b> showed a parasite reduction rate that is classed as “fast killer antimalarial” (similar to chloroquine) and was equipotent against a panel of resistant strains which includes clones resistant to chloroquine, pyrimethamine, and atovaquone (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). These results are in agreement with previously reported data for the hit compound <b>2</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In vivo, <b>14</b> was able to reduce the level of parasitemia under the limit of detection after just two doses (ED<sub>90</sub> = 9.3 mg/kg, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) in comparison to <b>2</b> where a reduction of 81% of parasitemia after four doses of 120 mg/kg was achieved. This major improvement of <b>14</b> over <b>2</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) may be a consequence of the improvement in the in vitro antiplasmodial potency and the more balanced pharmacokinetic profile of <b>14</b> for an oral dosing (%F 90, Cl = 42 mL/min/kg, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Finally, we tried unsuccessfully to generate in vitro resistant mutant to <b>14</b>. Although this result prevented the identification of the target, it also suggests that the propensity of resistance to this chemical class might be low. All these results indicated the potential of both <b>14</b> and the scaffold for discovering a novel antimalarial. However, the progression of <b>14</b> was limited by its negligible solubility in biorelevant media (1.2 μg/mL in FASSIF, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison between efficacy profiles of <b>2</b> (left) and <b>14</b> (right). Arrows indicate day of treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Optimization of <b>14</b></h3><div class="NLM_p">The chemical strategy next focused on identifying a more developable compound by finding an analogue with a more desirable physicochemical profile than <b>14</b>. Increasing the sp<sup>3</sup> character and flexibility, reducing aromaticity, and reducing lipophilicity were thus considered in designing the next iteration of compounds (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The goal was to explore the RHS and LHS separately and to identify the most suitable combination.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Strategy to improve physicochemical profile of <b>14</b> (X = C or N). Guidelines used to improve the physicochemical profile were to increase sp<sup>3</sup> character and flexibility/reduce aromaticity and lipophilicity (Alk, alkyl; Py, 3-pyridine).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Right-Hand Side</h3><div class="NLM_p">We first initiated our SAR expansion campaign by using a dual approach. The first approach targeted close analogues of <b>14</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, <b>15a</b>–<b>c</b>). The second approach was designed to simplify the template by modifying the THiQ (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, <b>16a</b>–<b>b</b>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR Study around Right-Hand Side of <b>14</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0012.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0013.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">In vitro antimalarial activities of test drugs against sensitive strain 3D7A by [<sup>3</sup>H]hypoxanthine incorporation assay. Standard deviations (included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>) were extracted from two/three independent biological replicates.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Fasted state simulated intestinal fluid (pH 6.5).</p></div></div><div></div></div><div class="NLM_p">By using the first approach, we prepared two aza-THiQ derivatives. While the 2-aza analogue (<b>15a</b>) caused a drop in potency of 1 order of magnitude compared with <b>14</b>, the 5-aza (<b>15b</b>) derivative is equipotent. For the second approach, the <i>para</i> (<b>16</b>) amino benzyl analogues showed potency comparable to <b>14</b>. Finally, as trifluoromethylation improves the pharmacokinetics (compare <b>4</b> to <b>14</b>), the trifluoromethyl derivatives of <b>15b</b> and <b>16</b> were prepared (<b>15c</b> and <b>16b</b>, respectively) to compare the in vivo activity of both compounds. <b>15c</b> and <b>16b</b> notably improved the aqueous solubility compared to <b>14</b>. However, while <b>16b</b> at 50 mg/kg dose was able to reduce the parasitemia under the limit of detection after 2 days of treatment having an ED<sub>90</sub> < 20 mg/kg (AUC<sub>ED90</sub> < 2.5 μg·h/mL/day, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), <b>15c</b> did not show the same effect at the highest doses tested (67 mg/kg). We therefore carried out a second iteration of optimization based on <b>16b</b> aimed at exploring the SAR of the RHS while maintaining similar lipophilicity (ChromlogD<sub>7.4</sub> = 3.2) (see next section) (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Graphs: In vivo profile for <b>16b</b> (left) and <b>17a</b> (right). Table: key in vivo data for <b>16b</b> and <b>17a</b>. <sup>a</sup>Clearance (Cl) and half-life (<i>t</i><sub>1/2</sub>) mouse, iv, 1 mg/kg. <sup>b</sup>Oral bioavailability, mouse, po, 10 mg/kg. <sup>c</sup>Reference <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">29</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR Study around Right-Hand Side of <b>16b</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0014.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0015.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">In vitro antimalarial activities of test drugs against sensitive strain 3D7A by [<sup>3</sup>H]hypoxanthine incorporation assay. Standard deviations (included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>) were extracted from two/three independent biological replicates</p></div></div><div></div></div><div class="NLM_p">No differences in the antiplasmodial potency were found with the tertiary cyclic amine <b>17a</b> or when the aryl group was replaced by a pyridyl group (<b>17b</b>). However, all the attempts to replace this particular aromatic ring with an alkyl group were unsuccessful.</div><div class="NLM_p">We compared the in vivo output for both compounds to decide the most optimum RHS. While both compounds have similar profiles, the lower clearance of <b>17a</b> led us to select this RHS to be combined with the best LHS.</div><div class="NLM_p last">Concluding this section, potent in vitro, highly oral available, low clearance compounds can be obtained with the best right-hand sides.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Left–Hand Side</h3><div class="NLM_p">Encouragingly, when the top-phenyl ring (R<sub>3</sub>, <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>) was substituted by the four possible pyridine isomers (<b>18a</b>–<b>d</b>) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), the 6-pyridyl (<b>18a</b>) and 5-pyridyl (<b>18b</b>) showed a similar potency to <b>14</b>. The synthetic strategy followed was route C described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. SAR Study around Left-Hand side of <b>14</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0016.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0017.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">In vitro antimalarial activities of test drugs against sensitive strain 3D7A by [<sup>3</sup>H]hypoxanthine incorporation assay. Standard deviations (included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>) were extracted from two/three independent biological replicates;</p></div></div><div></div></div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Routes Used for Preparation of Compounds <b>18a</b>–<b>d</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All attempts to improve the physicochemical profile by removing an aromatic ring were unsuccessful. Only the substitution of the pyridine by an amide (cyclopropyl amide) showed submicromolar activity, but it was still an order of magnitude weaker than the best compounds (<b>18a</b> and <b>18b</b>).</div><div class="NLM_p"><b>18a</b> and <b>18b</b> presented similar profiles. <b>18a</b> had the better in vitro microsomal stability in human (<0.5 mL/min·g vs 1.45 mL/min·g) and was thus selected for further in vivo profiling. Pharmacokinetic analysis in mice showed that <b>18a</b> is a rapidly metabolized compound (>LBF) with low oral bioavailability. However, <b>18a</b> possessed high solubility in aqueous media (FASSIF soln = 390 μg/mL) and high in vivo potency (ED<sub>90</sub> = 33.8 mg/kg, AUC<sub>ED90</sub> of 1.4 μg·mL/day).</div><div class="NLM_p last">In conclusion, the left-hand side of the molecule allows the lipophilicity and solubility of the molecule to be controlled.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Mix and Matching</h3><div class="NLM_p">The final step of the proposed strategy was to find the most suitable combination of the RHS and LHS of the molecule which balanced the potency, physicochemical properties and PK. <b>17a-RHS</b> and <b>18a-LHS</b> were identified as the most suitable combination. <b>17a</b> has a promising pharmacokinetic profile but nonideal physicochemical features which might be mitigated by using the LHS of <b>18a</b>. Both compounds have a similar antimalarial potency.</div><div class="NLM_p">The resulting compound is <b>19</b> (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). A potent analogue equiactive panel of multidrug strains including clinical isolates resistant to chloroquine, pyrimethamine, and atovaquone and able to reduce the level of parasitemia under the limit of detection after 2 days of treatment (ED<sub>90</sub> 12.4 mg/kg, AUC<sub>ED90</sub> 0.08 μg·h/mL/day). <b>19</b> has low lipophilicity (ChromlogD<sub>7.4</sub> 1.3) and is highly soluble in aqueous media (FASSIF > 1000 μg/mL). These data show the additivity of the SAR and provide encouragement that the scaffold could be optimized toward the desired profile.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Key Data for <b>19</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0018.gif" alt="" id="fx10" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">result</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Pf</i> (3D7A) IC<sub>50</sub> μM<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ChromlogD<sub>7.4</sub></td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ratio Dd2, V1/S, Tm90C2B, 2B12/3D7<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">∼1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ED<sub>90</sub> (mg/kg)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">12.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tox<sub>50</sub><a class="ref internalNav" href="#t8fn4" aria-label="d">d</a>/<i>Pf</i> IC<sub>50</sub> (3D7)</td><td class="colsep0 rowsep0" align="left">>1000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">In vitro antimalarial activities of test drugs against sensitive strain 3D7A by [<sup>3</sup>H]hypoxanthine incorporation assay. Standard deviations (included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>) were extracted from two/three independent biological replicates.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">See <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> footnote.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Reference <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">29</a>.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">HepG2 cells.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Developability Assessment</h3><div class="NLM_p">To assess the potential of the scaffold, we first carried out an in vivo toxicological experiment. Two independent experiments were performed. <b>19</b> was administered (300 and 500 mg/kg) to female Swiss CD-1 mice. The concentration achieved at the highest dose was 68.9 μg·h/mL. Several parameters were considered: in-life observations, bodyweight evolution, relative organ weight, hematology, and clinical chemistry. No serious adverse effects were observed, although slight adverse clinical signs (passivity) were seen at 500 mg/kg in the functional observatory battery.</div><div class="NLM_p">A risk associated with the core is its potential to generate genotoxic metabolites such as hydrazine through an acid-catalyzed hydrolytic ring-opening mechanism or Phase I metabolism (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> We chose <b>17a</b> and <b>19</b> as tool compounds for further evaluation of this issue. The results were inconclusive because both compounds behaved differently in a preliminary assessment. <b>19</b> remained chemically unaltered in acid media (SGF at pH 1.6) for at least for 24 h at 37 °C, while <b>17a</b> showed degradation product after 14 h under the assay conditions. When both compounds were assessed in an in vivo model using high concentrations (300 and 500 mg/kg), both <b>20a</b>,<b>b</b> and <b>21a</b>,<b>b</b> were detected. By HPLC, levels of 18.4/19.3% (250 and 500 mg/kg doses, respectively) of <b>21a</b> were detected and 2.6/2.3% levels (300 and 500 mg/kg doses respectively) of <b>21b</b>. According to the mechanism proposed in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, the detection of <b>21</b> may lead to the generation of hydrazine (hydrazine levels were not measured). The discrepancy between the quantities of <b>21</b> detected for the two compounds indicates our lack of understanding of this mechanism.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proposed mechanism of 1,3,4-aminoxadiazole degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Target Elucidation Efforts</h3><div class="NLM_p last">Genomic and chemoproteomics approaches were explored to elucidate the biological target of these compounds. Several attempts were made with different analogues to generate in vitro resistant mutants, but none were isolated with any of the analogues tested, so no genomic work could be undertaken. Attempts were made to identify malaria proteins using pull down experiments in which different analogues of <b>14</b> were linked to a matrix and were competed with free active analogues. Although several <i>falciparum</i> proteins were identified, no specific binding was detected as none of them competed with the free compounds. In parallel experiments using K562 whole<b>-</b>cell lysate, <i>hu</i>FECH was identified as a potential target of different analogues of <b>14</b>, additional studies showed that FECH inhibition was also observed with compounds which were inactive against <i>P. falciparum</i> growth, discarding this target as responsible of its MoA. Capturing experiments using kinobeads were also attempted using <b>14</b> and <b>18a</b>. Several proteins were identified from this but were discarded as potential targets because none were detected by both analogues.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Pharmacophore Elucidation</h3><div class="NLM_p">We wish to encourage others to identify new chemotypes with the same antiparasitic profile as the aminoxadiazoles. 3D pharmacophores are a spatial arrangement of chemical features that can be used to search for chemically distinct molecules that are able to make similar interactions.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> We make available to the research community the <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a> 3D pharmacophore models constructed using over 400 analogues of the amino-oxazole series from the GSK compound collection with measured antiplasmodial activity. Because it is challenging to unambiguously assign their bioactive conformation, we cannot define one absolute active pharmacophore. Nevertheless, the molecules are quite rigid, with a relatively small number of low-energy conformers, and by overlaying conformers of two representative compounds it was possible to define four overlapping 3D pharmacophore models which show significant enrichment of active members of the series over inactive members (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). There is considerable intersection between the hits found by each of the four pharmacophores, so we recommend searching using all four before combining the hits.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Pharmacophore model 8, which gave the highest enrichment performance against the project compounds, was built from common features of superimposed compounds <b>4</b> (green sticks) and <b>18</b> (gray sticks). Pharmacophore features are indicated with circles: aromatic centroids and normal features orange cationic and hydrogen-bond donor features; projected points purple; hydrogen-bond acceptors cyan. (B) Enrichment performance of pharmacophore 8 against 418 project compounds, binned by activity (pIC<sub>50</sub>). The proportion of compounds detected by the model within each activity bin is colored green. The model matched 81% of compounds with pIC<sub>50</sub> > 6.5 and only 6% of compounds with pIC<sub>50</sub> ≤ 5.5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have shown the potential of the basic tetra-aromatic template exemplified by <b>19</b> to deliver a novel antimalarial chemotherapy. Although simplification of the template looks quite challenging, we have shown the versatility of the template, suggesting that further SAR exploration of the scaffold is possible. The fast killing profile, low tendency to develop resistance mutants, the robust in vivo efficacy among different members of the series, and the efficacy against a panel of resistant strains makes this template a promising antimalarial scaffold. However, the aminoxadiazole core has the potential to deliver genotoxic metabolites, thus making progression of this particular core a challenging and risky task. We have therefore, stopped any further investment in this compound-class.</div><div class="NLM_p last">A pharmacophore model has been built. We publish here the coordinates and key interactions and encourage efforts to identify new chemotypes through virtual library screening which might conserve the same antiparasitological profile of the aminoxadiazole containing analogues.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All animal studies were ethically reviewed and carried out in accordance with European Directive 2010/63/EU and the GSK Policy on the Care, Welfare, and Treatment of Animals. The human biological samples were sourced ethically, and their research use was in accord with the terms of the informed consents</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Pharmacophore Modeling</h3><div class="NLM_p">Modeling was carried out using MOE version 2014.09 (Chemical Computing Group). Stochastic conformational searches were carried out on compounds <b>4</b> and <b>18</b> (Amber12 force field, iteration limit 1000, rejection limit 100, RMSD limit 1.0). Flexible fitting was used to align the two compounds (default parameters), producing eight distinct aligned molecule pairs. For each aligned pair, a pharmacophore model was built by hand, generating eight pharmacophore models, using the same features for each. The 0.8 Å radius aromatic features were placed at the midpoint of overlaid aromatic centroids. The 1.5 Å radius π-normal points were placed at aromatic normal projected points. Hydrogen-bond acceptor points were placed with radius 0.8 Å at the midpoint of the oxadiazole nitrogen atoms. A hydrogen-bond donor feature was placed with radius 0.8 Å at the aniline nitrogen. At its projected point, a hydrogen-bond donor projected point was placed with radius 1.5 Å. Finally, at the centroid of the basic centers, a cation feature was placed with radius 2.0 Å. This was repeated for all eight superimposed pairs.</div><div class="NLM_p">To validate the models, 418 compounds from the GSK antiplasmodium project with measured activity were prepared as described above (Amber12 force field with standard R-field solvation) and placed in a multiconformer database with a maximum of 50 conformers per molecule. The database was then searched using the eight pharmacophore models in turn, requiring all 12 features to match. Hit rates varied between pharmacophores, with one (model 4) only retrieving 64 molecules, while model 8 found 217. Four models (1, 2, 5, and 8) found similar compounds to one another (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Table SX1</a>) and were far superior to the others at enrichment of the more potent compounds in the set (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Figures SX1, SX2</a>). Models 1, 2, 5, and 8 are shown in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Figure SX3</a>.</div><div class="NLM_p last">We recommend that the best approach for hit identification within a compound database would be to combine hits from screening models 1, 2, 5, and 8. As the models are rather specific, depending on the size and composition of the database, we also recommend relaxing the criteria so that one or possibly two mismatches are allowed, requiring only 10 or 11 out of the 12 features in each pharmacophore model to match. Models 1, 2, 5, and 8 in MOE pharmacophore file format are given in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">Supporting Information</a>, configured to match 11 out of 12 features. Because this is an ASCII text file format containing feature coordinates and radii, it could be used to build equivalent pharmacophore models in other formats.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Materials and Methods</h4><div class="NLM_p last">All starting materials were purchased from commercial sources and used as received or synthesized via literature procedures. Solvents were dried using a commercial solvent purification system and stored under nitrogen. All final compounds were characterized by <sup>1</sup>H NMR spectroscopy and LCMS. <sup>1</sup>H NMR spectra were recorded on a Bruker Avance 400 MHz spectrometer at 293 K. Purity was determined by HPLC (Acquity UPLC BEH C18 1.7 μ 2.1 mm × 50 mm) at 35 °C. All compounds tested present a purity >95%. Method: acetate NH<sub>4</sub> 25 mM + 10% ACN at pH 6.6/ACN, 0–0.2 min 100:0; 0.2–1.0 min 10:90; 1.0–1.8 min 10:90; 1.8–2.0 min 100:0. Flow: 0.8 mL/min. The UV detection wavelength was 254 and 210 nm. Positive ion mass spectra (high resolution mass spectroscopy) was acquired using a QSTAR Elite (AB Sciex Instruments) mass spectrometer, equipped with a turbospray source, over a mass range of 250–700, with a scan time of 1 s. The elemental composition was calculated using Analyst QS 2.0 software.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-Methyl-<i>N</i>-(5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-yl)-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]oxazepin-7-amine (<b>2</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route A: a mixture of 4-methyl-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]oxazepin-7-amine (305 mg, 1.7 mmol) and 1,1′-thiocarbonyldiimidazole (305 mg, 1.7 mmol) were dissolved in 5 mL of anhydrous THF at rt. The reaction mixture was stirred overnight. Solvent was removed under reduced pressure to give a crude material that was dissolved in 25 mL of EtOAc and washed with 25 mL of water. Phases were separated in a separative funnel, and the organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to dryness to give a crude material that was dissolved in 10 mL of dry THF and combined with 3-bromobenzohydrazide (361 mg, 1.7 mmol). The reaction mixture was heated at 60 °C for 3 h and after reaction completion. After that time, thereaction mixture was allowed to cool down to rt, and the solvent was evaporated under reduced pressure to give a crude material that was triturated with diethyl eter. The solid was filtered and dried under vacuum to give a solid (700 mg, 1.6 mmol) that was dissolved in 8 mL of anhydrous DMF and <i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbodiimide hydrochloride was added (401 mg, 2.1 mmol). The mixture was heated at 80 °C overnight. After cooling down to rt, the reaction mixture was diluted with water (40 mL) and extracted with EtOAc (2 × 50 mL). The organic layer was washed with water (2 × 30 mL), dried over anhydrous sodium sulfate, filtered, and concentrated to dryness, affording the corresponding oxadiazole intermediate (intermediate type A) as a white solid (MS: <i>m</i>/<i>e</i> 401 (MH<sup>+</sup>)). Compound <b>2</b> was obtained by irradiating a mixture of 3-pyridinylboronic acid (92 mg, 0.7 mmol), <i>N</i>-(5-(3-bromophenyl)-1,3,4-oxadiazol-2-yl)-4-methyl-2,3,4,5-tetrahydrobenzo[<i>f</i>][1,4]oxazepin-7-amine (300 mg, 0.7 mmol) (oxadiazole intermediate type A), potassium carbonate (413 mg, 3 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (17.3 mg, 0.02 mmol) in a microwave device for 90 min at 85 °C. Reaction mixture was diluted with EtOAc (30 mL) and washed with water (2 × 20 mL). Phases were separated in a separative funnel, and organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to dryness to give a crude material that was purified on a silica gel cartridge to give 250 mg of <b>2</b> (0.6 mmol). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 8.91 (d, <i>J</i> = 1.8 Hz, 1H), 8.67 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.17 (s, 1H), 8.00 (d, <i>J</i> = 7.8 Hz, 1H), 7.95 (dt, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.72 (d, <i>J</i> = 7.8 Hz, 1H), 7.58–7.65 (m, 1H), 7.39–7.46 (m, 3H), 7.34 (dd, <i>J</i> = 8.5, 2.9 Hz, 1H), 7.04 (d, <i>J</i> = 8.3 Hz, 1H), 4.01–4.12 (m, 2H), 3.80 (s, 2H), 2.98–3.10 (m, 2H), 2.45 ppm (s, 3H). MS: <i>m</i>/<i>e</i> 400 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (251 nm). <i>R</i><sub>t</sub>: 1.06 min (Acquity UPLC BEH C18 1.7 μ, 2.1 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 5% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-(2-Methyl-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>c</i>]azepin-8-yl)-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>4</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route A: To a previously cooled at 0 °C solution of 2-methyl-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>c</i>]azepin-8-amine (0.5 g, 2.8 mmol), and triethylamine (0.6 mL, 4.2 mmol) in DCM (50 mL), thiophosgene (0.5 mL, 4.2 mmol) was added dropwise over a 30 min period. The mixture was stirred at 0 °C for 1 h, and after that time, the solvent was evaporated under vacuum to give a crude material that was combined with 3-bromo benzoic hydrazide (0.7 g, 3.4 mmol) in dry THF (5 mL) at rt. The resulting solution was stirred for 18 h. Removal of the solvents under vacuum afforded a solid that was suspended, triturated with diethyl ether (50 mL) for 1 h, and filtered to give a solid that was dissolved in EtOH (5 mL), and DCC (0.5 g, 2.5 mmol) was added. The reaction mixture was kept under stirring at rt overnight. After that time, ethanol was stripped off to get a solid, which was triturated with EtOAc and then with water. The resulting solid was purified using a silica gel cartridge to give the corresponding <b>Int-A</b> (0.4 g). This intermediate was combined with 3-pyridinylboronic acid (0.1 g, 7.5 mmol) and potassium carbonate (0.1 g, 8.1 mmol) in a mixture of 1,4-dioxane (9 mL) and water (1 mL). To this mixture, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (31 mg, 0.1 mmol) was added, and the reaction mixture was heated at 110 °C under N<sub>2</sub> atm for 3 h. Brine and EtOAc were added, and phases were separated in a separative funnel, the organic layer was dried over anhydrous sodium sulfate, and filtered, and the solvent was evaporated to give a crude material that was purified using a silica gel cartridge to afford 80 mg of <b>4</b> (0.002 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (s, 1H), 9.03 (d, <i>J</i> = 2.02 Hz, 1H), 8.72 (dd, <i>J</i> = 1.52, 4.80 Hz, 1H), 8.19–8.26 (m, 2H), 7.98–8.05 (m, 2H), 7.80 (t, <i>J</i> = 7.83 Hz, 1H), 7.66–7.74 (m, 1H), 7.63 (dd, <i>J</i> = 4.42, 7.71 Hz, 1H), 7.34 (s, 1H), 7.12 (d, <i>J</i> = 0.76 Hz, 1H), 2.93–3.00 (m, 2H), 2.90 (s, 3H), 2.74 (dd, <i>J</i> = 4.67, 6.44 Hz, 2H), 1.78 (br s, 2H), 1.58 (br s, 2H). MS: <i>m</i>/<i>e</i> 398 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (241 nm). <i>R</i><sub>t</sub>: 1.26 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-(2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>5</b>)</h4><div id="sec5_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30">i </h5><div class="NLM_p last">A microwave vial was charged with methyl-3-bromobenzoate (1.7 g, 8.1 mmol), 3-pyridinylboronic acid (1 g, 8.1 mmol), sodium carbonate (8.6 g, 8.1 mmol), DME (6 mL), and water (2 mL). The resulting mixture was purged with argon, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (286 mg, 0.4 mmol) was added, and the vial was sealed. Reaction mixture was irradiated in a microwave device at 100 °C for 0.5 h. Reaction mixture was cooled down to rt, filtered through a Celite cartridge, and the cartridge was washed with DCM/EtOH. Solvents were removed under reduced pressure to give a crude material that was dissolved in DCM and washed with brine. Phases were separated in a separative funnel, and the organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to dryness to afford methyl 3-(pyridin-3-yl)benzoate (210 mg, 1 mmol).</div></div><div id="sec5_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31">ii </h5><div class="NLM_p last">Hydrazine monohydrate (0.7 mL, 9.4 mmol) was added to a rt solution of methyl 3-(pyridin-3-yl)benzoate (200 mg, 0.9 mmol) in ethanol (10 mL). The reaction mixture was stirred at rt for 5 h. Solvents were removed under reduced pressure, and toluene was added to the residue and evaporated twice. The residue was triturated with <sup><i>t</i></sup>BuOMe and <i>n</i>-hexanes to obtain 18.5 mg of desired 3-(pyridin-3-yl)benzohydrazide as a gray solid. The filtrate was evaporated under vacuum to obtain 167 mg of a mixture of starting ester and desired product. This mixture, hydrazine monohydrate (1 mL, 12.8 mmol), and ethanol (10 mL) were added to a microwave vial, and it was placed in a heating block at 90 °C. The reaction mixture was stirred at 90 °C for 60 h. After cooling down to rt, the solvents were removed under reduced pressure. The residue was coevaporated with toluene twice to afford 3-(pyridin-3-yl)benzohydrazide (<b>Int-D</b>) as a white solid (164 mg, 0.8 mmol).</div></div><div id="sec5_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32">iii </h5><div class="NLM_p last">To a suspension of 2-methyl-1,2,3,4-tetrahydroisoquinolin-7-amine (679 mg, 4.2 mmol) in DCM (8 mL), 1,1′-thiocarbonyldiimidazole (746 mg, 4.2 mmol) was added, and the reaction mixture was stirred at rt under nitrogen atm. for 1.5 h. After that time, it was diluted with DCM and washed with water. After separation of the phases in a separative funnel, the organic layer was dried over anhydrous sodium sulfate, and the solvent was evaporated under vacuum to afford 7-isothiocyanato-2-methyl-1,2,3,4-tetrahydroisoquinoline (855 mg, 4.2 mmol) that was used as such in next step.</div></div><div id="sec5_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33">iv </h5><div class="NLM_p last">A solution of 7-isothiocyanato-2-methyl-1,2,3,4-tetrahydroisoquinoline (157 mg, 0.8 mmol) in 2-MeTHF (8 mL) was added to a rt stirring mixture of 3-(pyridin-3-yl)benzohydrazide (<b>Int-D</b>) (164 mg, 0.8 mmol) in 2-MeTHF (8 mL). The reaction mixture was stirred at rt for 1 h, <i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide (175 mg, 0.8 mmol) was added, and the reaction mixture was stirred at reflux for 3 h. After cooling down to rt, EtOAc and water were added, a precipitate appeared, and it was filtered off and dried under vacuum to obtain 90 mg of intermediate <i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-2-(3-(pyridin-3-yl)benzoyl)hydrazinecarbothioamide. The filtrate was added to a separative funnel and layers were separated; the organic layer was washed with brine, dried over anhydrous sodium sulfate, and concentrated under vacuum to afford 300 mg of crude product. This crude was purified by preparative HPLC to give 92 mg of <b>5</b> (0.24 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (s, 1H), 8.96 (dd, <i>J</i> = 0.76, 2.27 Hz, 1H), 8.64 (dd, <i>J</i> = 1.52, 4.80 Hz, 1H), 8.10–8.19 (m, 2H), 7.87–7.99 (m, 2H), 7.67–7.77 (m, 1H), 7.55 (ddd, <i>J</i> = 0.76, 4.74, 7.89 Hz, 1H), 7.31–7.40 (m, 2H), 7.10 (d, <i>J</i> = 8.34 Hz, 1H), 3.48 (s, 2H), 2.73–2.81 (m, 2H), 2.54–2.62 (m, 2H), 2.30–2.37 (m, 3H). MS: <i>m</i>/<i>e</i> 384 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (251 nm). <i>R</i><sub>t</sub>: 0.94 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-(3-(Pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>Int-B</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, Route B: To a previously cooled at 0 °C solution of 3-bromobenzoic hydrazide (10 g, 46.5 mmol) in 240 mL of a (5:1) mixture of 1,4-dioxane and water, NaHCO<sub>3</sub> (4.1 g, 51.2 mmol) was added portionwise, followed by addition of CNBr (5.4 g, 51.2 mmol). The reaction mixture was stirred at rt for 18 h. The solid formed was filtered, washed with water, and dried under vacuum to afford 11.5 g of the corresponding oxadiazole product. 3-Pyridinylboronic acid (7 g, 57.5 mmol), and potassium carbonate (8.6 g, 62.3 mmol) were added to the oxadiazole (11.5 g) in a mixture of 1,4-dioxane (120 mL) and water (30 mL). To this mixture, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (2.35 g, 3.4 mmol) was added, and the reaction mixture was heated under nitrogen at 110 °C for 3 h. After that time solvents were evaporated under vacuum. Water was added to the reaction mixture and stirred for 10 min. Solid obtained was filtered and washed with EtOAc to afford 7.5 g of <b>Int-B</b> as a brown solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.00 (d, <i>J</i> = 1.8 Hz, 1H), 8.64–8.76 (m, 1H), 8.17–8.26 (m, 1H), 8.13 (s, 1H), 7.86–8.00 (m, 2H), 7.75 (s, 1H), 7.56–7.67 (m, 1H), 7.38 ppm (s, 2H). MS: <i>m</i>/<i>e</i> 239 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (276 nm). <i>R</i><sub>t</sub>: 0.86 min (Acquity UPLC BEH C18 1.7 m, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Bromo-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazole (<b>Int-C</b>)</h4><div class="NLM_p last">To a suspension of 5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (300 mg, 1.3 mmol) in ACN (18 mL) was added copper(II) bromide (844 mg, 3.8 mmol); after 10 min, <i>tert</i>-butyl nitrite (0.6 mL, 5 mmol) was added. The reaction mixture was refluxed for 30 min, and then heating was stopped. ACN was evaporated, and the reaction mixture was diluted with a mixture of DCM/MeOH 5%, washed with a saturated aqueous solution of NaHCO<sub>3,</sub> and brine. The organic phase was dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure to afford 270 mg of an orangish oil which was purified on a silica gel cartridge to obtain 100 mg of <b>Int-C</b> (0.3 mmol). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.05 (d, <i>J</i> = 2.0 Hz, 1H), 8.71 (dd, <i>J</i> = 4.8, 1.3 Hz, 1H), 8.33 (s, 1H), 8.22–8.30 (m, 1H), 8.07–8.19 (m, 2H), 7.76–7.87 (m, 1H), 7.56–7.67 ppm (m, 1H). MS: <i>m</i>/<i>e</i> 302 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (251 nm). <i>R</i><sub>t</sub>: 1.03 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(2-Methylisoindolin-5-yl)-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>6</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route B: 2-Methylisoindolin-5-amine (49 mg, 0.3 mmol) was added to a suspension of <b>Int-C</b> (100 mg, 0.3 mmol) in 1,4-dioxane (2.5 mL) under nitrogen atmosphere. The resulting reaction mixture was degassed for 15 min. Sodium <i>tert</i>-butoxide (49 mg, 0.8 mmol), XantPhos (17.3 mg, 0.03 mmol), and Pd<sub>2</sub>(dba)<sub>3</sub> (27 mg, 0.03 mmol) were added to the reaction mixture and degassed for 15 min and heated at 110 °C for 3 h. The reaction mixture was poured into water (15 mL) and extracted with EtOAc (2 × 50 mL). The combined organic layers were washed with brine (20 mL), dried over anhydrous sodium sulfate, and concentrated under vacuum to give a crude material that was purified through a silica gel cartridge and repurified by semipreparative HPLC to afford 25 mg of <b>6</b> (0.06 mmol, 21% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59–10.91 (m, 1H), 9.02 (d, <i>J</i> = 2.02 Hz, 1H), 8.72 (dd, <i>J</i> = 1.30, 4.80 Hz, 1H), 8.23–8.25 (m, 1H), 8.22 (s, 1H), 8.01 (t, <i>J</i> = 7.60 Hz, 2H), 7.79 (t, <i>J</i> = 8.10 Hz, 1H), 7.61 (br s, 2H), 7.49 (dd, <i>J</i> = 2.30, 8.30 Hz, 1H), 7.28 (d, <i>J</i> = 8.08 Hz, 1H), 3.89 (s, 2H), 3.84 (s, 2H), 2.55 (s, 3H). MS: <i>m</i>/<i>e</i> 370 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (254 nm). <i>R</i><sub>t</sub>: 0.92 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-Phenyl-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>7</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route A: A solution of 3-bromobenzohydrazide (1.6 g, 7.4 mmol), and phenyl isothiocyanate (1 g, 7.4 mmol) in 10 mL of anydrous THF were stirred and heated at 60 °C for 20 h. Reaction mixture was allowed to cool down to rt. Solvent was evaporated under reduced pressure to give a crude material that was triturated with diethyl eter. The resulting solid was filtered to give 2-(3-bromobenzoyl)-<i>N</i>-phenylhydrazine carbodiimide (2 g) that was subsequently dissolved in 8 mL of anhydrous DMF and stirred at 80 °C for 2 h with EDCI (1.4 g, 7.4 mmol). The reaction mixture was diluted with water (50 mL) and extracted with EtOAc (2 × 60 mL). Combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated to dryness to give 1.2 g of the corresponding <b>Int-A</b>: 5-(3-bromophenyl)-<i>N</i>-phenyl-1,3,4-oxadiazol-2-a (3.8 mmol, 66% yield). Then 100 mg of the corresponding <b>Int-A</b> (0.3 mmol) were charged on a 25 mL microwave vial with 3-pyridinylboronic acid (39 mg, 0.3 mmol), potassium carbonate (175 mg, 1.3 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (7.3 mg, 6.3 μmol). The vial was sealed and purged with Ar several times. Finally, a 6 mL solution of a 1:1 mixture of toluene/ethanol was added, and the resulting reaction mixture was irradiated in the microwave for 1 h at 85 °C. Reaction mixture was diluted with EtOAc and washed with water. The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to dryness. The crude was purified on a silica gel cartridge to afford 50 mg of <b>7</b> (0.15 mmol, 55% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1H), 8.75 (d, <i>J</i> = 3.79 Hz, 1H), 8.27 (s, 1H), 8.09 (d, <i>J</i> = 7.58 Hz, 1H), 8.02 (td, <i>J</i> = 1.83, 7.96 Hz, 1H), 7.73–7.83 (m, 1H), 7.60–7.72 (m, 3H), 7.46–7.58 (m, 3H), 7.35 (s, 1H), 7.21 (t, <i>J</i> = 7.33 Hz, 1H). MS: <i>m</i>/<i>e</i> 315 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (299 nm). <i>R</i><sub>t</sub>: 1.19 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-(3-(Pyridin-3-yl)phenyl)-<i>N</i>-(3-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-amine (<b>8</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route B: To a suspension of <b>Int-C</b> (60 mg, 0.19 mmol) in ethanol (2 mL), 3-(trifluoromethyl)aniline (0.05 mL, 0.4 mmol) was added and the reaction mixture was refluxed for 3 h. Solvent was evaporated under vacuum to give a crude material that was purified on a silica gel cartridge to afford 15 mg of <b>8</b> (0.03 mmol, 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99–11.37 (m, 1H), 8.96 (d, <i>J</i> = 1.77 Hz, 1H), 8.65 (d, <i>J</i> = 3.79 Hz, 1H), 8.16 (br s, 2H), 8.09 (s, 1H), 7.96 (t, <i>J</i> = 7.20 Hz, 2H), 7.79–7.89 (m, 1H), 7.74 (t, <i>J</i> = 8.30 Hz, 1H), 7.62 (t, <i>J</i> = 8.60 Hz, 1H), 7.55 (tt, <i>J</i> = 4.80, 7.80 Hz, 1H), 7.39 (d, <i>J</i> = 7.33 Hz, 1H). MS: <i>m</i>/<i>e</i> 383 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (282 nm). <i>R</i><sub>t</sub>: 1.20 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(3-Chlorophenyl)-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>9</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route B: To a suspension of <b>Int-C</b> (60 mg, 0.2 mmol) in ethanol (2 mL), 3-chloroaniline (50.7 mg, 0.4 mmol) was added. The mixture was refluxed overnight. Solvent was evaporated under vacuum to give a crude material that was purified on a silica gel cartridge to give 5 mg of <b>9</b> (0.01 mmol, 7% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.94–11.28 (m, 1H), 9.03 (d, <i>J</i> = 2.02 Hz, 1H), 8.75 (tt, <i>J</i> = 1.30, 4.80 Hz, 1H), 8.23 (d, <i>J</i> = 1.52 Hz, 2H), 8.03 (br s, 2H), 7.87 (t, <i>J</i> = 2.00 Hz, 1H), 7.81 (t, <i>J</i> = 7.80 Hz, 1H), 7.58–7.66 (m, 2H), 7.48 (t, <i>J</i> = 7.80 Hz, 1H), 7.12–7.19 (m, 1H). MS: <i>m</i>/<i>e</i> 349 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (282 nm). <i>R</i><sub>t</sub>: 1.17 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 5-(2-Fluoro-5-(pyridin-3-yl)phenyl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>10</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route A: To a previously cooled at 0 °C solution of 2-methyl-1,2,3,4-tetrahydroisoquinolin-7-amine (1 g, 6.2 mmol) and triethylamine (1.3 mL, 9.2 mmol) in DCM (100 mL), thiophosgene (0.7 mL, 9.2 mmol) was added dropwise over 15 min period. The reaction mixture was stirred at 0 °C for 1 h, and the solvent was evaporated under vacuum to give a crude material that was washed with Et<sub>2</sub>O. The resulting solid was combined with 5-bromo-2-fluorobenzohydrazide (350 mg, 1.5 mmol) in THF (25 mL). The reaction mixture was stirred at rt overnight, and then 2 h under reflux. Solvent was evaporated under vacuum to give a crude material that was dissolved in ethanol (20 mL). <i>N</i>,<i>N</i>′-Dicyclohexylcarboxamide (310 mg, 1.5 mmol) was added, and the mixture was stirred at rt under N<sub>2</sub> atm. for 48 h. Solvent was evaporated under vacuum to give a crude material that was dissolved in EtOAc, and brine was added. Phases were separated in a separative funnel, and the organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated to give a crude material that was purified on a silica gel cartridge to obtain the corresponding <b>Int-A</b> (MS: <i>m</i>/<i>e</i> 404 (MH<sup>+</sup>)). 5-(5-Bromo-2-fluorophenyl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>Int-A</b>) (330 mg, 0.8 mmol), 3-pyridinylboronic acid (121 mg, 1 mmol) in 1,4-dioxane (12 mL) were combined with K<sub>2</sub>CO<sub>3</sub> (339 mg, 2.4 mmol) in water (4 mL). This mixture was degassed with a steady stream of nitrogen for 30 min at rt, and PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (15.8 mg, 0.02 mmol) was added. The reaction mixture was degassed with N<sub>2</sub> for 5 min and heated under nitrogen at 110 °C for 5 h and at rt overnight. More 3-pyridinylboronic acid (201 mg, 1.7 mmol) was added, and the reaction mixture was heated at 110 °C for 3 h. After that time, the solvent was evaporated to dryness to give a crude material that was dissolved in DCM, filtered, and washed with water and brine. The organic layer was dried over anhydrous sodium sulfate and filtered, and the solvent was evaporated under vacuum to afford a crude material. It was purified using a silica gel cartridge to obtain a brown oil which was purified by semipreparative HPLC to afford 55 mg of <b>10</b> (0.13 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (s, 1H), 8.93 (d, <i>J</i> = 2.02 Hz, 1H), 8.62 (dd, <i>J</i> = 1.52, 4.80 Hz, 1H), 8.08–8.19 (m, 2H), 7.93–8.02 (m, 1H), 7.61 (dd, <i>J</i> = 8.72, 10.48 Hz, 1H), 7.48–7.55 (m, 1H), 7.29–7.38 (m, 2H), 7.09 (d, <i>J</i> = 8.08 Hz, 1H), 3.48 (br s, 2H), 2.76 (t, <i>J</i> = 5.68 Hz, 2H), 2.53–2.63 (m, 2H), 2.33 (s, 3H). MS: <i>m</i>/<i>e</i> 402 (MH<sup>+</sup>). Purity was determined as 95% by HPLC (250 nm). <i>R</i><sub>t</sub>: 0.94 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 5-(3-Fluoro-5-(pyridin-3-yl)phenyl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>11</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route A: To a previously cooled at 0 °C solution of 2-methyl-1,2,3,4-tetrahydroisoquinolin-7-amine, hydrochloride (300 mg, 1.5 mmol) and triethylamine (0.5 mL, 3.8 mmol) in DCM (20 mL) and thiophosgene (0.2 mL, 2.3 mmol) was added dropwise. The mixture was stirred at 0 °C for 1 h, and the solvent was evaporated. The residue (308 mg, 1.5 mmol) was combined with 3-bromo-5-fluorobenzhydrazide (351 mg, 1.5 mmol) in THF (35 mL) and heated at 60 °C for 3 h. 3-Bromo-5-fluorobenzohydrazide (351 mg, 1.5 mmol) was added and heated at 60 °C for 2 h more. Then, a third addition of 3-bromo-5-fluorobenzohydrazide (702 mg, 3 mmol) was carried out and the reaction mixture was heated at 60 °C overnight. Solvent was removed under vacuum to give a crude material that was triturated with <sup><i>t</i></sup>BuOMe. The solid (659 mg) was filtered off and dissolved in ethanol (10 mL), and <i>N</i>,<i>N</i>′-dicyclohexylcarboxamide (311 mg, 1.5 mmol) was added and stirred at rt under N<sub>2</sub> atmosphere overnight. DCC (0.5 equiv) was added, and the mixture was heated at 60 °C for 3 h and stirred at rt overnight. Ethanol was removed under vacuum to give a crude material that was dissolved in EtOAc and washed with brine. Phases were separated in a separative funnel, and the organic layer was dried over anhydrous sodium sulfate, filtered, and evaporated to give a crude material that was chromatographied on a silica gel cartridge to obtain the corresponding <b>Int-A</b> (MS: <i>m</i>/<i>e</i> 404 (MH<sup>+</sup>)) (270 mg, 0.7 mmol). 5-(3-Bromo-5-fluorophenyl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>Int-A</b>) (270 mg, 0.7 mmol) and 3-pyridinylboronic acid (206 mg, 1.7 mmol) in 1,4-dioxane (12 mL) were combined with potassium carbonate (278 mg, 2 mmol) in water (4 mL). This mixture was desgassed with a steady stream of N<sub>2</sub> for 30 min at rt, and PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (25.8 mg, 0.03 mmol) was added. The reaction mixture was degassed with N<sub>2</sub> for 5 min and then heated under nitrogen at 110 °C for 5 h. After that time, the reaction was concentrated to dryness, dissolved in DCM, and washed with water, phases were separated in a separative funnel, and the organic layer was washed with brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under vacuum to obtain a crude material that was purified on a silica gel cartridge to give 115 mg of <b>11</b> (0.3 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.66(s, 1H), 9.0 (d, <i>J</i> = 2.02 Hz, 1H), 8.68 (dd, <i>J</i> = 1.26, 4.80 Hz, 1H), 8.0–8.22 (m, 1H), 8.0 (s, 1H), 7.9 (d, <i>J</i> = 9.85 Hz, 1H), 7.60 (d, <i>J</i> = 8.84 Hz, 1H), 7.57 (dd, <i>J</i> = 4.80, 7.83 Hz, 1H), 7.33–7.36 (m, 2H), 7.17 (d, <i>J</i> = 8.08 Hz, 1H), 3.50 (s, 2H), 2.78 (t, <i>J</i> = 5.68 Hz, 2H), 2.58–2.61 (m, 2H), 2.35 (s, 3H). MS: <i>m</i>/<i>e</i> 402 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (251 nm). <i>R</i><sub>t</sub>: 0.97 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-(4-Fluoro-3-(pyridin-3-yl)phenyl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>12</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route A: To a previously cooled at 0 °C solution of 2-methyl-1,2,3,4-tetrahydroisoquinolin-7-amine (1 g, 6.2 mmol) and triethylamine (1.3 mL, 9.2 mmol) in DCM (100 mL), thiophosgene (0.7 mL, 9.2 mmol) was added dropwise over 15 min period, and the reaction mixture was stirred at 0 °C for 1 h. After that time, the solvent was evaporated under vacuum to give a solid that was washed with Et<sub>2</sub>O. The resulting solid (920 mg) and 3-bromo-4-fluorobenzohydrazide (350 mg, 1.5 mmol) were combined in THF (25 mL), and the reaction mixture was stirred at rt for 48 h and refluxed for 2 h. The solvent was stripped off to give 657 mg of a crude material that was dissolved in ethanol (20 mL), and DCC (310 mg, 1.5 mmol) was added. Reaction mixture was stirred at rt under nitrogen atmosphere for 48 h, and after that time the solvent was removed under vacuum to give crude material that was dissolved in EtOAc and washed with brine. Phases were separated in a separative funnel, and the organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered, and the solvent was evaporated to give a crude material that was purified using a silica gel cartridge to give the corresponding <b>Int-A</b> (MS: <i>m</i>/<i>e</i> 404 (MH<sup>+</sup>). 5-(3-Bromo-4-fluorophenyl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (105 mg, 0.3 mmol) and 3-pyridinylboronic acid (38.4 mg, 0.3 mmol) in 1,4-dioxane (10 mL) were combined with potassium carbonate (108 mg, 0.8 mmol) in water (3 mL). This mixture was degassed with a steady stream of nitrogen for 30 min at rt. To this mixture, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (5 mg, 5.2 μmol) was added, and the reaction mixture was degassed with nitrogen for 5 min and heated under nitrogen atm at 110 °C for 5 h and at rt overnight. After that time, the reaction mixture was concentrated to dryness, dissolved in DCM, filtered, and washed with water. Phases were separated in a separative funnel, and the organic layer was washed with brine, dried over anhyd Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was evaporated to give a crude material that was purified on a silica gel cartridge to obtain a brown oil which was purified by semipreparative HPLC to obtain 21 mg of <b>12</b> (0.05 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (s, 1H), 8.82 (s, 1H), 8.66 (dd, <i>J</i> = 1.64, 4.67 Hz, 1H), 8.03–8.10 (m, 1H), 7.89–8.03 (m, 2H), 7.51–7.68 (m, 2H), 7.28–7.38 (m, 2H), 7.08 (d, <i>J</i> = 8.34 Hz, 1H), 3.47 (br s, 2H), 2.75 (m, 2H), 2.51–2.62 (m, 2H), 2.33 (s, 3H). MS: <i>m</i>/<i>e</i> 402 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (250 nm). <i>R</i><sub>t</sub>: 0.96 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-5-(3-(pyridin-3-yl)-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazol-2-amine (<b>13</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route A: To a previously cooled at 0 °C solution of 2-methyl-1,2,3,4-tetrahydroisoquinolin-7-amine, hydrochloride (200 mg, 1 mmol), and triethylamine (0.4 mL, 2.5 mmol) in DCM (15 mL), thiophosgene (0.1 mL, 1.5 mmol) was added dropwise. The mixture was stirred at 0 °C for 90 min. After that time, more thiophosgene (0.1 mL) was added, and the reaction mixture was stirred for 10 min at this temperature. After that time, solvent was evaporated under vacuum to give 206 mg of a crude material. This crude material and 3-bromo-5-(trifluoromethoxy)benzhydrazide (302 mg, 1 mmol) were combined in THF (15 mL) and stirred at room temperature overnight. More 3-bromo-5-(trifluoromethoxy)benzohydrazide (302 mg, 1 mmol) was added and heated at 50 °C for 3 h. Solvent was removed under vacuum to afford 659 mg of a crude material. This crude material was dissolved in ethanol (20 mL) and DCC (351 mg, 1.7 mmol) was added, and the reaction mixture was stirred at rt under N<sub>2</sub> atm overnight. DCC (135 mg, 0.6 mmol) was added and the mixture was heated at 60 °C for 3 h and stirred at rt overnight. Ethanol was removed under vacuum to give a crude material that was dissolved in EtOAc, filtered, and washed with water. Phases were separated in a separative funnel, and the organic layer was washed with brine, dried over anhyd Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was evaporated under vacuum to give a crude material that was purified using a silica gel cartridge to obtain the corresponding <b>Int-A</b> (MS: <i>m</i>/<i>e</i> 469 (MH<sup>+</sup>)). 5-(3-Bromo-5-(trifluoromethoxy)phenyl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (110 mg, 0.2 mmol) and 3-pyridinylboronic acid (72 mg, 0.6 mmol) in 1,4-dioxane (9 mL) were combined with potassium carbonate (97 mg, 0.7 mmol) in water (3 mL). This mixture was desgassed with a steady stream of nitrogen for 30 min at rt. PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (9 mg, 9.4 μmol) was added, and the reaction mixture was degassed with a steady stream of N<sub>2</sub> and then heated under nitrogen at 110 °C for 5 h. The solvent was evaporated to dryness to give a crude material that was dissolved in DCM and washed with water. Phases were separated in a funnel, the organic layer was washed with brine, dried over anhyd Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was evaporated to give a crude material that was was purified on a silica gel cartridge to give 77 mg of <b>13</b> (0.2 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.67 (s, 1H), 9.00 (m, 1H), 8.67 (dd, <i>J</i> = 1.52, 4.80 Hz, 1H), 8.18–8.26 (m, 1H), 8.16 (t, <i>J</i> = 1.39 Hz, 1H), 7.98 (s, 1H), 7.76–7.85 (m, 1H), 7.52–7.60 (m, 1H), 7.33–7.39 (m, 1H), 7.32 (d, <i>J</i> = 2.02 Hz, 1H), 7.09 (d, <i>J</i> = 8.34 Hz, 1H), 3.47 (s, 2H), 2.71–2.81 (m, 2H), 2.54–2.61 (m, 2H), 2.33 (s, 3H). MS: <i>m</i>/<i>e</i> 468 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (250 nm). <i>R</i><sub>t</sub>: 1.09 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-(2-Methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-5-(3-(pyridin-3-yl)-5-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-amine (<b>14</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route A: To a previously cooled at 0 °C solution of 2-methyl-1,2,3,4-tetrahydroisoquinolin-7-amine (1.9 g, 12 mmol) and triethylamine (2.5 mL, 18 mmol) in DCM (190 mL), thiophosgene (1.4 mL, 18 mmol) was added dropwise over 15 min. The mixture was stirred at 0 °C, and the solvent was evaporated under vacuum to give 1.85 g of a crude material. Then 750 mg (2.65 mmol) of this crude were combined with 7-isothiocyanato-2-methyl-1,2,3,4-tetrahydroisoquinoline (0.7 g, 3.2 mmol) in THF (15 mL) and stirred at 60 °C for 3 h and at rt overnight. The solvent was evaporated under reduced pressure, and the resulting crude material was combined with <i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide (0.6 g, 3.2 mmol) in ethanol (20 mL) and stirred at rt for 48 h. The solvent was evaporated under reduced pressure, and the crude was purified on a silica gel cartridge to afford 0.5 g the corresponding <b>Int-A</b> (1 mmol, 40% yield). This solid was combined with 3-pyridinylboronic acid (156 mg, 1.2 mmol), potassium carbonate (439 mg, 3.2 mmol), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (82 mg, 0.1 mmol) in a microwave vial, and it was sealed and then purged with Ar. A 3.5 mL solution of a mixture of toluene/ethanol (1:1) was added, and the resulting solution was irradiated in the microwave at 100 °C for 150 min. After this time, more 3-pyridinylboronic acid (27 mg, 0.2 mmol) and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (8 mg, 0.01 mmol) were added. The reaction mixture was irradiated for 30 min more at the same temperature. The reaction mixture was filtered through Celite and washed with EtOH. The solvent was evaporated under vacuum to give a crude material that was dissolved in a mixture of DCM:MeOH (5%) and washed with water. Phases were separated in a funnel, and the organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to give a crude material that was purified on a amino silica gel cartridge to give 300 mg of white solid that was triturated with <sup><i>t</i></sup>BuOMe. The resulting solid was filtered, rinsed with more <sup><i>t</i></sup>BuOMe, and collected to afford 125 mg of <b>14</b> (0.27 mmol, 26% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.63–10.88 (m, 1H), 9.12 (d, <i>J</i> = 2.0 Hz, 1H), 8.76 (dd, <i>J</i> = 4.8, 1.3 Hz, 1H), 8.47 (s, 1H), 8.36 (s, 1H), 8.33 (br s, 1H), 8.21 (s, 1H), 7.61–7.69 (m, 1H), 7.43 (s, 1H), 7.40 (s, 1H), 7.17 (d, <i>J</i> = 8.3 Hz, 1H), 3.55 (s, 2H), 2.84 (t, <i>J</i> = 5.4 Hz, 2H), 2.65 (t, <i>J</i> = 5.7 Hz, 2H), 2.41 ppm (s, 3H). MS: <i>m</i>/<i>e</i> 452 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (311 nm). <i>R</i><sub>t</sub>: 1.06 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-(7-Methyl-5,6,7,8-tetrahydro-1,7-naphthyridin-2-yl)-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>15a</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route B: 150 mg of <b>Int-B</b> were added to a stirring solution of 2-chloro-7-methyl-5,6,7,8-tetrahydro-1,7-naphthyridine (114 mg, 0.6 mmol) in 1,4- dioxane (10 mL), and NaO<sup><i>t</i></sup>Bu (151 mg, 1.6 mmol) were added under nitrogen atmosphere. The mixture was degassed for 15 min. Xantphos (36 mg, 0.06 mmol) and Pd<sub>2</sub>(dba)<sub>3</sub> (57 mg, 0.06 mmol) were added to the reaction mixture and degassed for 15 min. After 2 h heating at 110 °C, the reaction mixture was filtered under reduced pressure and the solvent was evaporated to give a crude material that was purified using a silica gel cartridge. Then it was further purified by preparative HPLC to afford <b>15a</b> (12 mg, 5%) as an off-white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 11.15–11.48 (m, 1H), 8.97–9.07 (m, 1H), 8.65–8.74 (m, 1H), 8.22 (d, <i>J</i> = 1.5 Hz, 2H), 8.00 (s, 2H), 7.82 (s, 2H), 7.66–7.72 (m, 1H), 7.58–7.65 (m, 1H), 3.55 (s, 2H), 2.81–2.88 (m, 2H), 2.69 (s, 2H), 2.44 ppm (s, 3H). MS: <i>m</i>/<i>e</i> 385 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (301 nm). <i>R</i><sub>t</sub>: 0.97 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-(6-Methyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>15b</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route B: To a stirred solution of <b>Int-C</b> (0.25 g, 0.8 mmol) in 1,4-dioxane (15 mL), 6-methyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine (0.16 g, 1 mmol) and sodium <i>tert</i>-butoxide (0.2 g, 2 mmol) were added at rt, and the reaction mixture was degassed for 15 min. Xantphos (0.05 g, 0.08 mmol) and Pd<sub>2</sub>(dba)<sub>3</sub> (0.08 g, 0.08 mmol) were added, and the reaction mixture was again degassed for 15 min and heated at 110 °C for 1 h. After that time, the reaction mixture was poured into water, extracted with EtOAc, and washed with brine solution. The organic layer was dried over anhydrous sodium sulfate and the solvent was evaporated under vacuum to give a crude material that was purified on a silica gel cartridge, followed by purification by preparative HPLC to afford 25 mg of <b>15b</b> (0.06 mmol, 8% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.00 (br s, 1 H), 9.05 (br s, 1 H), 8.64 (br s, 2 H), 8.17–8.28 (m, 2 H), 7.98–8.06 (m, 2 H), 7.89 (s, 1 H), 7.76–7.85 (m, 1 H), 7.64 (br s, 1 H), 3.78 (br s, 2 H), 2.82–3.04 (m, 4 H), 2.54 ppm (s, 3H). MS: <i>m</i>/<i>e</i> 385 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (252 nm). <i>R</i><sub>t</sub>: 0.92 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-(Pyridin-3-yl)-5-(trifluoromethyl)benzohydrazide (<b>Int-E</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route C: To a solution of methyl 3-bromo-5-(trifluoromethyl)benzoate (1 g, 3.5 mmol), pyridin-3-ylboronic acid (0.6 g, 4.6 mmol), and PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.05 g, 0.07 mmol) in toluene (10 mL), a suspension of potassium carbonate (1.5 g, 10.6 mmol) in ethanol (2.5 mL) was added. The reaction mixture was degassed with a steady stream of N<sub>2</sub>, and then irradiated in the microwave at 100 °C for 3 h. The reaction mixture was filtered through Celite, and the solvent was evaporated under vacuum to afford a crude that was purified using a silica gel cartridge to give 870 mg of methyl 3-(pyridin-3-yl)-5-(trifluoromethyl)benzoate [MS: <i>m</i>/<i>e</i> 295 (MH<sup>+</sup>)]. This compound was dissolved in ethanol (10 mL) and hydrazine hydrate (1.8 mL, 37 mmol) was added and stirred at 60–70 °C for 2 h. Solvent and hydrazine were evaporated to dryness to afford 800 mg of a pale-yellow solid which corresponds to <b>Int-E.</b><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.16 (br s, 1H), 9.05 (d, <i>J</i> = 1.8 Hz, 1H), 8.66 (dd, <i>J</i> = 4.5, 1.3 Hz, 1H), 8.45 (s, 1H), 8.21–8.30 (m, 2H), 8.17 (s, 1H), 7.56 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 4.64 ppm (br s, 2H).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(6-Methyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-yl)-5-(3-(pyridin-3-yl)-5-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-amine (<b>15c</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route C: <b>Int-E</b> (0.45 g, 1.6 mmol) and 3-isothiocyanato-6-methyl-5,6,7,8-tetrahydro-1,6-naphthyridine (0.3 g, 1.6 mmol) were combined in ethanol (11 mL), and stirred at 60 °C for 90 min. Ethanol was removed under vacuum to give a crude material that was dissolved in EtOAc, brine was added, and the phases were separated in a funnel. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and filtered, and the solvent was evaporated under vacuum to give a material that was purified on a silica gel cartridge to give 427 mg of <b>15c</b> (0.9 mmol, 59% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.91–11.03 (m, 1 H), 9.05 (d, <i>J</i> = 1.77 Hz, 1 H), 8.69 (dd, <i>J</i> = 4.80, 1.52 Hz, 1 H), 8.55 (d, <i>J</i> = 2.53 Hz, 1 H), 8.41 (s, 1 H), 8.30 (s, 1 H), 8.25–8.29 (m, 1 H), 8.15 (s, 1 H), 7.78 (d, <i>J</i> = 2.53 Hz, 1 H), 7.58 (ddd, <i>J</i> = 7.83, 4.55, 0.76 Hz, 1 H), 3.55 (s, 2 H), 2.86 (s, 2 H), 2.64–2.74 (m, 2 H), 2.37 (s, 3 H). MS: <i>m</i>/<i>e</i> 453 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (249 nm). <i>R</i><sub>t</sub>: 1.02 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(4-((Dimethylamino)methyl)phenyl)-5-(3-(pyridin-3-yl)phenyl)-1,3,4-oxadiazol-2-amine (<b>16a</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route B: 4-((dimethylamino)methyl)aniline hydrochloride (16.7 mg, 0.09 mmol) was dissolved in ethanol (2 mL) under N<sub>2</sub> atmosphere, and <b>Int-C</b> (27 mg, 0.09 mmol) was added. The reaction mixture was heated at 80 °C during 3 h and at rt overnight. Then 30 mg more of the aniline were added, and the reaction mixture was heated 2 h at 80 °C. Solvent was evaporated under reduced pressure to give a crude material that was purified by preparative HPLC to give 20 mg of <b>16a</b> (0.05 mmol, 60% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.91 (d, <i>J</i> = 2.27 Hz, 1 H), 8.67 (dd, <i>J</i> = 4.80, 1.77 Hz, 1 H), 8.19 (t, <i>J</i> = 1.52 Hz, 1 H), 8.01 (dt, <i>J</i> = 7.77, 1.29 Hz, 1 H), 7.95 (dt, <i>J</i> = 8.34, 1.89 Hz, 1 H), 7.72 (dt, <i>J</i> = 8.08, 1.39 Hz, 1 H), 7.58–7.65 (m, 1 H), 7.52 (d, <i>J</i> = 8.59 Hz, 3 H), 7.40–7.45 (m, 1 H), 7.35 (d, <i>J</i> = 8.34 Hz, 2 H), 3.42 (s, 2 H), 2.26 (s, 6 H). MS: <i>m</i>/<i>e</i> 372 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (254 nm). <i>R</i><sub>t</sub>: 0.90 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(4-((Dimethylamino)methyl)phenyl)-5-(3-(pyridin-3-yl)-5-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-amine (<b>16b</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route C: A solution of <b>Int-E</b> (0.15 g, 0.5 mmol) and 1-(4-isothiocyanatophenyl)-<i>N</i>,<i>N</i>-dimethylmethanamine (0.1 g, 0.5 mmol in THF (1 mL) was stirred at 60 °C for 30 min. Solvent was evaporated under vacuum to give a crude material that was combined with DCC (125 mg, 0.6 mmol) in EtOH (10 mL), and the reaction mixture was stirred at 60 °C for 1 h. Solvent was evaporated under reduced pressure to give a crude material that was purified on a silica gel cartridge to afford 210 mg of <b>16b</b> (0.5 mmol, 79% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.80 (s, 1H), 9.05 (d, <i>J</i> = 2.0 Hz, 1H), 8.65–8.75 (m, 1H), 8.42 (s, 1H), 8.29 (s, 1H), 8.25–8.27 (m, 1H), 8.15 (s, 1H), 7.55–7.62 (m, 3H), 7.29 (d, <i>J</i> = 8.6 Hz, 2H), 3.36–3.38 (m, 2H), 2.15 ppm (s, 6H). MS: <i>m</i>/<i>e</i> 440 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (307 nm). <i>R</i><sub>t</sub>: 1.02 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-(3-(Pyridin-3-yl)-5-(trifluoromethyl)phenyl)-<i>N</i>-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2-amine (<b>17a</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route C: A solution of <b>Int-E</b> (0.1 g, 0.5 mmol) and 1-(4-isothiocyanatobenzyl)pyrrolidine (0.1 g, 0.5 mmol) in THF (1 mL) was stirred at 60 °C for 30 min. The solvent was evaporated under reduced pressure, affording a pale-yellow solid (240 mg, 0.480 mmol). The product and DCC (99 mg, 0.5 mmol) were combined in EtOH (10 mL) and stirred at 60 °C for 1 h. The solvent was evaporated under reduced pressure, and the crude material was purified using a silica gel cartridge to give 111 mg of <b>17a</b> (0.2 mmol, 49% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.81–10.92 (m, 1H), 9.12 (d, <i>J</i> = 2.0 Hz, 1H), 8.76 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.49 (s, 1H), 8.32–8.39 (m, 2H), 8.23 (s, 1H), 7.62–7.69 (m, 3H), 7.39 (d, <i>J</i> = 8.1 Hz, 2H), 3.56–3.77 (m, 2H), 2.47–2.55 (m, 2H), 1.78 ppm (br s, 4H). CH<sub>2</sub> signal not visible in the spectrum conditions. MS: <i>m</i>/<i>e</i> 466 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (307 nm). <i>R</i><sub>t</sub>: 1.02 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(6-((Dimethylamino)methyl)pyridin-3-yl)-5-(3-(pyridin-3-yl)-5-(trifluoromethyl)phenyl)-1,3,4-oxadiazol-2-amine (<b>17b</b>)</h4><div class="NLM_p last"><a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route C: <b>Int-E</b> (138 mg, 0.5 mmol) and 1-(5-isothiocyanatopyridin-2-yl)-<i>N</i>,<i>N</i>-dimethylmethanamine (95 mg, 0.5 mmol) were combined in ethanol (5 mL) and stirred at 60 °C for 2 h. Then EDC (94 mg, 0.5 mmol) was added, and the reaction remained at rt overnight. The reaction mixture was concentrated to dryness and redissolved in water and EtOAc. Phases were separated in a separative funnel, and the organic layer was washed with brine, dried over anhydrous sodium sulfate, and filtered, and solvent was evaporated to obtain a crude material that was purified on a silica gel cartridge to afford 28 mg of <b>17b</b> (0.06 mmol, 12% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.91–11.18 (m, 1H), 9.03–9.09 (m, 1H), 8.67–8.77 (m, 2H), 8.39–8.46 (m, 1H), 8.30–8.32 (m, 1H), 8.25–8.30 (m, 1H), 8.15–8.19 (m, 1H), 8.05–8.10 (m, 1H), 7.55–7.61 (m, 1H), 7.41–7.48 (m, 1H), 3.51 (s, 2H), 2.20 ppm (s, 6H). MS: <i>m</i>/<i>e</i> 441 (MH<sup>+</sup>). Purity was determined as 95% by HPLC (252 nm). <i>R</i><sub>t</sub>: 0.99 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Methyl [3,4′-Bipyridine]-2′-carboxylate (<b>Int-18a</b>)</h4><div class="NLM_p last">A solution of 3-pyridinylboronic acid (537 mg, 4.4 mmol), methyl 4-bromopicolinate (786 mg, 3.6 mmol), and cesium carbonate (2.4 g, 7.3 mmol) in a mixture of ACN (20 mL) and water (10 mL) was degassed with Ar and stirred for 15 min. To this solution was added [1,1′-bis(diphenylphosphino)ferrocene]dichloro-palladium(II) (297 mg, 0.4 mmol) and bubbled with argon for another 15 min and stirred at 60 °C under argon overnight. The reaction mixture was filtered through Celite, the aqueous layer was extracted with EtOAc, and the organic phase was washed with a 1 N aqueous solution of NaOH, water, and brine. Organic layer was dried over sodium sulfate, filtered through silica gel, and evaporated under vacuum to give a crude material that was purified using a silica gel cartridge to give 86 mg of <b>Int-18a</b> (0.4 mmol, 11% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.14 (d, <i>J</i> = 2.0 Hz, 1H), 8.89 (d, <i>J</i> = 5.1 Hz, 1H), 8.78 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.44 (d, <i>J</i> = 1.3 Hz, 1H), 8.37 (dt, <i>J</i> = 8.1, 1.9 Hz, 1H), 8.14 (dd, <i>J</i> = 5.1, 1.8 Hz, 1H), 7.65 (dd, <i>J</i> = 7.6, 4.8 Hz, 1H), 4.00 ppm (s, 3H).</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 5-([3,4′-Bipyridin]-2′-yl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>18a</b>)</h4><div class="NLM_p last">To a solution of methyl [3,4′-bipyridine]-2′-carboxylate (<b>Int-18a</b>) (84 mg, 0.4 mmol) in ethanol (5 mL) was added hydrazine monohydrate (0.2 mL, 4.4 mmol) and stirred at rt overnight. The reaction mixture was evaporated under vacuum to obtain a yellow solid, and toluene was added in order to remove water and evaporated under vacuum to give 102 mg of [3,4′-bipyridine]-2′-carbohydrazide as a whitish solid. The hydrazide and 7-isothiocyanato-2-methyl-1,2,3,4-tetrahydroisoquinoline (97 mg, 0.5 mmol) were combined in THF (10 mL) and stirred at 60 °C for 2 h. Solvent was evaporated under reduced pressure to give a crude material that was combined with DCC (98 mg, 0.5 mmol) in ethanol (20 mL). The reaction mixture was stirred at 80 °C for 2 h. After this time, ethanol was removed under vacuum to give a crude material that was dissolved in EtOAc, and brine was added. Phases were separated in a separative funnel, and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and the solvent was evaporated under vacuum to give a crude material that was purified on a silica amino cartridge to afford 56 mg of <b>18a</b> (0.15 mmol, 30% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.72–10.89 (m, 1H), 9.17 (d, <i>J</i> = 1.8 Hz, 1H), 8.90 (d, <i>J</i> = 5.1 Hz, 1H), 8.80 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.44 (d, <i>J</i> = 1.0 Hz, 1H), 8.35–8.42 (m, 1H), 8.04 (dd, <i>J</i> = 5.3, 1.8 Hz, 1H), 7.64–7.73 (m, 1H), 7.42–7.49 (m, 1H), 7.40 (s, 1H), 7.18 (d, <i>J</i> = 8.3 Hz, 1H), 3.56 (s, 2H), 2.80–2.88 (m, 2H), 2.62–2.70 (m, 2H), 2.41 ppm (s, 3H). MS: <i>m</i>/<i>e</i> 385 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (323 nm). <i>R</i><sub>t</sub>: 0.9 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Methyl [3,3′-Bipyridine]-5-carboxylate (<b>Int-18b</b>)</h4><div class="NLM_p last">To a mixture of methyl 5-bromonicotinate (330 mg, 1.5 mmol) and pyridin-3-ylboronic acid (188 mg, 1.5 mmol) in ACN (4 mL), a saturated solution of sodium bicarbonate (4 mL, 1.5 mmol) and [1,1′-bis(diphenylphosphino)ferrocene]dichloro-palladium(II) (35 mg, 0.04 mmol) were added. This reaction mixture was purged with N<sub>2</sub> and heated at 90 °C in a microwave device during 15 min. The layers were separated, and the aqueous one was extracted with EtOAc. The combined organic phases were washed with brine, dried over magnesium sulfate, and filtered, and the solvent was evaporated under vacuum to give a crude material that was purified on a silica gel cartridge to afford 175 mg of <b>Int-18b</b> (0.8 mmol, 53%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 9.27 (d, <i>J</i> = 2.0 Hz, 1H), 9.02 (d, <i>J</i> = 2.3 Hz, 1H), 8.91 (d, <i>J</i> = 2.0 Hz, 1H), 8.71 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.52 (t, <i>J</i> = 2.1 Hz, 1H), 7.95 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H), 7.46 (dd, <i>J</i> = 7.6, 5.1 Hz, 1H), 4.02 ppm (s, 3H). MS: <i>m</i>/<i>e</i> 215 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (245 nm). <i>R</i><sub>t</sub>: 0.96 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 5-([3,3′-Bipyridin]-5-yl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>18b</b>)</h4><div class="NLM_p last">To a solution of <b>Int-18b</b> (175 mg, 0.8 mmol) in ethanol (5 mL), hydrazine monohydrate (0.5 mL, 9.8 mmol) was added and the reaction mixture was refluxed during 16 h. The solvent was removed under reduced pressure to give a crude material that was combined with 7-isothiocyanato-2-methyl-1,2,3,4-tetrahydroisoquinoline (137 mg, 0.7 mmol) in ethanol (12 mL). The reaction mixture was stirred at 80 °C under nitrogen atmosphere until reaction reached completion. EDCI (107 mg, 0.6 mmol) was added and the stirring continued overnight. Ethanol was removed under vacuum to give a crude material that was dissolved in DCM and washed with water. Phases were separated in a separative funnel, and the organic layer was dried over anhydrous sodium sulfate, filtered, and evaporated under vacuum to give the a crude material that was purified on a silica amino cartridge and by preparative HPLC to afford 20 mg of <b>18b</b> (0.05 mmol, 9% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 10.77 (s, 1H), 8.97–9.38 (m, 3H), 8.71–8.87 (m, <i>J</i> = 1.64, 4.67 Hz, 1H), 8.48–8.67 (m, <i>J</i> = 2.15, 2.15 Hz, 1H), 8.34 (td, <i>J</i> = 1.80, 8.27 Hz, 1H), 7.66 (dd, <i>J</i> = 4.80, 7.83 Hz, 1H), 7.31–7.49 (m, 2H), 7.18 (d, <i>J</i> = 8.34 Hz, 1H), 3.56 (s, 2H), 2.59–2.94 (m, 4H), 2.41 (s, 3H). MS: <i>m</i>/<i>e</i> 385 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (251 nm). <i>R</i><sub>t</sub>: 0.86 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Methyl [2,3′-Bipyridine]-4-carboxylate (<b>Int-18c</b>)</h4><div class="NLM_p last">Methyl 2-bromoisonicotinate (1.5 g, 6.8 mmol) and pyridin-3-ylboronic acid (1.1 g, 8.9 mmol) in ACN (8 mL) were combined with a 10% solution of sodium bicarbonate (8 mL, 6.8 mmol), and then bis(diphenylphosphino)ferrocene]dichloro-palladium(II) (0.2 g, 0.2 mmol) was added. The reaction mixture was degassed with a steady stream of N<sub>2</sub> and irradiated in a microwave device at 100 °C for 1 h. The reaction mixture was filtered through a Celite cartridge, and water was added, phases were separated in a separative funnel, and the organic phase was washed with brine, dried over anhydrous MgSO<sub>4</sub>, and filtered, and the solvent was evaporated under vacuum to afford a crude material that was purified on a silica gel cartridge to give 540 mg of <b>Int-18c</b> (2.5 mmol, 37% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.38 (d, <i>J</i> = 1.5 Hz, 1H), 9.00 (d, <i>J</i> = 5.1 Hz, 1H), 8.71–8.82 (m, 1H), 8.53–8.62 (m, 1H), 8.47 (s, 1H), 7.93 (dd, <i>J</i> = 4.9, 1.4 Hz, 1H), 7.62 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 3.99–4.07 ppm (m, 3H).</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 5-([2,3′-Bipyridin]-4-yl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>18c</b>)</h4><div class="NLM_p last">To a solution of methyl [2,3′-bipyridine]-4-carboxylate (<b>Int-18c</b>) (532 mg, 2.5 mmol) in ethanol (8 mL) was added hydrazine hydrate (1.5 mL, 29.8 mmol) and stirred at room temperature for 40 min. Solvent and hydrazine were evaporated under vacuum to afford a brownish solid that was resuspended in EtOH, and the solid was filtered and washed with DCM, affording 220 mg of an off-white solid corresponding to desired product. The filtrate was evaporated under vacuum to afford a solid that was washed with DCM to give 70 mg of desired product. Both batches were dissolved together in MeOH and filtered through a nylon filter to eliminate rests of catalyst from the previous reaction. Solvent was evaporated under vacuum to give 277 mg of [2,3′-bipyridine]-4-carbohydrazide (1.3 mmol, 53% yield). 2,3′-Bipyridine]-4-carbohydrazide (137 mg, 0.6 mmol) and 7-isothiocyanato-2-methyl-1,2,3,4-tetrahydroisoquinoline (157 mg, 0.8 mmol) were combined in ethanol (12 mL) and stirred at 80 °C under nitrogen atmosphere until reaction completion. EDCI (123 mg, 0.6 mmol) was added, and the reaction mixture was stirred overnight. Ethanol was removed under vacuum to give a crude material that was dissolved in DCM, water was added, and phases were separated in a separative funnel. The organic layer was dried over anhydrous sodium sulfate and evaporated under reduced pressure to give a crude material that was purified on a amino silica gel cartridge and then by preparative HPLC to afford 60 mg of <b>18c</b> (0.15 mmol, 24% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (s, 1H), 9.38 (d, <i>J</i> = 2.3 Hz, 1H), 9.0 (dd, <i>J</i> = 5.1, 8.0 Hz, 1H), 8.77 (dd, <i>J</i> = 4.7, 1.6 Hz, 1H), 8.56 (dt, <i>J</i> = 8.3, 1.9 Hz, 1H), 8.41 (s, 1H), 7.89 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 7.65 (ddd, <i>J</i> = 8.1, 4.8, 0.8 Hz, 1H), 7.46 (dd, <i>J</i> = 8.2, 2.4 Hz, 1H), 7.41 (d, <i>J</i> = 2 Hz, 1H), 7.19 (d, <i>J</i> = 8.3 Hz, 1H), 3.56 (s, 2H), 2.86–2.83 (m, 2H), 2.67–2.64 (m, 2H), 2.41 (s, 3H). MS: <i>m</i>/<i>e</i> 385 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (250 nm). <i>R</i><sub>t</sub>: 0.90 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Ethyl [2,3′-Bipyridine]-6-carboxylate (<b>Int-18d</b>)</h4><div class="NLM_p last">A solution of 3-pyridinylboronic acid (0.6 g, 4.6 mmol) and methyl 6-bromo-2-pyridinecarboxylate (1 g, 4.6 mmol) in a mixture of toluene (24 mL) and ethanol (60 mL) was stirred and bubbled with argon for 15 min. To this solution, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.3 g, 0.5 mmol) was added and the reaction mixture was bubbled with argon for another 15 min. To this solution, a saturated solution of sodium bicarbonate (17 mL, 18.5 mmol) was added dropwise during 10 min, and the reaction mixture was stirred at 85 °C under argon for 2 h. Reaction mixture was filtered through Celite, the organic solvent was removed under vacuum, and the aqueous layer was extracted with EtOAc. Organic phase was washed with 1 N aqueous solution of NaOH, water, and brine, dried over anhydrous sodium sulfate, filtered through silica gel, and evaporated under vacuum to give a crude material that was purified on a silica gel cartridge to give 256 mg of <b>Int-18d</b> along with triphenyl phosphonium oxide (2:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.33–9.43 (m, 1H), 8.71–8.82 (m, 1H), 8.52–8.60 (m, 1H), 8.35–8.42 (m, 1H), 8.17–8.25 (m, 1H), 8.09–8.16 (m, 1H), 7.67 (d, <i>J</i> = 1.26 Hz, 1H), 4.47 (d, <i>J</i> = 7.07 Hz, 2H), 1.44 (t, <i>J</i> = 7.20 Hz, 3H).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 5-([2,3′-Bipyridin]-6-yl)-<i>N</i>-(2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-1,3,4-oxadiazol-2-amine (<b>18d</b>)</h4><div class="NLM_p last">To a solution of <b>Int-18d</b> (165 mg, 0.7 mmol) in ethanol (5 mL), hydrazine monohydrate (0.4 mL, 8.7 mmol) was added and the reaction mixture was stirred at rt overnight. Solvent was removed under reduced pressure to give a crude material that was combined with 7-isothiocyanato-2-methyl-1,2,3,4-tetrahydroisoquinoline (130 mg, 0.6 mmol) in THF (10 mL) and stirred at 60 °C overnight. The solvent was evaporated under reduced pressure to give a crude material that was combined with DCC (131 mg, 0.6 mmol) in ethanol (20 mL) and stirred at 80 °C overnight. Ethanol was removed under vacuum to give a crude material that was dissolved in EtOAc and brine was added, and phases were separated in a funnel. The organic layer was dried and filtered, and the solvent was evaporated under reduced pressure to give a crude material that was purified on a silica amino cartridge to afford 98 mg of <b>18d</b> (0.2 mmol, 40% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (br.s, 1H), 9.42 (s, 1H), 8.77 (dd, <i>J</i> = 4.7, 1.6 Hz, 1H), 8.57 (dt, <i>J</i> = 8.1, 2 Hz, 1H), 8.31–8.17 (m, 3H), 7.68–7.66 (m, 1H), 7.45 (dd, <i>J</i> = 7.8, 4.8 Hz, 2H), 7.18 (d, <i>J</i> = 8.8 Hz, 1H), 3.56 (br.s, 2H), 2.86- 2.84 (m, 2H), 2.67–2.64 (m, 2H), 2.42 (m, 3H). MS: <i>m</i>/<i>e</i> 385 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (249 nm). <i>R</i><sub>t</sub>: 0.89 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 5-([3,4′-Bipyridin]-2′-yl)-<i>N</i>-(4-(pyrrolidin-1-ylmethyl)phenyl)-1,3,4-oxadiazol-2-amine (<b>19</b>)</h4><div class="NLM_p last">To a solution of <b>Int-18a</b> (326 mg, 1.5 mmol) in ethanol (20 mL), hydrazine monohydrate (0.8 mL, 17.2 mmol) was added and the reaction mixture was stirred at rt overnight. The solvent was evaporated under vacuum to give a crude material that was combined with 1-(4-isothiocyanatobenzyl)pyrrolidine (332 mg, 1.5 mmol) in ethanol (20 mL) and stirred at 80 °C for 2 h until reaction completion. EDCI (350 mg, 1.8 mmol) was added, and it was stirred at 80 °C overnight. The reaction was cooled down to rt, and the solid was filtered and rinsed with EtOH to give a crude material that was purified by preparative HPLC to give 147 mg of <b>19</b> (0.3 mmol, 24% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.84–11.00 (m, 1H), 9.17 (d, <i>J</i> = 1.8 Hz, 1H), 8.90 (d, <i>J</i> = 5.3 Hz, 1H), 8.80 (d, <i>J</i> = 3.5 Hz, 1H), 8.45 (s, 1H), 8.35–8.43 (m, 1H), 8.05 (br s, 1H), 7.66–7.71 (m, 1H), 7.64 (d, <i>J</i> = 8.3 Hz, 2H), 7.37 (d, <i>J</i> = 8.3 Hz, 2H), 3.59 (s, 2H), 2.48 (br s, 4H), 1.76 ppm (br s, 4H). MS: <i>m</i>/<i>e</i> 399 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (255 nm). <i>R</i><sub>t</sub>: 0.84 min (Acquity UPLC BEH C18 1.7 μ Acquity UPLC BE<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile). HRMS: (ES) calcd for C<sub>23</sub>H<sub>22</sub>N<sub>6</sub>O (M + H)<sup>+</sup> 397.1782, found 397.1798.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-(3-(Pyridin-3-yl)-5-(trifluoromethyl)benzoyl)-<i>N</i>-(4-(pyrrolidin-1 ylmethyl)phenyl)hydrazinecarboxamide (<b>20a</b>)</h4><div class="NLM_p last"><b>Int-E</b> (300 mg, 1.1 mmol) and 1-(4-isocyanatobenzyl)pyrrolidine (216 mg, 1.1 mmol) were combined in ethanol (10 mL) and stirred at 70 °C for 1 h. Then 1-(4-isocyanatobenzyl)pyrrolidine (216 mg, 1.1 mmol) was added and it was heated at 70 °C for 1h at rt for 48 h. After that time, another equivalent of 1-(4-isocyanatobenzyl)pyrrolidine (216 mg, 1.1 mmol) was added, and the reaction mixture was heated at 70 °C for 1 h and at rt for 48 h. The solvent was evaporated under vacuum to give a crude material that was purified on a silica amino cartridge to afford 150 mg of <b>20a</b> (0.3 mmol, 29% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.75 (br s, 1H), 9.16 (d, <i>J</i> = 1.77 Hz, 1H), 8.96 (br s, 1H), 8.75 (dd, <i>J</i> = 1.64, 4.67 Hz, 1H), 8.64 (s, 1H), 8.28–8.48 (m, 4H), 7.60–7.69 (m, 1H), 7.49 (d, <i>J</i> = 8.34 Hz, 2H), 7.25 (d, <i>J</i> = 8.59 Hz, 2H), 3.55 (s, 2H), 2.46 (br s, 4H), 1.74 (t, <i>J</i> = 3.28 Hz, 4H). MS: <i>m</i>/<i>e</i> 484 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (245 nm). <i>R</i><sub>t</sub>: 0.93 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-([3,4′-Bipyridine]-2′-carbonyl)-<i>N</i>-(4-(pyrrolidin-1-ylmethyl)phenyl)hydrazinecarboxamide (<b>20b</b>)</h4><div class="NLM_p last"><b>Int-18a</b> (100 mg, 0.5 mmol) and 1-(4-isocyanatobenzyl)pyrrolidine (94 mg, 0.5 mmol) were combined in ethanol (3 mL) and stirred at 70 °C for 1 h. The reaction was cooled down to rt, and more 1-(4-isocyanatobenzyl)pyrrolidine (94 mg, 0.5 mmol) was added to the reaction mixture that was heated again at 70 °C for 1 h. A third addition of 1-(4-isocyanatobenzyl)pyrrolidine (216 mg, 1.1 mmol) was carried out, and the reaction mixture was heated at 70 °C for 1 h and at rt. overnight. Solvent was evaporated under vacuum to give a crude material that was triturated with <sup><i>t</i></sup>BuOMe, filtered, rinsed with <sup><i>t</i></sup>BuOMe and EtOAc, and dried under vacuum to obtain 110 mg of <b>20b</b> (0.3 mmol, 57% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 10.53 (br s, 1H), 9.16 (br s, 1H), 8.87 (d, <i>J</i> = 4.5 Hz, 2H), 8.79 (d, <i>J</i> = 3.8 Hz, 1H), 8.31–8.48 (m, 3H), 8.14 (d, <i>J</i> = 3.8 Hz, 1H), 7.66 (dd, <i>J</i> = 7.6, 4.8 Hz, 1H), 7.47 (d, <i>J</i> = 8.1 Hz, 2H), 7.25 (d, <i>J</i> = 8.1 Hz, 2H), 3.56 (br s, 2H), 3.40 (br s, 2H), 2.48 (br s, 4H), 1.75 ppm (br s, 4H). MS: <i>m</i>/<i>e</i> 417 (MH<sup>+</sup>). Purity was determined as >90% by HPLC (245 nm). <i>R</i><sub>t</sub>: 0.80 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> [3,4′-Bipyridine]-2′-carbohydrazide (<b>Int-F</b>)</h4><div class="NLM_p last">To a solution of <b>Int-18a</b> (500 mg, 2.3 mmol) in ethanol (10 mL), hydrazine monohydrate (0.6 mL, 11.7 mmol) was added and the reaction mixture was stirred at rt overnight. The solvent was evaporated under vacuum to give a yellow solid that was triturated with EtOH, filtered, and rinsed with cool EtOH to obtain 275 mg of [3,4′-bipyridine]-2′-carbohydrazide (<b>Int-F</b>) a yellowish solid (1.3 mmol, 55% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.06 (br s, 1H), 9.13 (d, <i>J</i> = 1.52 Hz, 1H), 8.78 (t, <i>J</i> = 5.05 Hz, 2H), 8.35 (br s, 2H), 8.00–8.13 (m, 1H), 7.65 (dd, <i>J</i> = 4.93, 7.71 Hz, 1H), 4.69 (d, <i>J</i> = 4.04 Hz, 2H). MS: <i>m</i>/<i>e</i> 215 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (260 nm). <i>R</i><sub>t</sub>: 0.77 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 3-(Pyridin-3-yl)-5-(trifluoromethyl)benzoic Acid (<b>21a</b>)</h4><div class="NLM_p last"><b>Int-E</b> (500 mg, 1.8 mmol) and 2-iodoxybenzoic acid (2.2 g, 3.6 mmol) were combined in ethanol (10 mL) and stirred at 70 °C for 48 h. The reaction was allowed to reach rt, and the solvent was evaporated until dryness to give a crude material that was partitioned between DCM and a satd solution of NaHCO<sub>3.</sub> Phases were separated in a funnel, and the organic layer was washed with brine, dried over MgSO<sub>4</sub>, and filtered, and the solvent was evaporated to obtain 55 mg of <b>21a</b> (0.2 mmol, 11% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.06–14.02 (m, 1H), 9.09 (d, <i>J</i> = 1.52 Hz, 1H), 8.74 (d, <i>J</i> = 3.79 Hz, 1H), 8.55 (s, 1H), 8.42 (s, 1H), 8.24–8.36 (m, 2H), 8.02 (d, <i>J</i> = 7.33 Hz, 1H). MS: <i>m</i>/<i>e</i> 268 (MH<sup>+</sup>). Purity was determined as >95% by HPLC (245 nm). <i>R</i><sub>t</sub>: 0.84 min (Acquity UPLC BEH C18 1.7 μ, 3 mm × 50 mm, CH<sub>3</sub>COO<sup>–</sup>NH<sub>4</sub><sup>+</sup> 25 mM + 10% acetonitrile at pH 6.6/acetonitrile).</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> [3,4′-Bipyridine]-2′-carboxylic Acid, Hydrochloride (<b>21b</b>)</h4><div class="NLM_p last"><b>Int-F</b> (250 mg, 1.2 mmol) and 4 mL of a 6 N aqueous solution of hydrochloric acid were refluxed overnight. The reaction mixture was concentrated to dryness to obtain a yellow solid that was triturated with <sup><i>t</i></sup>BuOMe, filtered, and rinsed with <sup><i>t</i></sup>BuOMe to obtain a 192 mg of <b>21b</b> along with a 12% of starting material. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 9.43 (d, <i>J</i> = 1.8 Hz, 1H), 8.88–9.04 (m, 3H), 8.76 (d, <i>J</i> = 5.3 Hz, 1H), 8.56 (d, <i>J</i> = 1.3 Hz, 1H), 8.23 (dd, <i>J</i> = 5.2, 1.9 Hz, 1H), 8.04–8.17 (m, 2H), 7.88 ppm (dd, <i>J</i> = 5.3, 2.0 Hz, 1H).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01441">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01441" class="ext-link">10.1021/acs.jmedchem.6b01441</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Description of the pharmacophore modeling; protocols for cell drug susceptibility studies; assessment of in vitro frequency of spontaneous resistance and characterization of resistant mutants; in vivo efficacy in <i>P. falciparum</i> mouse model; hERG inhibition determination and cell cytotoxicity assays; tolerability studies; PK studies methodology; intrinsic clearance determination; FaSSIF solubility determination and ChromlogD protocol; IC<sub>50</sub> standard deviation and controls; PRR figures for compounds <b>2</b> and <b>14</b>; in vivo controls (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf">jm6b01441_si_001.pdf (966.4 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_002.csv">jm6b01441_si_002.csv (1.37 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01441" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Félix Calderón</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0486-6883" title="Orcid link">http://orcid.org/0000-0003-0486-6883</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#640201080d1c4a164a0705080001160b0a49160b090b2403170f4a070b09"><span class="__cf_email__" data-cfemail="caacafa6a3b2e4b8e4a9aba6aeafb8a5a4e7b8a5a7a58aadb9a1e4a9a5a7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Sandoval</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María José Lafuente-Monasterio</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María J. Almela</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pablo Castañeda</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Belén Jiménez Díaz</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María S. Martínez-Martínez</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaume Vidal</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Íñigo Angulo-Barturen</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Bamborough</span> - <span class="hlFld-Affiliation affiliation">Medicines
Research Center, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy Burrows</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture (MMV), 21 route de Pré-Bois, PO Box 1826, 1215 Geneva 15, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas Cammack</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María J. Chaparro</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José M. Coterón</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina de Cozar</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benigno Crespo</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatriz Díaz</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerard Drewes</span> - <span class="hlFld-Affiliation affiliation">Cellzome
GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Esther Fernández</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Santiago Ferrer-Bazaga</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Teresa Fraile</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco J. Gamo</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonja Ghidelli-Disse</span> - <span class="hlFld-Affiliation affiliation">Cellzome
GmbH, GlaxoSmithKline, Meyerhofstrasse 1, 69117 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rubén Gómez</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Haselden</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophie Huss</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Luisa León</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaime de Mercado</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon J. F. Macdonald</span> - <span class="hlFld-Affiliation affiliation">Medicines
Research Center, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4859-8246" title="Orcid link">http://orcid.org/0000-0002-4859-8246</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Ignacio Martín Hernando</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sara Prats</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Margarita Puente</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne Rodríguez</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan C. de la Rosa</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lourdes Rueda</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolyn Selenski</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Willis</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture (MMV), 21 route de Pré-Bois, PO Box 1826, 1215 Geneva 15, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David M. Wilson</span> - <span class="hlFld-Affiliation affiliation">Tres
Cantos, Medicines Development Campus, DDW, GlaxoSmithKline, Severo
Ochoa 2, 28760 Tres
Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Witty</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture (MMV), 21 route de Pré-Bois, PO Box 1826, 1215 Geneva 15, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors contributed to the preparation of this manuscript. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d50e4936-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Jose María Bueno, Gary Boyle and Stephanie Gresham for helpful discussions, Laura de las Heras for her input to develop this manuscript and our colleagues from Pharmacology Department and Biology for the measurement of the ADMET properties of compounds described in this paper. We acknowledge financial support from Medicines for Malaria Venture (MMV).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i71" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i71"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72"> Abbreviations Used</h2><tr><td class="NLM_term">ACN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">ACTs</td><td class="NLM_def"><p class="first last">artemisinin combination therapies</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">Alk</td><td class="NLM_def"><p class="first last">alkyl</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">ChromlogD<sub>7.4</sub></td><td class="NLM_def"><p class="first last">chromatographic distribution coefficient at buffer pH 7.4</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">compd</td><td class="NLM_def"><p class="first last">compound</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DDW</td><td class="NLM_def"><p class="first last">Diseases of Developing World</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">ED<sub>90</sub></td><td class="NLM_def"><p class="first last">dose of compound that eradicates 90% of the pathogen</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">FaSSIF</td><td class="NLM_def"><p class="first last">fasted state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">%<i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">GlaxoSmithKline</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">hu</td><td class="NLM_def"><p class="first last">human</p></td></tr><tr><td class="NLM_term">iCl<sub>i</sub></td><td class="NLM_def"><p class="first last">in vitro intrinsic clearance</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">concentration of drug that gives 50% of inhibition in vitro</p></td></tr><tr><td class="NLM_term">Int</td><td class="NLM_def"><p class="first last">intermediate</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LBF</td><td class="NLM_def"><p class="first last">liver blood flow</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography mass spectrometry</p></td></tr><tr><td class="NLM_term">LHS</td><td class="NLM_def"><p class="first last">left-hand side</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">MOE</td><td class="NLM_def"><p class="first last">molecular operational environment</p></td></tr><tr><td class="NLM_term">MMV</td><td class="NLM_def"><p class="first last">Medicines for Malaria Venture</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance spectroscopy:</p></td></tr><tr><td class="NLM_term"><i>Pf</i></td><td class="NLM_def"><p class="first last"><i>Plasmodium falciparum</i></p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">from Latin per os (by mouth)</p></td></tr><tr><td class="NLM_term">RHS</td><td class="NLM_def"><p class="first last">right-hand side</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term"><i>R</i><sub>t</sub></td><td class="NLM_def"><p class="first last">retention time</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodefiency disorder</p></td></tr><tr><td class="NLM_term">SGF</td><td class="NLM_def"><p class="first last">simulated gastric fluid</p></td></tr><tr><td class="NLM_term"><sup><i>t</i></sup>BuOMe</td><td class="NLM_def"><p class="first last"><i>tert</i>-butylmethyl ether</p></td></tr><tr><td class="NLM_term">TCAMS</td><td class="NLM_def"><p class="first last">Tres Cantos Antimalarial Set</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">ThiQ</td><td class="NLM_def"><p class="first last">tetrahydroisoquinoline</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half life</p></td></tr><tr><td class="NLM_term">US</td><td class="NLM_def"><p class="first last">United States</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr><tr><td class="NLM_term">°C</td><td class="NLM_def"><p class="first last">degrees Celsius</p></td></tr><tr><td class="NLM_term">2-MeTHF</td><td class="NLM_def"><p class="first last">2-methyltetrahydrofuran</p></td></tr><tr><td class="NLM_term">3D</td><td class="NLM_def"><p class="first last">Three dimensions</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span> </span><span class="NLM_article-title">Antimalarial Drug Discovery: Recent Progress and Future Directions</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1016/B978-0-444-62652-3.00003-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2FB978-0-444-62652-3.00003-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=23384667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=97-151&author=F.+Calder%C3%B3nauthor=D.+M.+Wilsonauthor=F.-J.+Gamo&title=Antimalarial+Drug+Discovery%3A+Recent+Progress+and+Future+Directions&doi=10.1016%2FB978-0-444-62652-3.00003-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery: recent progress and future directions</span></div><div class="casAuthors">Calderon, Felix; Wilson, David M.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">97-151</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This article discusses the recent developments and future perspectives on antimalarial chemotherapy, with a focus on the individual compds. and mechanisms rather than treatments as part of a combination product.  Antimalarial drugs with a complex mode of action and inhibiting defined mol. targets were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Nl668Y00BLVg90H21EOLACvtfcHk0liGdyN7naaaNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGrsbc%253D&md5=48771e096c9f2096b95eb5d915a1e9e2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-62652-3.00003-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-62652-3.00003-X%26sid%3Dliteratum%253Aachs%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DGamo%26aufirst%3DF.-J.%26atitle%3DAntimalarial%2520Drug%2520Discovery%253A%2520Recent%2520Progress%2520and%2520Future%2520Directions%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D52%26spage%3D97%26epage%3D151%26doi%3D10.1016%2FB978-0-444-62652-3.00003-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>World Malaria Report 2016; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/malaria/publications/world-malaria-report-2016/en/" class="extLink">http://www.who.int/malaria/publications/world-malaria-report-2016/en/</a> (accessed February, 16, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Malaria+Report+2016%3B+World+Health+Organization%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fmalaria%2Fpublications%2Fworld-malaria-report-2016%2Fen%2F+%28accessed+February%2C+16%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Malaria%2520Report%25202016%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Sachs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaney, P.</span><span> </span><span class="NLM_article-title">The Economic and Social Burden of Malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span><span class="refDoi"> DOI: 10.1038/415680a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2F415680a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=11832956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=680-685&author=J.+Sachsauthor=P.+Malaney&title=The+Economic+and+Social+Burden+of+Malaria&doi=10.1038%2F415680a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The economic and social burden of malaria</span></div><div class="casAuthors">Sachs, Jeffrey; Malaney, Pia</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">6872</span>),
    <span class="NLM_cas:pages">680-685</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Where malaria prospers most, human societies have prospered least.  The global distribution of per-capita gross domestic product shows a striking correlation between malaria and poverty, and malaria-endemic countries also have lower rates of economic growth.  There are multiple channels by which malaria impedes development, including effects on fertility, population growth, saving and investment, worker productivity, absenteeism, premature mortality and medical costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJw0oyArOfc7Vg90H21EOLACvtfcHk0liGdyN7naaaNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrY%253D&md5=0c755731170660d29535bc48425b494e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F415680a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F415680a%26sid%3Dliteratum%253Aachs%26aulast%3DSachs%26aufirst%3DJ.%26aulast%3DMalaney%26aufirst%3DP.%26atitle%3DThe%2520Economic%2520and%2520Social%2520Burden%2520of%2520Malaria%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D680%26epage%3D685%26doi%3D10.1038%2F415680a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span>Trends in Reported Malaria Incidence; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/en/" class="extLink">http://www.who.int/en/</a> (accessed Nov 19, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Trends+in+Reported+Malaria+Incidence%3B+World+Health+Organization%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fen%2F+%28accessed+Nov+19%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Reported%2520Malaria%2520Incidence%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ranson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">N’guessan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moiroux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nkuni, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbel, V.</span><span> </span><span class="NLM_article-title">Pyrethroid Resistance in African Anopheline Mosquitoes: What Are the Implications for Malaria Control?</span> <span class="citation_source-journal">Trends Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.pt.2010.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2Fj.pt.2010.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=20843745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=91-98&author=H.+Ransonauthor=R.+N%E2%80%99guessanauthor=J.+Linesauthor=N.+Moirouxauthor=Z.+Nkuniauthor=V.+Corbel&title=Pyrethroid+Resistance+in+African+Anopheline+Mosquitoes%3A+What+Are+the+Implications+for+Malaria+Control%3F&doi=10.1016%2Fj.pt.2010.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control?</span></div><div class="casAuthors">Ranson, Hilary; N'Guessan, Raphael; Lines, Jonathan; Moiroux, Nicolas; Nkuni, Zinga; Corbel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The use of pyrethroid insecticides in malaria vector control has increased dramatically in the past decade through the scale up of insecticide treated net distribution programs and indoor residual spraying campaigns.  Inevitably, the major malaria vectors have developed resistance to these insecticides and the resistance alleles are spreading at an exceptionally rapid rate throughout Africa.  Although substantial progress has been made on understanding the causes of pyrethroid resistance, remarkably few studies have focused on the epidemiol. impact of resistance on current malaria control activities.  As we move into the malaria eradication era, it is vital that the implications of insecticide resistance are understood and strategies to mitigate these effects are implemented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmOhvu-LCsBbVg90H21EOLACvtfcHk0lguHNKcQG0eAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yntbY%253D&md5=09bae65cf0bbef6db92d60e4125f8379</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2010.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2010.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DRanson%26aufirst%3DH.%26aulast%3DN%25E2%2580%2599guessan%26aufirst%3DR.%26aulast%3DLines%26aufirst%3DJ.%26aulast%3DMoiroux%26aufirst%3DN.%26aulast%3DNkuni%26aufirst%3DZ.%26aulast%3DCorbel%26aufirst%3DV.%26atitle%3DPyrethroid%2520Resistance%2520in%2520African%2520Anopheline%2520Mosquitoes%253A%2520What%2520Are%2520the%2520Implications%2520for%2520Malaria%2520Control%253F%26jtitle%3DTrends%2520Parasitol.%26date%3D2011%26volume%3D27%26spage%3D91%26epage%3D98%26doi%3D10.1016%2Fj.pt.2010.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Van den Berg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameneshewa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnzava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hii, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dash, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ejov, M.</span><span> </span><span class="NLM_article-title">Global Trends in the Use of Insecticides to Control Vector-borne Diseases</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1289/ehp.1104340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1289%2Fehp.1104340" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=577-582&author=H.+Van+den+Bergauthor=M.+Zaimauthor=R.+S.+Yadavauthor=A.+Soaresauthor=B.+Ameneshewaauthor=A.+Mnzavaauthor=J.+Hiiauthor=A.+P.+Dashauthor=M.+Ejov&title=Global+Trends+in+the+Use+of+Insecticides+to+Control+Vector-borne+Diseases&doi=10.1289%2Fehp.1104340"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1289%2Fehp.1104340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.1104340%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bden%2BBerg%26aufirst%3DH.%26aulast%3DZaim%26aufirst%3DM.%26aulast%3DYadav%26aufirst%3DR.%2BS.%26aulast%3DSoares%26aufirst%3DA.%26aulast%3DAmeneshewa%26aufirst%3DB.%26aulast%3DMnzava%26aufirst%3DA.%26aulast%3DHii%26aufirst%3DJ.%26aulast%3DDash%26aufirst%3DA.%2BP.%26aulast%3DEjov%26aufirst%3DM.%26atitle%3DGlobal%2520Trends%2520in%2520the%2520Use%2520of%2520Insecticides%2520to%2520Control%2520Vector-borne%2520Diseases%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2012%26volume%3D120%26spage%3D577%26epage%3D582%26doi%3D10.1289%2Fehp.1104340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dondorp, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, N. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Socheat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Seidlein, L.</span><span> </span><span class="NLM_article-title">Artemisinin Resistance: Current Status and Scenarios for Containment</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1038/nrmicro2331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnrmicro2331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=20208550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVKjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=272-280&author=A.+M.+Dondorpauthor=S.+Yeungauthor=L.+Whiteauthor=C.+Nguonauthor=N.+P.+J.+Dayauthor=D.+Socheatauthor=L.+von+Seidlein&title=Artemisinin+Resistance%3A+Current+Status+and+Scenarios+for+Containment&doi=10.1038%2Fnrmicro2331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance: current status and scenarios for containment</span></div><div class="casAuthors">Dondorp, Arjen M.; Yeung, Shunmay; White, Lisa; Nguon, Chea; Day, Nicholas P. J.; Socheat, Duong; von Seidlein, Lorenz</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">272-280</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Artemisinin combination therapies are the first-line treatments for uncomplicated Plasmodium falciparum malaria in most malaria-endemic countries.  Recently, partial artemisinin-resistant P. falciparum malaria has emerged on the Cambodia-Thailand border.  Exposure of the parasite population to artemisinin monotherapies in subtherapeutic doses for over 30 years, and the availability of substandard artemisinins, have probably been the main driving force in the selection of the resistant phenotype in the region.  A multifaceted containment program has recently been launched, including early diagnosis and appropriate treatment, decreasing drug pressure, optimizing vector control, targeting the mobile population, strengthening management and surveillance systems, and operational research.  Math. modeling can be a useful tool to evaluate possible strategies for containment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfWzrD-ixBLVg90H21EOLACvtfcHk0lguHNKcQG0eAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVKjsr0%253D&md5=b607e6a017568d0d6a71a0248d13724b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2331%26sid%3Dliteratum%253Aachs%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DL.%26aulast%3DNguon%26aufirst%3DC.%26aulast%3DDay%26aufirst%3DN.%2BP.%2BJ.%26aulast%3DSocheat%26aufirst%3DD.%26aulast%3Dvon%2BSeidlein%26aufirst%3DL.%26atitle%3DArtemisinin%2520Resistance%253A%2520Current%2520Status%2520and%2520Scenarios%2520for%2520Containment%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2010%26volume%3D8%26spage%3D272%26epage%3D280%26doi%3D10.1038%2Fnrmicro2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Straimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnädig, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramadani, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dacheux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urnov, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercereau-Puijalon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit-Vical, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span> </span><span class="NLM_article-title">Drug Resistance. K13-propeller Mutations Confer Artemisinin Resistance in Plasmodium Falciparum Clinical Isolates</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1126/science.1260867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1126%2Fscience.1260867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=25502314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=428-431&author=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=V.+Duruauthor=A.+P.+Ramadaniauthor=M.+Dacheuxauthor=N.+Khimauthor=L.+Zhangauthor=S.+Lamauthor=P.+D.+Gregoryauthor=F.+D.+Urnovauthor=O.+Mercereau-Puijalonauthor=F.+Benoit-Vicalauthor=R.+M.+Fairhurstauthor=D.+M%C3%A9nardauthor=D.+A.+Fidock&title=Drug+Resistance.+K13-propeller+Mutations+Confer+Artemisinin+Resistance+in+Plasmodium+Falciparum+Clinical+Isolates&doi=10.1126%2Fscience.1260867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates</span></div><div class="casAuthors">Straimer, Judith; Gnaedig, Nina F.; Witkowski, Benoit; Amaratunga, Chanaki; Duru, Valentine; Ramadani, Arba Pramundita; Dacheux, Melanie; Khim, Nimol; Zhang, Lei; Lam, Stephen; Gregory, Philip D.; Urnov, Fyodor D.; Mercereau-Puijalon, Odile; Benoit-Vical, Francoise; Fairhurst, Rick M.; Menard, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6220</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The emergence of artemisinin resistance in Southeast Asia imperils efforts to reduce the global malaria burden.  We genetically modified the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival rates after drug exposure in vitro; these rates correlate with parasite clearance half-lives in artemisinin-treated patients.  With isolates from Cambodia, where resistance first emerged, survival rates decreased from 13 to 49% to 0.3 to 2.4% after the removal of K13 mutations.  Conversely, survival rates in wild-type parasites increased from ≤0.6% to 2 to 29% after the insertion of K13 mutations.  These mutations conferred elevated resistance to recent Cambodian isolates compared with that of ref. lines, suggesting a contemporary contribution of addnl. genetic factors.  Our data provide a conclusive rationale for worldwide K13-propeller sequencing to identify and eliminate artemisinin-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Ml-eUMKETLVg90H21EOLACvtfcHk0liEbfBg9GAXbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D&md5=5776238fb78428d16bcaed8d16fa73af</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1260867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1260867%26sid%3Dliteratum%253Aachs%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DRamadani%26aufirst%3DA.%2BP.%26aulast%3DDacheux%26aufirst%3DM.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DGregory%26aufirst%3DP.%2BD.%26aulast%3DUrnov%26aufirst%3DF.%2BD.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DDrug%2520Resistance.%2520K13-propeller%2520Mutations%2520Confer%2520Artemisinin%2520Resistance%2520in%2520Plasmodium%2520Falciparum%2520Clinical%2520Isolates%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D428%26epage%3D431%26doi%3D10.1126%2Fscience.1260867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">White, N. J.</span><span> </span><span class="NLM_article-title">Antimalarial Drug Resistance</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1084</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span><span class="refDoi"> DOI: 10.1172/JCI21682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1172%2FJCI21682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=15085184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1yisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=1084-1092&author=N.+J.+White&title=Antimalarial+Drug+Resistance&doi=10.1172%2FJCI21682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance</span></div><div class="casAuthors">White, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1084-1092</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Malaria, the most prevalent and most pernicious parasitic disease of humans, is estd. to kill between one and two million people, mainly children, each year.  Resistance has emerged to all classes of antimalarial drugs except the artemisinins and is responsible for a recent increase in malaria-related mortality, particularly in Africa.  The de novo emergence of resistance can be prevented by the use of antimalarial drug combinations.  Artemisinin-deriv. combinations are particularly effective, since they act rapidly and are well tolerated and highly effective.  Widespread use of these drugs could roll back malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo66DKib7C1nLVg90H21EOLACvtfcHk0liEbfBg9GAXbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1yisrc%253D&md5=5ebd8b2c447f183515238a9527d56121</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1172%2FJCI21682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI21682%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DAntimalarial%2520Drug%2520Resistance%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D113%26spage%3D1084%26epage%3D1092%26doi%3D10.1172%2FJCI21682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Farooq, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, R. C.</span><span> </span><span class="NLM_article-title">Drug Resistance in Malaria</span> <span class="citation_source-journal">J. Vector Borne Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=15672556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FksFSruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=45-53&author=U.+Farooqauthor=R.+C.+Mahajan&title=Drug+Resistance+in+Malaria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance in malaria</span></div><div class="casAuthors">Farooq Umar; Mahajan R C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vector borne diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">45-53</span>
        ISSN:<span class="NLM_cas:issn">0972-9062</span>.
    </div><div class="casAbstract">Ever since the discovery of the first case of chloroquine resistance along the Thai-Combodian border in the late 1950s, Southeast Asia has played an important role as a focus for the development of drug resistance in Plasmodium falciparum.  Although the first case of quinine resistance had been reported much earlier from South America, the onset of chloroquine resistance marked the beginning of a new chapter in the history of malaria in Southeast Asia and by 1973 chloroquine finally had to be replaced by the combination of sulphadoxine and pyrimethamine (SP) as first line drug for the treatment of uncomplicated malaria in Thailand and more than 10 African countries have also switched their first line drug to SP.  In 1985, eventually SP was replaced by mefloquine.  The rapid development of resistance to this new drug leads to the introduction of artemisinin as a combination drug in the mid-1990s.  It is mandatory to mention here that therapeutic regimens for prevention and treatment of chloroquine-resistant P. falciparum are associated with higher costs and side-effects compared to chloroquine.  Additionally, some of these alternative treatments are associated with more side-effects, take longer time for cure and are more difficult to comply with than chloroquine.  Urgent efforts are needed to identify effective, affordable, alternative antimalarial regimens.  Molecular markers for antimalarial resistance have been identified, including pfmdr-1 and pfcrt polymorphisms associated with chloroquine resistance and dhfr and dhps polymorphisms associated with SP resistance.  Polymorphisms in pfmdr-1 may also be associated with resistance to chloroquine, mefloquine and artemisinin.  Use of such genetic information for the early detection of resistance foci and future monitoring of drug resistant malaria is a potentially useful epidemiological tool, in conjunction with the conventional in vitro and in vivo drug sensitivity assessments.  The purpose of this review is to describe the state of knowledge regarding drug resistant malaria and to outline the changing patterns of drug resistance including its determinants, current status in diverse geographical areas, molecular markers and their implications to limit the advent, spread and intensification of drug resistant malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmE7AgNfHRkKcY7HFp97qMfW6udTcc2eYxzoqxa-vQCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FksFSruw%253D%253D&md5=052b83e60c632150e7cc2ad7e7b94364</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarooq%26aufirst%3DU.%26aulast%3DMahajan%26aufirst%3DR.%2BC.%26atitle%3DDrug%2520Resistance%2520in%2520Malaria%26jtitle%3DJ.%2520Vector%2520Borne%2520Dis.%26date%3D2004%26volume%3D41%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Guiguemde, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span> </span><span class="NLM_article-title">Global Phenotypic Screening for Antimalarials</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2Fj.chembiol.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=22284359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=116-129&author=W.+A.+Guiguemdeauthor=A.+A.+Shelatauthor=J.+F.+Garcia-Bustosauthor=T.+Diaganaauthor=F.+J.+Gamoauthor=R.+K.+Guy&title=Global+Phenotypic+Screening+for+Antimalarials&doi=10.1016%2Fj.chembiol.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Global Phenotypic Screening for Antimalarials</span></div><div class="casAuthors">Guiguemde, W. Armand; Shelat, Anang A.; Garcia-Bustos, Jose F.; Diagana, Thierry T.; Gamo, Francisco-Javier; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-129</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria, a devastating infectious disease caused by Plasmodium spp., leads to roughly 655,000 deaths per yr, mostly of African children.  To compd. the problem, drug resistance has emerged to all classical antimalarials and may be emerging for artemisinin-based combination therapies.  To address the need for new antimalarials with novel mechanisms, several groups carried out phenotypic screening campaigns to identify compds. inhibiting growth of the blood stages of Plasmodium falciparum.  In this review, we describe the characterization of these compds., explore currently ongoing strategies to develop lead mols., and endorse the concept of a "malaria box" of publicly accessible active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCn0XMDvpiA7Vg90H21EOLACvtfcHk0lin_IqQAlzeXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CrsbY%253D&md5=56eacb3713c558ad449cc78eae8b7b14</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DGuiguemde%26aufirst%3DW.%2BA.%26aulast%3DShelat%26aufirst%3DA.%2BA.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DDiagana%26aufirst%3DT.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DGlobal%2520Phenotypic%2520Screening%2520for%2520Antimalarials%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D116%26epage%3D129%26doi%3D10.1016%2Fj.chembiol.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gardner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berriman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzberg, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nene, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shallom, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiuoli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selengut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidya, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlamb, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraunholz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadden, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carucci, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newbold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrell, B.</span><span> </span><span class="NLM_article-title">Genome Sequence of the Human Malaria Parasite Plasmodium Falciparum</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1038/nature01097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnature01097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=12368864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFais7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2002&pages=498-511&author=M.+J.+Gardnerauthor=N.+Hallauthor=E.+Fungauthor=O.+Whiteauthor=M.+Berrimanauthor=R.+W.+Hymanauthor=J.+M.+Carltonauthor=A.+Painauthor=K.+E.+Nelsonauthor=S.+Bowmanauthor=I.+T.+Paulsenauthor=K.+Jamesauthor=J.+A.+Eisenauthor=K.+Rutherfordauthor=S.+L.+Salzbergauthor=A.+Craigauthor=S.+Kyesauthor=M.+S.+Chanauthor=V.+Neneauthor=S.+J.+Shallomauthor=B.+Suhauthor=J.+Petersonauthor=S.+Angiuoliauthor=M.+Perteaauthor=J.+Allenauthor=J.+Selengutauthor=D.+Haftauthor=M.+W.+Matherauthor=A.+B.+Vaidyaauthor=D.+M.+Martinauthor=A.+H.+Fairlambauthor=M.+J.+Fraunholzauthor=D.+S.+Roosauthor=S.+A.+Ralphauthor=G.+I.+McFaddenauthor=L.+M.+Cummingsauthor=G.+M.+Subramanianauthor=C.+Mungallauthor=J.+C.+Venterauthor=D.+J.+Carucciauthor=S.+L.+Hoffmanauthor=C.+Newboldauthor=R.+W.+Davisauthor=C.+M.+Fraserauthor=B.+Barrell&title=Genome+Sequence+of+the+Human+Malaria+Parasite+Plasmodium+Falciparum&doi=10.1038%2Fnature01097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Genome sequence of the human malaria parasite Plasmodium falciparum</span></div><div class="casAuthors">Gardner, Malcolm J.; Hall, Neil; Fung, Eula; White, Owen; Berriman, Matthew; Hyman, Richard W.; Carlton, Jane M.; Pain, Arnab; Nelson, Karen E.; Bowman, Sharen; Paulsen, Ian T.; James, Keith; Eisen, Jonathan A.; Rutherford, Kim; Salzberg, Steven L.; Craig, Alister; Kyes, Sue; Chan, Man-Suen; Nene, Vishvanath; Shallom, Shamira J.; Suh, Bernard; Peterson, Jeremy; Angiuoli, Sam; Pertea, Mihaela; Allen, Jonathan; Selengut, Jeremy; Haft, Daniel; Mather, Michael W.; Vaidya, Akhil B.; Martin, David M. A.; Fairlamb, Alan H.; Fraunholz, Martin J.; Roos, David S.; Ralph, Stuart A.; McFadden, Geoffrey I.; Cummings, Leda M.; Subramanian, G. Mani; Mungall, Chris; Venter, J. Craig; Carucci, Daniel J.; Hoffman, Stephen L.; Newbold, Chris; Davis, Ronald W.; Fraser, Claire M.; Barrell, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">6906</span>),
    <span class="NLM_cas:pages">498-511</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The parasite Plasmodium falciparum is responsible for hundreds of millions of cases of malaria, and kills more than one million African children annually.  The genome sequence of P. falciparum clone 3D7 is reported.  The 23-megabase nuclear genome consists of 14 chromosomes, encodes about 5300 genes, and is the most (A + T)-rich genome sequenced to date.  Genes involved in antigenic variation are concd. in the subtelomeric regions of the chromosomes.  Compared to the genomes of free-living eukaryotic microbes, the genome of this intracellular parasite encodes fewer enzymes and transporters, but a large proportion of genes are devoted to immune evasion and host-parasite interactions.  Many nuclear-encoded proteins are targeted to the apicoplast, an organelle involved in fatty-acid and isoprenoid metab.  The genome sequence provides the foundation for future studies of this organism, and is being exploited in the search for new drugs and vaccines to fight malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWsAOvRnNBYLVg90H21EOLACvtfcHk0lin_IqQAlzeXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFais7Y%253D&md5=d575af8bb4fef318660e0e6268f3f675</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature01097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01097%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DM.%2BJ.%26aulast%3DHall%26aufirst%3DN.%26aulast%3DFung%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DO.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DHyman%26aufirst%3DR.%2BW.%26aulast%3DCarlton%26aufirst%3DJ.%2BM.%26aulast%3DPain%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DK.%2BE.%26aulast%3DBowman%26aufirst%3DS.%26aulast%3DPaulsen%26aufirst%3DI.%2BT.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DEisen%26aufirst%3DJ.%2BA.%26aulast%3DRutherford%26aufirst%3DK.%26aulast%3DSalzberg%26aufirst%3DS.%2BL.%26aulast%3DCraig%26aufirst%3DA.%26aulast%3DKyes%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DM.%2BS.%26aulast%3DNene%26aufirst%3DV.%26aulast%3DShallom%26aufirst%3DS.%2BJ.%26aulast%3DSuh%26aufirst%3DB.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DAngiuoli%26aufirst%3DS.%26aulast%3DPertea%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DSelengut%26aufirst%3DJ.%26aulast%3DHaft%26aufirst%3DD.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DMartin%26aufirst%3DD.%2BM.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFraunholz%26aufirst%3DM.%2BJ.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DMcFadden%26aufirst%3DG.%2BI.%26aulast%3DCummings%26aufirst%3DL.%2BM.%26aulast%3DSubramanian%26aufirst%3DG.%2BM.%26aulast%3DMungall%26aufirst%3DC.%26aulast%3DVenter%26aufirst%3DJ.%2BC.%26aulast%3DCarucci%26aufirst%3DD.%2BJ.%26aulast%3DHoffman%26aufirst%3DS.%2BL.%26aulast%3DNewbold%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DR.%2BW.%26aulast%3DFraser%26aufirst%3DC.%2BM.%26aulast%3DBarrell%26aufirst%3DB.%26atitle%3DGenome%2520Sequence%2520of%2520the%2520Human%2520Malaria%2520Parasite%2520Plasmodium%2520Falciparum%26jtitle%3DNature%26date%3D2002%26volume%3D419%26spage%3D498%26epage%3D511%26doi%3D10.1038%2Fnature01097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Guiguemde, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharlow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazouni, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowble, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forquer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinley, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRisi, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riscoe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span> </span><span class="NLM_article-title">Chemical Genetics of Plasmodium Falciparum</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1038/nature09099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnature09099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=20485428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1OjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=311-315&author=W.+A.+Guiguemdeauthor=A.+A.+Shelatauthor=D.+Bouckauthor=S.+Duffyauthor=G.+J.+Crowtherauthor=P.+H.+Davisauthor=D.+C.+Smithsonauthor=M.+Connellyauthor=J.+Clarkauthor=F.+Zhuauthor=M.+B.+Jimenez-Diazauthor=M.+S.+Martinezauthor=E.+B.+Wilsonauthor=A.+K.+Tripathiauthor=J.+Gutauthor=E.+R.+Sharlowauthor=I.+Bathurstauthor=F.+E.+Mazouniauthor=J.+W.+Fowbleauthor=I.+Forquerauthor=P.+L.+McGinleyauthor=S.+Castroauthor=I.+Angulo-Barturenauthor=S.+Ferrerauthor=P.+J.+Rosenthalauthor=J.+L.+DeRisiauthor=D.+J.+Sullivanauthor=J.+S.+Lazoauthor=D.+S.+Roosauthor=M.+K.+Riscoeauthor=M.+A.+Phillipsauthor=P.+K.+Rathodauthor=W.+C.+Van+Voorhisauthor=V.+M.+Averyauthor=R.+K.+Guy&title=Chemical+Genetics+of+Plasmodium+Falciparum&doi=10.1038%2Fnature09099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics of Plasmodium falciparum</span></div><div class="casAuthors">Guiguemde, W. Armand; Shelat, Anang A.; Bouck, David; Duffy, Sandra; Crowther, Gregory J.; Davis, Paul H.; Smithson, David C.; Connelly, Michele; Clark, Julie; Zhu, Fangyi; Jimenez-Diaz, Maria B.; Martinez, Maria S.; Wilson, Emily B.; Tripathi, Abhai K.; Gut, Jiri; Sharlow, Elizabeth R.; Bathurst, Ian; El Mazouni, Farah; Fowble, Joseph W.; Forquer, Isaac; McGinley, Paula L.; Castro, Steve; Angulo-Barturen, Inigo; Ferrer, Santiago; Rosenthal, Philip J.; De Risi, Joseph L.; Sullivan, David J., Jr.; Lazo, John S.; Roos, David S.; Riscoe, Michael K.; Phillips, Margaret A.; Rathod, Pradipsinh K.; Van Voorhis, Wesley C.; Avery, Vicky M.; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">311-315</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malaria caused by Plasmodium falciparum is a disease that is responsible for 880,000 deaths per yr worldwide.  Vaccine development has proved difficult and resistance has emerged for most antimalarial drugs.  To discover new antimalarial chemotypes, we have used a phenotypic forward chem. genetic approach to assay 309,474 chems.  Here we disclose structures and biol. activity of the entire library-many of which showed potent in vitro activity against drug-resistant P. falciparum strains-and detailed profiling of 172 representative candidates.  A reverse chem. genetic study identified 19 new inhibitors of 4 validated drug targets and 15 novel binders among 61 malarial proteins.  Phylochemogenetic profiling in several organisms revealed similarities between Toxoplasma gondii and mammalian cell lines and dissimilarities between P. falciparum and related protozoans.  One exemplar compd. displayed efficacy in a murine model.  Our findings provide the scientific community with new starting points for malaria drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC5VVynAR2NLVg90H21EOLACvtfcHk0lhxhZfRlOppPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1OjtL4%253D&md5=b1b838f5e43adeb4de019c3e41c33017</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09099%26sid%3Dliteratum%253Aachs%26aulast%3DGuiguemde%26aufirst%3DW.%2BA.%26aulast%3DShelat%26aufirst%3DA.%2BA.%26aulast%3DBouck%26aufirst%3DD.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DCrowther%26aufirst%3DG.%2BJ.%26aulast%3DDavis%26aufirst%3DP.%2BH.%26aulast%3DSmithson%26aufirst%3DD.%2BC.%26aulast%3DConnelly%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DMartinez%26aufirst%3DM.%2BS.%26aulast%3DWilson%26aufirst%3DE.%2BB.%26aulast%3DTripathi%26aufirst%3DA.%2BK.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DSharlow%26aufirst%3DE.%2BR.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DMazouni%26aufirst%3DF.%2BE.%26aulast%3DFowble%26aufirst%3DJ.%2BW.%26aulast%3DForquer%26aufirst%3DI.%26aulast%3DMcGinley%26aufirst%3DP.%2BL.%26aulast%3DCastro%26aufirst%3DS.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DDeRisi%26aufirst%3DJ.%2BL.%26aulast%3DSullivan%26aufirst%3DD.%2BJ.%26aulast%3DLazo%26aufirst%3DJ.%2BS.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DChemical%2520Genetics%2520of%2520Plasmodium%2520Falciparum%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D311%26epage%3D315%26doi%3D10.1038%2Fnature09099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Plouffe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">In Silico Activity Profiling Reveals the Mechanism of Action of Antimalarials Discovered in a High-throughput Screen</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">9059</span><span class="NLM_x">–</span> <span class="NLM_lpage">9064</span><span class="refDoi"> DOI: 10.1073/pnas.0802982105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1073%2Fpnas.0802982105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=18579783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9059-9064&author=D.+Plouffeauthor=A.+Brinkerauthor=C.+McNamaraauthor=K.+Hensonauthor=N.+Katoauthor=K.+Kuhenauthor=A.+Nagleauthor=F.+Adrianauthor=J.+T.+Matzenauthor=P.+Andersonauthor=T.+G.+Namauthor=N.+S.+Grayauthor=A.+Chatterjeeauthor=J.+Janesauthor=S.+F.+Yanauthor=R.+Tragerauthor=J.+S.+Caldwellauthor=P.+G.+Schultzauthor=Y.+Zhouauthor=E.+A.+Winzeler&title=In+Silico+Activity+Profiling+Reveals+the+Mechanism+of+Action+of+Antimalarials+Discovered+in+a+High-throughput+Screen&doi=10.1073%2Fpnas.0802982105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen</span></div><div class="casAuthors">Plouffe, David; Brinker, Achim; McNamara, Case; Henson, Kerstin; Kato, Nobutaka; Kuhen, Kelli; Nagle, Advait; Adrian, Francisco; Matzen, Jason T.; Anderson, Paul; Nam, Tae-gyu; Gray, Nathanael S.; Chatterjee, Arnab; Janes, Jeff; Yan, S. Frank; Trager, Richard; Caldwell, Jeremy S.; Schultz, Peter G.; Zhou, Yingyao; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9059-9064</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The growing resistance to current first-line antimalarial drugs represents a major health challenge.  To facilitate the discovery of new antimalarials, we have implemented an efficient and robust high-throughput cell-based screen (1,536-well format) based on proliferation of Plasmodium falciparum (Pf) in erythrocytes.  From a screen of ≈ 1.7 million compds., we identified a diverse collection of ≈ 6,000 small mols. comprised of > 530 distinct scaffolds, all of which show potent antimalarial activity (< 1.25 μM).  Most known antimalarials were identified in this screen, thus validating our approach.  In addn., we identified many novel chem. scaffolds, which likely act through both known and novel pathways.  We further show that in some cases the mechanism of action of these antimalarials can be detd. by in silico compd. activity profiling.  This method uses large datasets from unrelated cellular and biochem. screens and the guilt-by-assocn. principle to predict which cellular pathway and/or protein target is being inhibited by select compds.  In addn., the screening method has the potential to provide the malaria community with many new starting points for the development of biol. probes and drugs with novel antiparasitic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL9PFy0SUhdbVg90H21EOLACvtfcHk0lhxhZfRlOppPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCiurw%253D&md5=bf14f093078c982e3604089588827166</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0802982105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0802982105%26sid%3Dliteratum%253Aachs%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DHenson%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DAnderson%26aufirst%3DP.%26aulast%3DNam%26aufirst%3DT.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%2BF.%26aulast%3DTrager%26aufirst%3DR.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DIn%2520Silico%2520Activity%2520Profiling%2520Reveals%2520the%2520Mechanism%2520of%2520Action%2520of%2520Antimalarials%2520Discovered%2520in%2520a%2520High-throughput%2520Screen%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9059%26epage%3D9064%26doi%3D10.1073%2Fpnas.0802982105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Cozar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderwall, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peishoff, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardon, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span> </span><span class="NLM_article-title">Thousands of Chemical Starting Points for Antimalarial Lead Identification</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1038/nature09107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnature09107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=20485427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Ois7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=305-312&author=F.+J.+Gamoauthor=L.+M.+Sanzauthor=J.+Vidalauthor=C.+de+Cozarauthor=E.+Alvarezauthor=J.+L.+Lavanderaauthor=D.+E.+Vanderwallauthor=D.+V.+S.+Greenauthor=V.+Kumarauthor=S.+Hasanauthor=J.+R.+Brownauthor=C.+E.+Peishoffauthor=L.+R.+Cardonauthor=J.+F.+Garcia-Bustos&title=Thousands+of+Chemical+Starting+Points+for+Antimalarial+Lead+Identification&doi=10.1038%2Fnature09107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Thousands of chemical starting points for antimalarial lead identification</span></div><div class="casAuthors">Gamo, Francisco-Javier; Sanz, Laura M.; Vidal, Jaume; de Cozar, Cristina; Alvarez, Emilio; Lavandera, Jose-Luis; Vanderwall, Dana E.; Green, Darren V. S.; Kumar, Vinod; Hasan, Samiul; Brown, James R.; Peishoff, Catherine E.; Cardon, Lon R.; Garcia-Bustos, Jose F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">305-310</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malaria is a devastating infection caused by protozoa of the genus Plasmodium.  Drug resistance is widespread, no new chem. class of antimalarials has been introduced into clin. practice since 1996 and there is a recent rise of parasite strains with reduced sensitivity to the newest drugs.  We screened nearly 2 million compds. in GlaxoSmithKline's chem. library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 μM concn.  More than 8,000 also showed potent activity against the multidrug resistant strain Dd2.  Most (82%) compds. originate from internal company projects and are new to the malaria community.  Analyses using historic assay data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host-pathogen interaction related targets.  Chem. structures and assocd. data are hereby made public to encourage addnl. drug lead identification efforts and further research into this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHijpWK_kBF7Vg90H21EOLACvtfcHk0liZ1zUvdSJmrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Ois7k%253D&md5=a1fd8c0b89a5650ecba31f5456928b42</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature09107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09107%26sid%3Dliteratum%253Aachs%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3Dde%2BCozar%26aufirst%3DC.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DVanderwall%26aufirst%3DD.%2BE.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DHasan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DPeishoff%26aufirst%3DC.%2BE.%26aulast%3DCardon%26aufirst%3DL.%2BR.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26atitle%3DThousands%2520of%2520Chemical%2520Starting%2520Points%2520for%2520Antimalarial%2520Lead%2520Identification%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D305%26epage%3D312%26doi%3D10.1038%2Fnature09107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span>ChEMBL-NTD; <span class="NLM_publisher-name">EMBL-EBI</span>: <span class="NLM_publisher-loc">Hinxton, Cambridgeshire, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span><a href="http://www.ebi.ac.uk/chemblntd" class="extLink">www.ebi.ac.uk/chemblntd</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ChEMBL-NTD%3B+EMBL-EBI%3A+Hinxton%2C+Cambridgeshire%2C+UK%2C+2017%3B+www.ebi.ac.uk%2Fchemblntd."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DChEMBL-NTD%26pub%3DEMBL-EBI%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueno, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coterón, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiandor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J.</span><span> </span><span class="NLM_article-title">An Invitation to Open Innovation in malaria Drug Discovery: 47 Quality Starting Points from the TCAMS</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1021/ml200135p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200135p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtValsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=741-746&author=F.+Calder%C3%B3nauthor=D.+Barrosauthor=J.+M.+Buenoauthor=J.+M.+Coter%C3%B3nauthor=E.+Fern%C3%A1ndezauthor=F.+J.+Gamoauthor=J.+L.+Lavanderaauthor=M.+L.+Le%C3%B3nauthor=S.+J.+F.+Macdonaldauthor=A.+Malloauthor=P.+Manzanoauthor=E.+Porrasauthor=J.+M.+Fiandorauthor=J.+Castro&title=An+Invitation+to+Open+Innovation+in+malaria+Drug+Discovery%3A+47+Quality+Starting+Points+from+the+TCAMS&doi=10.1021%2Fml200135p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS</span></div><div class="casAuthors">Calderon, Felix; Barros, David; Bueno, Jose Maria; Coteron, Jose Miguel; Fernandez, Esther; Gamo, Francisco Javier; Lavandera, Jose Luis; Leon, Maria Luisa; MacDonald, Simon J. F.; Mallo, Araceli; Manzano, Pilar; Porras, Esther; Fiandor, Jose Maria; Castro, Julia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">741-746</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In 2010, GlaxoSmithKline published the structures of 13533 chem. starting points for antimalarial lead identification.  By using an agglomerative structural clustering technique followed by computational filters such as antimalarial activity, physicochem. properties, and dissimilarity to known antimalarial structures, we have identified 47 starting points for lead optimization.  Their structures are provided.  We invite potential collaborators to work with us to discover new clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5fqzf76wMHrVg90H21EOLACvtfcHk0ljDJKOGuGi4Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtValsLnI&md5=706374895ecc775c2c790c07e1195564</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fml200135p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200135p%26sid%3Dliteratum%253Aachs%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBueno%26aufirst%3DJ.%2BM.%26aulast%3DCoter%25C3%25B3n%26aufirst%3DJ.%2BM.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DLe%25C3%25B3n%26aufirst%3DM.%2BL.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DMallo%26aufirst%3DA.%26aulast%3DManzano%26aufirst%3DP.%26aulast%3DPorras%26aufirst%3DE.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DCastro%26aufirst%3DJ.%26atitle%3DAn%2520Invitation%2520to%2520Open%2520Innovation%2520in%2520malaria%2520Drug%2520Discovery%253A%252047%2520Quality%2520Starting%2520Points%2520from%2520the%2520TCAMS%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D741%26epage%3D746%26doi%3D10.1021%2Fml200135p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rueda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellote, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Pichel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaparro, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Rosa, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos Martínez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, E.</span><span> </span><span class="NLM_article-title">Cyclopropyl Carboxamides: A New Oral Antimalarial Series Derived from the Tres Cantos Anti-malarial Set (TCAMS)</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">840</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1021/ml2001517</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2001517" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=840-844&author=L.+Ruedaauthor=I.+Castelloteauthor=J.+Castro-Pichelauthor=M.+J.+Chaparroauthor=J.+C.+de+la+Rosaauthor=A.+Garc%C3%ADa-Perezauthor=M.+Gordoauthor=M.+B.+Jimenez-D%C3%ADazauthor=A.+Kesslerauthor=S.+J.+F.+MacDonaldauthor=M.+Santos+Mart%C3%ADnezauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=E.+Fernandez&title=Cyclopropyl+Carboxamides%3A+A+New+Oral+Antimalarial+Series+Derived+from+the+Tres+Cantos+Anti-malarial+Set+%28TCAMS%29&doi=10.1021%2Fml2001517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml2001517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2001517%26sid%3Dliteratum%253Aachs%26aulast%3DRueda%26aufirst%3DL.%26aulast%3DCastellote%26aufirst%3DI.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26aulast%3DChaparro%26aufirst%3DM.%2BJ.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DJ.%2BC.%26aulast%3DGarc%25C3%25ADa-Perez%26aufirst%3DA.%26aulast%3DGordo%26aufirst%3DM.%26aulast%3DJimenez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DSantos%2BMart%25C3%25ADnez%26aufirst%3DM.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DFernandez%26aufirst%3DE.%26atitle%3DCyclopropyl%2520Carboxamides%253A%2520A%2520New%2520Oral%2520Antimalarial%2520Series%2520Derived%2520from%2520the%2520Tres%2520Cantos%2520Anti-malarial%2520Set%2520%2528TCAMS%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D840%26epage%3D844%26doi%3D10.1021%2Fml2001517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal-Mas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Rosa, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prats, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, E.</span><span> </span><span class="NLM_article-title">A Divergent SAR Study Allows Optimization of a Potent 5-HT<sub>2C</sub> Inhibitor to a Promising Antimalarial Scaffold</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1021/ml300008j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300008j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=373-377&author=F.+Calder%C3%B3nauthor=J.+Vidal-Masauthor=J.+Burrowsauthor=J.+C.+de+la+Rosaauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=T.+Muletauthor=S.+Pratsauthor=J.+Solanaauthor=M.+Wittyauthor=F.+J.+Gamoauthor=E.+Fernandez&title=A+Divergent+SAR+Study+Allows+Optimization+of+a+Potent+5-HT2C+Inhibitor+to+a+Promising+Antimalarial+Scaffold&doi=10.1021%2Fml300008j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml300008j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300008j%26sid%3Dliteratum%253Aachs%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DVidal-Mas%26aufirst%3DJ.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DJ.%2BC.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DPrats%26aufirst%3DS.%26aulast%3DSolana%26aufirst%3DJ.%26aulast%3DWitty%26aufirst%3DM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DFernandez%26aufirst%3DE.%26atitle%3DA%2520Divergent%2520SAR%2520Study%2520Allows%2520Optimization%2520of%2520a%2520Potent%25205-HT2C%2520Inhibitor%2520to%2520a%2520Promising%2520Antimalarial%2520Scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D373%26epage%3D377%26doi%3D10.1021%2Fml300008j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Chaparro, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueno, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colmenarejo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coterón, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de las Heras, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabarró, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafuente, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prats, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoval, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Villarejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderón, F.</span><span> </span><span class="NLM_article-title">Case Study of Small Molecules As Antimalarials: 2–Amino-1-phenylethanol (APE) Derivatives</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1021/ml500015r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500015r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=657-661&author=M.+J.+Chaparroauthor=J.+Vidalauthor=I.+Angulo-Barturenauthor=J.+M.+Buenoauthor=J.+Burrowsauthor=N.+Cammackauthor=P.+Casta%C3%B1edaauthor=G.+Colmenarejoauthor=J.+M.+Coter%C3%B3nauthor=L.+de+las+Herasauthor=E.+Fern%C3%A1ndezauthor=S.+Ferrerauthor=R.+Gabarr%C3%B3author=F.+J.+Gamoauthor=M.+Garc%C3%ADaauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=M.+J.+Lafuenteauthor=M.+L.+Le%C3%B3nauthor=M.+S.+Mart%C3%ADnezauthor=D.+Minickauthor=S.+Pratsauthor=M.+Puenteauthor=L.+Ruedaauthor=E.+Sandovalauthor=A.+Santos-Villarejoauthor=M.+Wittyauthor=F.+Calder%C3%B3n&title=Case+Study+of+Small+Molecules+As+Antimalarials%3A+2%E2%80%93Amino-1-phenylethanol+%28APE%29+Derivatives&doi=10.1021%2Fml500015r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml500015r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500015r%26sid%3Dliteratum%253Aachs%26aulast%3DChaparro%26aufirst%3DM.%2BJ.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DBueno%26aufirst%3DJ.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DCasta%25C3%25B1eda%26aufirst%3DP.%26aulast%3DColmenarejo%26aufirst%3DG.%26aulast%3DCoter%25C3%25B3n%26aufirst%3DJ.%2BM.%26aulast%3Dde%2Blas%2BHeras%26aufirst%3DL.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DGabarr%25C3%25B3%26aufirst%3DR.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DLafuente%26aufirst%3DM.%2BJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DM.%2BL.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DMinick%26aufirst%3DD.%26aulast%3DPrats%26aufirst%3DS.%26aulast%3DPuente%26aufirst%3DM.%26aulast%3DRueda%26aufirst%3DL.%26aulast%3DSandoval%26aufirst%3DE.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DWitty%26aufirst%3DM.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26atitle%3DCase%2520Study%2520of%2520Small%2520Molecules%2520As%2520Antimalarials%253A%25202%25E2%2580%2593Amino-1-phenylethanol%2520%2528APE%2529%2520Derivatives%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D657%26epage%3D661%26doi%3D10.1021%2Fml500015r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Keurulainen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vahermo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente-Felipe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoval-Izquierdo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo-Fernández, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro-López, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas-Valentín, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de las Heras-Dueña, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leino, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siiskonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell-Pages, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda-Casado, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuru, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yli-Kauhaluoma, J.</span><span> </span><span class="NLM_article-title">A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: <i>N</i>–[3-[(Benzimidazol-2-yl)amino]propyl]amides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4573</span><span class="NLM_x">–</span> <span class="NLM_lpage">4580</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4573-4580&author=L.+Keurulainenauthor=M.+Vahermoauthor=M.+Puente-Felipeauthor=E.+Sandoval-Izquierdoauthor=B.+Crespo-Fern%C3%A1ndezauthor=L.+Guijarro-L%C3%B3pezauthor=L.+Huertas-Valent%C3%ADnauthor=L.+de+las+Heras-Due%C3%B1aauthor=T.+O.+Leinoauthor=A.+Siiskonenauthor=L.+Ballell-Pagesauthor=L.+M.+Sanzauthor=P.+Casta%C3%B1eda-Casadoauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=M.+S.+Mart%C3%ADnez-Mart%C3%ADnezauthor=S.+Vieraauthor=P.+Kiuruauthor=F.+Calder%C3%B3nauthor=J.+Yli-Kauhaluoma&title=A+Developability-Focused+Optimization+Approach+Allows+Identification+of+in+Vivo+Fast-Acting+Antimalarials%3A+N%E2%80%93%5B3-%5B%28Benzimidazol-2-yl%29amino%5Dpropyl%5Damides&doi=10.1021%2Facs.jmedchem.5b00114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DKeurulainen%26aufirst%3DL.%26aulast%3DVahermo%26aufirst%3DM.%26aulast%3DPuente-Felipe%26aufirst%3DM.%26aulast%3DSandoval-Izquierdo%26aufirst%3DE.%26aulast%3DCrespo-Fern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DGuijarro-L%25C3%25B3pez%26aufirst%3DL.%26aulast%3DHuertas-Valent%25C3%25ADn%26aufirst%3DL.%26aulast%3Dde%2Blas%2BHeras-Due%25C3%25B1a%26aufirst%3DL.%26aulast%3DLeino%26aufirst%3DT.%2BO.%26aulast%3DSiiskonen%26aufirst%3DA.%26aulast%3DBallell-Pages%26aufirst%3DL.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCasta%25C3%25B1eda-Casado%26aufirst%3DP.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DViera%26aufirst%3DS.%26aulast%3DKiuru%26aufirst%3DP.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DYli-Kauhaluoma%26aufirst%3DJ.%26atitle%3DA%2520Developability-Focused%2520Optimization%2520Approach%2520Allows%2520Identification%2520of%2520in%2520Vivo%2520Fast-Acting%2520Antimalarials%253A%2520N%25E2%2580%2593%255B3-%255B%2528Benzimidazol-2-yl%2529amino%255Dpropyl%255Damides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4573%26epage%3D4580%26doi%3D10.1021%2Facs.jmedchem.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">McConville, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahamontes-Rosa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell-Pages, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Cózar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Mercado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Villarejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washbourn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span> </span><span class="NLM_article-title">Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6448</span><span class="NLM_x">–</span> <span class="NLM_lpage">6455</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00434</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00434" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1CitbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6448-6455&author=M.+McConvilleauthor=J.+Fern%C3%A1ndezauthor=I.+Angulo-Barturenauthor=N.+Bahamontes-Rosaauthor=L.+Ballell-Pagesauthor=P.+Casta%C3%B1edaauthor=C.+de+C%C3%B3zarauthor=B.+Crespoauthor=L.+Guijarroauthor=M.+Jim%C3%A9nez-D%C3%ADazauthor=M.+S.+Mart%C3%ADnez-Mart%C3%ADnezauthor=J.+de+Mercadoauthor=A.+Santos-Villarejoauthor=L.+M.+Sanzauthor=M.+Frigerioauthor=G.+Washbournauthor=S.+A.+Wardauthor=G.+L.+Nixonauthor=G.+A.+Biaginiauthor=N.+G.+Berryauthor=M.+J.+Blackmanauthor=F.+Calder%C3%B3nauthor=P.+M.+O%E2%80%99Neill&title=Carbamoyl+Triazoles%2C+Known+Serine+Protease+Inhibitors%2C+Are+a+Potent+New+Class+of+Antimalarials&doi=10.1021%2Facs.jmedchem.5b00434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials</span></div><div class="casAuthors">McConville, Matthew; Fernandez, Jorge; Angulo-Barturen, Inigo; Bahamontes-Rosa, Noemi; Ballell-Pages, Lluis; Castaneda, Pablo; de Cozar, Cristina; Crespo, Benigno; Guijarro, Laura; Jimenez-Diaz, Maria Belen; Martinez-Martinez, Maria S.; de Mercado, Jaime; Santos-Villarejo, Angel; Sanz, Laura M.; Frigerio, Micol; Washbourn, Gina; Ward, Stephen A.; Nixon, Gemma L.; Biagini, Giancarlo A.; Berry, Neil G.; Blackman, Michael J.; Calderon, Felix; O'Neill, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6448-6455</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of the GSK corporate collection, some 1.9 million compds., against Plasmodium falciparum (Pf), revealed almost 14000 active hits that are now known as the Tres Cantos Antimalarial Set (TCAMS).  Follow-up work by Calderon et al. clustered and computationally filtered the TCAMS through a variety of criteria and reported 47 series contg. a total of 522 compds.  From this enhanced set, we identified the carbamoyl triazole TCMDC-134379, a known serine protease inhibitor, as an excellent starting point for SAR profiling.  Lead optimization of TCMDC-134379 led to several mols. with improved antimalarial potency, metabolic stabilities in mouse and human liver microsomes, along with acceptable cytotoxicity profiles.  Analog (I) displayed potent in vitro activity (IC50 = 10 nM) and oral activity in a SCID mouse model of Pf infection with an ED50 of 100 and ED90 of between 100 and 150 mg kg-1, resp.  The results presented encourage further investigations to identify the target of these highly active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe5cb5tdfmTLVg90H21EOLACvtfcHk0lj-VQuPSkfbpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1CitbzI&md5=7b69cde5c4242d8ef8d906e77cad1e29</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00434%26sid%3Dliteratum%253Aachs%26aulast%3DMcConville%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DBahamontes-Rosa%26aufirst%3DN.%26aulast%3DBallell-Pages%26aufirst%3DL.%26aulast%3DCasta%25C3%25B1eda%26aufirst%3DP.%26aulast%3Dde%2BC%25C3%25B3zar%26aufirst%3DC.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DGuijarro%26aufirst%3DL.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3Dde%2BMercado%26aufirst%3DJ.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DFrigerio%26aufirst%3DM.%26aulast%3DWashbourn%26aufirst%3DG.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DNixon%26aufirst%3DG.%2BL.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DBlackman%26aufirst%3DM.%2BJ.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DCarbamoyl%2520Triazoles%252C%2520Known%2520Serine%2520Protease%2520Inhibitors%252C%2520Are%2520a%2520Potent%2520New%2520Class%2520of%2520Antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6448%26epage%3D6455%26doi%3D10.1021%2Facs.jmedchem.5b00434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibáñez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magán-Marchal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortés-Gil, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraile, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shultz, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span> </span><span class="NLM_article-title">A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e66967</span><span class="refDoi"> DOI: 10.1371/journal.pone.0066967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1371%2Fjournal.pone.0066967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=23825598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2qtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e66967&author=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=S.+Vieraauthor=J.+Ib%C3%A1%C3%B1ezauthor=T.+Muletauthor=N.+Mag%C3%A1n-Marchalauthor=H.+Garutiauthor=V.+G%C3%B3mezauthor=L.+Cort%C3%A9s-Gilauthor=A.+Mart%C3%ADnezauthor=S.+Ferrerauthor=M.+T.+Fraileauthor=F.+Calder%C3%B3nauthor=E.+Fern%C3%A1ndezauthor=L.+D.+Shultzauthor=D.+Leroyauthor=D.+M.+Wilsonauthor=J.+F.+Garc%C3%ADa-Bustosauthor=F.+J.+Gamoauthor=I.+Angulo-Barturen&title=A+New+In+Vivo+Screening+Paradigm+to+Accelerate+Antimalarial+Drug+Discovery&doi=10.1371%2Fjournal.pone.0066967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A new in vivo screening paradigm to accelerate antimalarial drug discovery</span></div><div class="casAuthors">Jimenez-Diaz, Maria Belen; Viera, Sara; Ibanez, Javier; Mulet, Teresa; Magan-Marchal, Noemi; Garuti, Helen; Gomez, Vanessa; Cortes-Gil, Lorena; Martiez, Antonio; Ferrer, Santiago; Fraile, Maria Teresa; Caldero, Felix; Fernandez, Esther; Shultz, Leonard D.; Leroy, Didier; Wilson, David M.; Garcia-Bustos, Jose Francisco; Gamo, Francisco Javier; Angulo-Barturen, Inigo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e66967</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The emergence of resistance to available antimalarials requires the urgent development of new medicines.  The recent disclosure of several thousand compds. active in vitro against the erythrocyte stage of Plasmodium falciparum has been a major breakthrough, though converting these hits into new medicines challenges current strategies.  A new in vivo screening concept was evaluated as a strategy to increase the speed and efficiency of drug discovery projects in malaria.  The new in vivo screening concept was developed based on human disease parameters, i.e. parasitemia in the peripheral blood of patients on hospital admission and parasite redn. ratio (PRR), which were allometrically down-scaled into P. berghei-infected mice.  Mice with an initial parasitemia (P0) of 1.5% were treated orally for two consecutive days and parasitemia measured 24 h after the second dose.  The assay was optimized for detection of compds. able to stop parasite replication (PRR = 1) or induce parasite clearance (PRR >1) with statistical power >99% using only two mice per exptl. group.  In the P. berghei in vivo screening assay, the PRR of a set of eleven antimalarials with different mechanisms of action correlated with human-equiv. data.  Subsequently, 590 compds. from the Tres Cantos Antimalarial Set with activity in vitro against P. falciparum were tested at 50 mg/kg (orally) in an assay format that allowed the evaluation of hundreds of compds. per mo.  The rate of compds. with detectable efficacy was 11.2% and about one third of active compds. showed in vivo efficacy comparable with the most potent antimalarials used clin.  High-throughput, high-content in vivo screening could rapidly select new compds., dramatically speeding up the discovery of new antimalarial medicines.  A global multilateral collaborative project aimed at screening the significant chem. diversity within the antimalarial in vitro hits described in the literature is a feasible task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXKzdqs7h8k7Vg90H21EOLACvtfcHk0lj-VQuPSkfbpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2qtbjJ&md5=35d24cc0f14f22be828f36714752ac78</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0066967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0066967%26sid%3Dliteratum%253Aachs%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DViera%26aufirst%3DS.%26aulast%3DIb%25C3%25A1%25C3%25B1ez%26aufirst%3DJ.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DMag%25C3%25A1n-Marchal%26aufirst%3DN.%26aulast%3DGaruti%26aufirst%3DH.%26aulast%3DG%25C3%25B3mez%26aufirst%3DV.%26aulast%3DCort%25C3%25A9s-Gil%26aufirst%3DL.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DFraile%26aufirst%3DM.%2BT.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DShultz%26aufirst%3DL.%2BD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26atitle%3DA%2520New%2520In%2520Vivo%2520Screening%2520Paradigm%2520to%2520Accelerate%2520Antimalarial%2520Drug%2520Discovery%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De66967%26doi%3D10.1371%2Fjournal.pone.0066967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Boström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowright, A. T.</span><span> </span><span class="NLM_article-title">Oxadiazoles in Medicinal Chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1830</span><span class="refDoi"> DOI: 10.1021/jm2013248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=A.+Llin%C3%A0sauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+Medicinal+Chemistry&doi=10.1021%2Fjm2013248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazoles in medicinal chemistry</span></div><div class="casAuthors">Bostrom Jonas; Hogner Anders; Llinas Antonio; Wellner Eric; Plowright Alleyn T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms.  Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities.  The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection.  In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner.  Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers.  The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments).  To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO9RQiG9xFS2Zyxfu64m4ffW6udTcc2eY7kVqitJQkFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D&md5=b934995431ced1be297e6f126262f3cb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830%26doi%3D10.1021%2Fjm2013248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Pace, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierro, P.</span><span> </span><span class="NLM_article-title">The New Era of 1,2,4-Oxadiazoles</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">4337</span><span class="NLM_x">–</span> <span class="NLM_lpage">4348</span><span class="refDoi"> DOI: 10.1039/b908937c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1039%2Fb908937c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=19830279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Gksb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=4337-4348&author=A.+Paceauthor=P.+Pierro&title=The+New+Era+of+1%2C2%2C4-Oxadiazoles&doi=10.1039%2Fb908937c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The new era of 1,2,4-oxadiazoles</span></div><div class="casAuthors">Pace, Andrea; Pierro, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4337-4348</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">This review covers the synthesis, the chem. and photochem. reactivity, and the use of 1,2,4-oxadiazoles in materials and as bioactive compds.  Further, the material in this survey includes some historical background, general features, state-of-the-art applications together with a crit. discussion about current limitations and suggestions for future developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS_Jcg58EXy7Vg90H21EOLACvtfcHk0liFSdvGPJqheA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Gksb7E&md5=9314bd3fbc51b2e5bc1a6eafa44646a4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fb908937c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb908937c%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DA.%26aulast%3DPierro%26aufirst%3DP.%26atitle%3DThe%2520New%2520Era%2520of%25201%252C2%252C4-Oxadiazoles%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D4337%26epage%3D4348%26doi%3D10.1039%2Fb908937c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV AIDS Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5843</span><span class="NLM_x">–</span> <span class="NLM_lpage">5855</span><span class="refDoi"> DOI: 10.1021/jm800245z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+Raltegravir%2C+a+Potent%2C+Selective+Orally+Bioavailable+HIV-Integrase+Inhibitor+for+the+Treatment+of+HIV+AIDS+Infection&doi=10.1021%2Fjm800245z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Raltegravir%252C%2520a%2520Potent%252C%2520Selective%2520Orally%2520Bioavailable%2520HIV-Integrase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520HIV%2520AIDS%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5843%26epage%3D5855%26doi%3D10.1021%2Fjm800245z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zareef, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamboa De Dominguez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arfan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Synthesis and Antimalarial Activity of Novel Chiral and Achiral Benzenesulfonamides Bearing 1, 3, 4-Oxadiazole Moieties</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.1080/14756360601114569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1080%2F14756360601114569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=17674812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslygtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=301-308&author=M.+Zareefauthor=R.+Iqbalauthor=N.+Gamboa+De+Dominguezauthor=J.+Rodriguesauthor=J.+H.+Zaidiauthor=M.+Arfanauthor=C.+T.+Supuran&title=Synthesis+and+Antimalarial+Activity+of+Novel+Chiral+and+Achiral+Benzenesulfonamides+Bearing+1%2C+3%2C+4-Oxadiazole+Moieties&doi=10.1080%2F14756360601114569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimalarial activity of novel chiral and achiral benzenesulfonamides bearing 1, 3, 4-oxadiazole moieties</span></div><div class="casAuthors">Zareef, Muhammad; Iqbal, Rashid; Gamboa de Dominguez, Neira; Rodrigues, Juan; Zaidi, Javid H.; Arfan, Muhammad; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-308</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of new benzenesulfonamides, most of which are chiral, incorporating 1, 3, 4-oxadiazole and amino acid moieties have been synthesized.  Some of these compds. were screened for antimalarial activity and also evaluated for their ability to inhibit hem polymn.  The electrophoretic anal. indicated that compd. I was effective in inhibiting the degrdn. of Hb.  The synthesized compds. were tested in mice infected with Plasmodium berghei.  These derivs. have the potential for the development of novel antimalarial lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ibmYXDuXaLVg90H21EOLACvtfcHk0ljakHolaOv11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslygtLw%253D&md5=e24b51959645edd843f2f1cba7c66268</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F14756360601114569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360601114569%26sid%3Dliteratum%253Aachs%26aulast%3DZareef%26aufirst%3DM.%26aulast%3DIqbal%26aufirst%3DR.%26aulast%3DGamboa%2BDe%2BDominguez%26aufirst%3DN.%26aulast%3DRodrigues%26aufirst%3DJ.%26aulast%3DZaidi%26aufirst%3DJ.%2BH.%26aulast%3DArfan%26aufirst%3DM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DSynthesis%2520and%2520Antimalarial%2520Activity%2520of%2520Novel%2520Chiral%2520and%2520Achiral%2520Benzenesulfonamides%2520Bearing%25201%252C%25203%252C%25204-Oxadiazole%2520Moieties%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2007%26volume%3D22%26spage%3D301%26epage%3D308%26doi%3D10.1080%2F14756360601114569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De-Cozar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llergo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span> </span><span class="NLM_article-title">P. falciparum in Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30949</span><span class="refDoi"> DOI: 10.1371/journal.pone.0030949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1371%2Fjournal.pone.0030949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=22383983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30949&author=L.+M.+Sanzauthor=B.+Crespoauthor=C.+De-Cozarauthor=X.+C.+Dingauthor=J.+L.+Llergoauthor=J.+N.+Burrowsauthor=J.+F.+Garc%C3%ADa-Bustosauthor=F.-J.+Gamo&title=P.+falciparum+in+Vitro+Killing+Rates+Allow+to+Discriminate+between+Different+Antimalarial+Mode-of-Action&doi=10.1371%2Fjournal.pone.0030949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span></div><div class="casAuthors">Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e30949</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemotherapy is still the cornerstone for malaria control.  Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately det. the parasite killing rate in response to treatment.  Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability.  However, these approaches are susceptible to artifacts, as viability and metab. are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions.  Moreover, traditional techniques do not allow to measure the speed-of-action of compds. on parasite viability, which is an essential efficacy determinant.  We present here a comprehensive methodol. to measure in vitro the direct effect of antimalarial compds. over the parasite viability, which is based on limiting serial diln. of treated parasites and re-growth monitoring.  This methodol. allows to precisely det. the killing rate of antimalarial compds., which can be quantified by the parasite redn. ratio and parasite clearance time, which are key mode-of-action parameters.  Importantly, we demonstrate that this technique readily permits to det. compd. killing activities that might be otherwise missed by traditional, metab.-based techniques.  The anal. of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compds. based on their antimalarial mode-of-action.  This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compds., which are crucially needed for the control and possibly the eradication of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaUZufRfYxbVg90H21EOLACvtfcHk0ljakHolaOv11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D&md5=65d5d1a24dbe1811301ac5e684c886c5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030949%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DDe-Cozar%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DLlergo%26aufirst%3DJ.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.-J.%26atitle%3DP.%2520falciparum%2520in%2520Vitro%2520Killing%2520Rates%2520Allow%2520to%2520Discriminate%2520between%2520Different%2520Antimalarial%2520Mode-of-Action%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30949%26doi%3D10.1371%2Fjournal.pone.0030949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Nassar, A-E F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarimont, C.</span><span> </span><span class="NLM_article-title">Improving the Decision-making Process in the Structural Modification of Drug Candidates: Enhancing Metabolic Stability</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1020</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2FS1359-6446%2804%2903280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=15574318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1020-1028&author=A-E+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+Decision-making+Process+in+the+Structural+Modification+of+Drug+Candidates%3A+Enhancing+Metabolic+Stability&doi=10.1016%2FS1359-6446%2804%2903280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Kamel, Amin M.; Clarimont, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1020-1028</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.  The activity-exposure-toxicity relationship, which can be described as the rule of three', presents the single most difficult challenge in the design of drug candidates and their subsequent advancement to the development stage.  ADME studies are widely used in drug discovery to optimize the balance of properties necessary to convert lead candidates into drugs that are safe and effective for humans.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokn5ucRSES-rVg90H21EOLACvtfcHk0ljakHolaOv11A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL&md5=67a85a167b62f0ea4e9f43d25f3e0866</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903280-5%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA-E%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520Decision-making%2520Process%2520in%2520the%2520Structural%2520Modification%2520of%2520Drug%2520Candidates%253A%2520Enhancing%2520Metabolic%2520Stability%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1020%26epage%3D1028%26doi%3D10.1016%2FS1359-6446%2804%2903280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Dıaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regadera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez de las Heras, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargallo-Viola, D.</span><span> </span><span class="NLM_article-title">A Murine Model of Falciparum-malaria by In Vivo Selection of Competent Strains in Non-myelodepleted Mice Engrafted with Humanerythrocytes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2252</span><span class="refDoi"> DOI: 10.1371/journal.pone.0002252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1371%2Fjournal.pone.0002252" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2252&author=I.+Angulo-Barturenauthor=M.+B.+Jimenez-D%C4%B1azauthor=T.+Muletauthor=J.+Rullasauthor=E.+Herrerosauthor=S.+Ferrerauthor=E.+Jim%C3%A9nezauthor=A.+Mendozaauthor=J.+Regaderaauthor=P.+J.+Rosenthalauthor=I.+Bathurstauthor=D.+L.+Pomplianoauthor=F.+G%C3%B3mez+de+las+Herasauthor=D.+Gargallo-Viola&title=A+Murine+Model+of+Falciparum-malaria+by+In+Vivo+Selection+of+Competent+Strains+in+Non-myelodepleted+Mice+Engrafted+with+Humanerythrocytes&doi=10.1371%2Fjournal.pone.0002252"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002252%26sid%3Dliteratum%253Aachs%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-D%25C4%25B1az%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DE.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRegadera%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DG%25C3%25B3mez%2Bde%2Blas%2BHeras%26aufirst%3DF.%26aulast%3DGargallo-Viola%26aufirst%3DD.%26atitle%3DA%2520Murine%2520Model%2520of%2520Falciparum-malaria%2520by%2520In%2520Vivo%2520Selection%2520of%2520Competent%2520Strains%2520in%2520Non-myelodepleted%2520Mice%2520Engrafted%2520with%2520Humanerythrocytes%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2252%26doi%3D10.1371%2Fjournal.pone.0002252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Jakopin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolenc, M. S.</span><span> </span><span class="NLM_article-title">Recent Advances in the Synthesis of 1,2,4- and 1,3,4-Oxadiazoles</span> <span class="citation_source-journal">Curr. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span><span class="refDoi"> DOI: 10.2174/138527208784911860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.2174%2F138527208784911860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFWmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=850-898&author=Z.+Jakopinauthor=M.+S.+Dolenc&title=Recent+Advances+in+the+Synthesis+of+1%2C2%2C4-+and+1%2C3%2C4-Oxadiazoles&doi=10.2174%2F138527208784911860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the synthesis of 1,2,4- and 1,3,4-oxadiazoles</span></div><div class="casAuthors">Jakopin, Ziga; Dolenc, Marija Sollner</div><div class="citationInfo"><span class="NLM_cas:title">Current Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">850-898</span>CODEN:
                <span class="NLM_cas:coden">CORCFE</span>;
        ISSN:<span class="NLM_cas:issn">1385-2728</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The synthesis of peptidomimetics is an area of research that gained a lot of attention in recent years.  Peptidomimetics are compds. designed to mimic the natural peptide but retain its activity with increased stability and bioavailibility, as a result of the structural changes introduced into the parent mol.  The most frequent of these changes are peptide bond surrogates, which contribute to the hydrolytic resistance of peptidomimetics.  1,2,4- And 1,3,4-oxadiazoles are commonly employed as bioisosteric replacements of the amide bond thus constituting these heterocycles as an important structural motif for the pharmaceutical industry.  The article will therefore provide an insight into the synthetic methodologies leading to 1,2,4- and 1,3,4-oxadiazole formation to give the reader an appreciation of the field.  This review covered all recent developments achieved in the classical synthesis.  Addnl., it focuses on the emerging methodologies of microwave-assisted and solid phase synthesis, thus revealing the scope of influence that these methodologies have in the synthesis of 1,2,4- and 1,3,4-oxadiazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jpuRcYHHErVg90H21EOLACvtfcHk0ljGJAIsgBOwMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFWmtb0%253D&md5=769ce1aba50a18160228f6d3d4eedc4e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F138527208784911860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138527208784911860%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3DZ.%26aulast%3DDolenc%26aufirst%3DM.%2BS.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Synthesis%2520of%25201%252C2%252C4-%2520and%25201%252C3%252C4-Oxadiazoles%26jtitle%3DCurr.%2520Org.%2520Chem.%26date%3D2008%26volume%3D12%26spage%3D850%26epage%3D898%26doi%3D10.2174%2F138527208784911860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Johnson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leet, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejwani, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.-Z.</span><span> </span><span class="NLM_article-title">Metabolism of 5-Isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-<i>N</i>-(2-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)pyrrolo[2,1-<i>f</i>][1,2,4]triazin-4-amine (BMS-645737): Identification of an Unusual <i>N</i>-Acetylglucosamine Conjugate in the Cynomolgus Monkey</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2475</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span><span class="refDoi"> DOI: 10.1124/dmd.108.022624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1124%2Fdmd.108.022624" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2475-2483&author=B.+M.+Johnsonauthor=A.+V.+Kamathauthor=J.+E.+Leetauthor=X.+Liuauthor=R.+S.+Bhideauthor=R.+W.+Tejwaniauthor=Y.+Zhangauthor=L.+Qianauthor=D.+D.+Weiauthor=L.+J.+Lombardoauthor=Y.-Z.+Shu&title=Metabolism+of+5-Isopropyl-6-%285-methyl-1%2C3%2C4-oxadiazol-2-yl%29-N-%282-methyl-1H-pyrrolo%5B2%2C3-b%5Dpyridin-5-yl%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-4-amine+%28BMS-645737%29%3A+Identification+of+an+Unusual+N-Acetylglucosamine+Conjugate+in+the+Cynomolgus+Monkey&doi=10.1124%2Fdmd.108.022624"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.022624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.022624%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DLeet%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DTejwani%26aufirst%3DR.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DD.%2BD.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DShu%26aufirst%3DY.-Z.%26atitle%3DMetabolism%2520of%25205-Isopropyl-6-%25285-methyl-1%252C3%252C4-oxadiazol-2-yl%2529-N-%25282-methyl-1H-pyrrolo%255B2%252C3-b%255Dpyridin-5-yl%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-4-amine%2520%2528BMS-645737%2529%253A%2520Identification%2520of%2520an%2520Unusual%2520N-Acetylglucosamine%2520Conjugate%2520in%2520the%2520Cynomolgus%2520Monkey%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2475%26epage%3D2483%26doi%3D10.1124%2Fdmd.108.022624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberhard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boesche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouwmeester, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuster, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span> </span><span class="NLM_article-title">Quantitative Chemical Proteomics Reveals Mechanisms of Action of Clinical ABL Kinase Inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1038/nbt1328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnbt1328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=17721511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWksLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1035-1044&author=M.+Bantscheffauthor=D.+Eberhardauthor=Y.+Abrahamauthor=S.+Bastuckauthor=M.+Boescheauthor=S.+Hobsonauthor=T.+Mathiesonauthor=J.+Perrinauthor=M.+Raidaauthor=C.+Rauauthor=V.+Readerauthor=G.+Sweetmanauthor=A.+Bauerauthor=T.+Bouwmeesterauthor=C.+Hopfauthor=U.+Kruseauthor=G.+Neubauerauthor=N.+Ramsdenauthor=J.+Rickauthor=B.+Kusterauthor=G.+Drewes&title=Quantitative+Chemical+Proteomics+Reveals+Mechanisms+of+Action+of+Clinical+ABL+Kinase+Inhibitors&doi=10.1038%2Fnbt1328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors</span></div><div class="casAuthors">Bantscheff, Marcus; Eberhard, Dirk; Abraham, Yann; Bastuck, Sonja; Boesche, Markus; Hobson, Scott; Mathieson, Toby; Perrin, Jessica; Raida, Manfred; Rau, Christina; Reader, Valerie; Sweetman, Gavain; Bauer, Andreas; Bouwmeester, Tewis; Hopf, Carsten; Kruse, Ulrich; Neubauer, Gitte; Ramsden, Nigel; Rick, Jens; Kuster, Bernhard; Drewes, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1035-1044</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors describe a chem. proteomics approach to profile the interaction of small mols. with hundreds of endogenously expressed protein kinases and purine-binding proteins.  This subproteome is captured by immobilized nonselective kinase inhibitors (kinobeads), and the bound proteins are quantified in parallel by mass spectrometry using isobaric tags for relative and abs. quantification (iTRAQ).  By measuring the competition with the affinity matrix, the authors assess the binding of drugs to their targets in cell lysates and in cells.  By mapping drug-induced changes in the phosphorylation state of the captured proteome, the authors also analyze signaling pathways downstream of target kinases.  Quant. profiling of the drugs imatinib (Gleevec), dasatinib (Sprycel) and bosutinib in K562 cells confirms known targets including ABL and SRC family kinases and identifies the receptor tyrosine kinase DDR1 and the oxidoreductase NQO2 as novel targets of imatinib.  The data suggest that the approach is a valuable tool for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsC3OpIuhl8LVg90H21EOLACvtfcHk0lha5KSaFWURLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWksLvF&md5=ed20d4684a8a6733aba24ca64602bae8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnbt1328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1328%26sid%3Dliteratum%253Aachs%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DEberhard%26aufirst%3DD.%26aulast%3DAbraham%26aufirst%3DY.%26aulast%3DBastuck%26aufirst%3DS.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DHobson%26aufirst%3DS.%26aulast%3DMathieson%26aufirst%3DT.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRaida%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DReader%26aufirst%3DV.%26aulast%3DSweetman%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DKruse%26aufirst%3DU.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DRick%26aufirst%3DJ.%26aulast%3DKuster%26aufirst%3DB.%26aulast%3DDrewes%26aufirst%3DG.%26atitle%3DQuantitative%2520Chemical%2520Proteomics%2520Reveals%2520Mechanisms%2520of%2520Action%2520of%2520Clinical%2520ABL%2520Kinase%2520Inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1035%26epage%3D1044%26doi%3D10.1038%2Fnbt1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bergamini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doce, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leggate, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plavec, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rharbaoui, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rausch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span> </span><span class="NLM_article-title">A Selective Inhibitor Reveals PI3Kγ Dependence of T(H)17 Cell Differentiation</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1038/nchembio.957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnchembio.957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=22544264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Gqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=576-582&author=G.+Bergaminiauthor=K.+Bellauthor=S.+Shimamuraauthor=T.+Wernerauthor=A.+Cansfieldauthor=K.+M%C3%BCllerauthor=J.+Perrinauthor=C.+Rauauthor=K.+Ellardauthor=C.+Hopfauthor=C.+Doceauthor=D.+Leggateauthor=R.+Manganoauthor=T.+Mathiesonauthor=A.+O%E2%80%99Mahonyauthor=I.+Plavecauthor=F.+Rharbaouiauthor=F.+Reinhardauthor=M.+M.+Savitskiauthor=N.+Ramsdenauthor=E.+Hirschauthor=G.+Drewesauthor=O.+Rauschauthor=M.+Bantscheffauthor=G.+Neubauer&title=A+Selective+Inhibitor+Reveals+PI3K%CE%B3+Dependence+of+T%28H%2917+Cell+Differentiation&doi=10.1038%2Fnchembio.957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation</span></div><div class="casAuthors">Bergamini, Giovanna; Bell, Kathryn; Shimamura, Satoko; Werner, Thilo; Cansfield, Andrew; Mueller, Katrin; Perrin, Jessica; Rau, Christina; Ellard, Katie; Hopf, Carsten; Doce, Carola; Leggate, Daniel; Mangano, Raffaella; Mathieson, Toby; O'Mahony, Alison; Plavec, Ivan; Rharbaoui, Faiza; Reinhard, Friedrich; Savitski, Mikhail M.; Ramsden, Nigel; Hirsch, Emilio; Drewes, Gerard; Rausch, Oliver; Bantscheff, Marcus; Neubauer, Gitte</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">576-582</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We devised a high-throughput chemoproteomics method that enabled multiplexed screening of 16,000 compds. against native protein and lipid kinases in cell exts.  Optimization of one chem. series resulted in CZC24832, which is to our knowledge the first selective inhibitor of phosphoinositide 3-kinase γ (PI3Kγ) with efficacy in in vitro and in vivo models of inflammation.  Extensive target- and cell-based profiling of CZC24832 revealed regulation of interleukin-17-producing T helper cell (TH17) differentiation by PI3Kγ, thus reinforcing selective inhibition of PI3Kγ as a potential treatment for inflammatory and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqinUn8kLqw_LVg90H21EOLACvtfcHk0lha5KSaFWURLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Gqt7c%253D&md5=0141d8596ee10d4d796de57fb87a2c19</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.957%26sid%3Dliteratum%253Aachs%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DShimamura%26aufirst%3DS.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DCansfield%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DEllard%26aufirst%3DK.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DDoce%26aufirst%3DC.%26aulast%3DLeggate%26aufirst%3DD.%26aulast%3DMangano%26aufirst%3DR.%26aulast%3DMathieson%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DPlavec%26aufirst%3DI.%26aulast%3DRharbaoui%26aufirst%3DF.%26aulast%3DReinhard%26aufirst%3DF.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DRausch%26aufirst%3DO.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DNeubauer%26aufirst%3DG.%26atitle%3DA%2520Selective%2520Inhibitor%2520Reveals%2520PI3K%25CE%25B3%2520Dependence%2520of%2520T%2528H%252917%2520Cell%2520Differentiation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D576%26epage%3D582%26doi%3D10.1038%2Fnchembio.957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wolber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendix, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Molecule-pharmacophore Superpositioning and Pattern Matching in Computational Drug Design</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.drudis.2007.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2Fj.drudis.2007.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=18190860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVWhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=23-29&author=G.+Wolberauthor=T.+Seidelauthor=F.+Bendixauthor=T.+Langer&title=Molecule-pharmacophore+Superpositioning+and+Pattern+Matching+in+Computational+Drug+Design&doi=10.1016%2Fj.drudis.2007.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecule-pharmacophore superpositioning and pattern matching in computational drug design</span></div><div class="casAuthors">Wolber, Gerhard; Seidel, Thomas; Bendix, Fabian; Langer, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Three-dimensional (3D) pharmacophore modeling is a technique for describing the interaction of a small mol. ligand with a macromol. target.  Since chem. features in a pharmacophore model are well known and highly transparent for medicinal chemists, these models are intuitively understandable and have been increasingly successful in computational drug discovery in the past few years.  The performance and applicability of pharmacophore modeling depends on two main factors: the definition and placement of pharmacophoric features and the alignment techniques used to overlay 3D pharmacophore models and small mols.  An overview of key technologies and latest developments in the area of 3D pharmacophores is given and provides insight into different approaches as implemented by the 3D pharmacophore modeling packages like Catalyst, MOE, Phase and LigandScout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf1WZmfDtNXLVg90H21EOLACvtfcHk0lh3b3aKMPEK7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVWhtA%253D%253D&md5=ce232a83e23dac545e35b600de6aeb33</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DWolber%26aufirst%3DG.%26aulast%3DSeidel%26aufirst%3DT.%26aulast%3DBendix%26aufirst%3DF.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DMolecule-pharmacophore%2520Superpositioning%2520and%2520Pattern%2520Matching%2520in%2520Computational%2520Drug%2520Design%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D23%26epage%3D29%26doi%3D10.1016%2Fj.drudis.2007.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Alf Claesson, <span class="NLM_string-name hlFld-ContribAuthor">Alexander Minidis</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic Approach to Organizing Structural Alerts for Reactive Metabolite Formation from Potential Drugs. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2018,</strong> <em>31 </em>
                                    (6)
                                     , 389-411. <a href="https://doi.org/10.1021/acs.chemrestox.8b00046" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.8b00046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.8b00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.8b00046%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DSystematic%252BApproach%252Bto%252BOrganizing%252BStructural%252BAlerts%252Bfor%252BReactive%252BMetabolite%252BFormation%252Bfrom%252BPotential%252BDrugs%26aulast%3DClaesson%26aufirst%3DAlf%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21022018%26date%3D21052018%26date%3D10052018%26volume%3D31%26issue%3D6%26spage%3D389%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aizhan Abdildinova, <span class="NLM_string-name hlFld-ContribAuthor">Young-Dae Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Current Parallel Solid-Phase Synthesis of Drug-like Oxadiazole and Thiadiazole Derivatives for Combinatorial Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2018,</strong> <em>20 </em>
                                    (6)
                                     , 309-329. <a href="https://doi.org/10.1021/acscombsci.8b00044" title="DOI URL">https://doi.org/10.1021/acscombsci.8b00044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.8b00044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.8b00044%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DCurrent%252BParallel%252BSolid-Phase%252BSynthesis%252Bof%252BDrug-like%252BOxadiazole%252Band%252BThiadiazole%252BDerivatives%252Bfor%252BCombinatorial%252BChemistry%26aulast%3DAbdildinova%26aufirst%3DAizhan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27032018%26date%3D26042018%26date%3D07052018%26date%3D01052018%26volume%3D20%26issue%3D6%26spage%3D309%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dilep  Kumar Sigalapalli</span>, <span class="hlFld-ContribAuthor ">Manasa  Kadagathur</span>, <span class="hlFld-ContribAuthor ">Arbaz  Sujat Shaikh</span>, <span class="hlFld-ContribAuthor ">Govinda S.  Jadhav</span>, <span class="hlFld-ContribAuthor ">Bulti  Bakchi</span>, <span class="hlFld-ContribAuthor ">Bathini  Nagendra Babu</span>, <span class="hlFld-ContribAuthor ">Neelima D.  Tangellamudi</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave‐Assisted TBHP‐Mediated Synthesis of 2‐Amino‐1,3,4‐oxadiazoles in Water. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (42)
                                     , 13248-13258. <a href="https://doi.org/10.1002/slct.202003516" title="DOI URL">https://doi.org/10.1002/slct.202003516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202003516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202003516%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DMicrowave%2525E2%252580%252590Assisted%252BTBHP%2525E2%252580%252590Mediated%252BSynthesis%252Bof%252B2%2525E2%252580%252590Amino%2525E2%252580%2525901%25252C3%25252C4%2525E2%252580%252590oxadiazoles%252Bin%252BWater%26aulast%3DKumar%2BSigalapalli%26aufirst%3DDilep%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D42%26spage%3D13248%26epage%3D13258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krzysztof Z.  Walczak</span>, <span class="hlFld-ContribAuthor ">Wojciech  Szczepankiewicz</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,4-Oxadiazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00019-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00019-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00019-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00019-6%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C3%25252C4-Oxadiazoles%26aulast%3DWalczak%26aufirst%3DKrzysztof%2BZ.%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esther  Fernández</span>, <span class="hlFld-ContribAuthor ">María Isabel  Castellote</span>, <span class="hlFld-ContribAuthor ">María Jesús  Chaparro</span>, <span class="hlFld-ContribAuthor ">Beatriz  Díaz</span>, <span class="hlFld-ContribAuthor ">Jorge  Fernández</span>, <span class="hlFld-ContribAuthor ">Mariola  Gordo</span>, <span class="hlFld-ContribAuthor ">Laura  de las Heras</span>, <span class="hlFld-ContribAuthor ">María Luisa  León</span>, <span class="hlFld-ContribAuthor ">Lourdes  Rueda</span>, <span class="hlFld-ContribAuthor ">Félix  Calderón</span>. </span><span class="cited-content_cbyCitation_article-title">A decade of malaria phenotypic screenings: Key lessons on the discovery and development of new antimalarial drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-23. <a href="https://doi.org/10.1016/bs.armc.2019.07.001" title="DOI URL">https://doi.org/10.1016/bs.armc.2019.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2019.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2019.07.001%26sid%3Dliteratum%253Aachs%26atitle%3DA%252Bdecade%252Bof%252Bmalaria%252Bphenotypic%252Bscreenings%25253A%252BKey%252Blessons%252Bon%252Bthe%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bnew%252Bantimalarial%252Bdrugs%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DEsther%26date%3D2019%26spage%3D1%26epage%3D23%26pub%3DElsevier%26atitle%3DMedicinal%252BChemistry%252BApproaches%252Bto%252BMalaria%252Band%252BOther%252BTropical%252BDiseases%26date%3D2019%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nader M.  Boshta</span>, <span class="hlFld-ContribAuthor ">Enas A.  Elgamal</span>, <span class="hlFld-ContribAuthor ">Ibrahim E. T.  El-Sayed</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive amide and α-aminophosphonate inhibitors for methicillin-resistant Staphylococcus aureus (MRSA). </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2018,</strong> <em>149 </em>
                                    (12)
                                     , 2349-2358. <a href="https://doi.org/10.1007/s00706-018-2303-y" title="DOI URL">https://doi.org/10.1007/s00706-018-2303-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-018-2303-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-018-2303-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DBioactive%252Bamide%252Band%252B%2525CE%2525B1-aminophosphonate%252Binhibitors%252Bfor%252Bmethicillin-resistant%252BStaphylococcus%252Baureus%252B%252528MRSA%252529%26aulast%3DBoshta%26aufirst%3DNader%2BM.%26date%3D2018%26date%3D2018%26volume%3D149%26issue%3D12%26spage%3D2349%26epage%3D2358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Geoffrey  Schwertz</span>, <span class="hlFld-ContribAuthor ">Matthias C.  Witschel</span>, <span class="hlFld-ContribAuthor ">Matthias  Rottmann</span>, <span class="hlFld-ContribAuthor ">Ubolsree  Leartsakulpanich</span>, <span class="hlFld-ContribAuthor ">Penchit  Chitnumsub</span>, <span class="hlFld-ContribAuthor ">Aritsara  Jaruwat</span>, <span class="hlFld-ContribAuthor ">Watcharee  Amornwatcharapong</span>, <span class="hlFld-ContribAuthor ">Wanwipa  Ittarat</span>, <span class="hlFld-ContribAuthor ">Anja  Schäfer</span>, <span class="hlFld-ContribAuthor ">Raphael A.  Aponte</span>, <span class="hlFld-ContribAuthor ">Nils  Trapp</span>, <span class="hlFld-ContribAuthor ">Pimchai  Chaiyen</span>, <span class="hlFld-ContribAuthor ">François  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Inhibitors of
              Plasmodial
              Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (9)
                                     , 931-943. <a href="https://doi.org/10.1002/cmdc.201800053" title="DOI URL">https://doi.org/10.1002/cmdc.201800053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800053%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPotent%252BInhibitors%252Bof%252BPlasmodial%252BSerine%252BHydroxymethyltransferase%252B%252528SHMT%252529%252BFeaturing%252Ba%252BSpirocyclic%252BScaffold%26aulast%3DSchwertz%26aufirst%3DGeoffrey%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D9%26spage%3D931%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0019.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Artemisinin (<b>1</b>), <b>2</b> (antimalarial containing oxadiazole scaffolds discovered by GSK), and the one described by Zareef et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (<b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Routes Used for Preparation of Compounds <b>2</b>–<b>17</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison between efficacy profiles of <b>2</b> (left) and <b>14</b> (right). Arrows indicate day of treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Strategy to improve physicochemical profile of <b>14</b> (X = C or N). Guidelines used to improve the physicochemical profile were to increase sp<sup>3</sup> character and flexibility/reduce aromaticity and lipophilicity (Alk, alkyl; Py, 3-pyridine).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Graphs: In vivo profile for <b>16b</b> (left) and <b>17a</b> (right). Table: key in vivo data for <b>16b</b> and <b>17a</b>. <sup>a</sup>Clearance (Cl) and half-life (<i>t</i><sub>1/2</sub>) mouse, iv, 1 mg/kg. <sup>b</sup>Oral bioavailability, mouse, po, 10 mg/kg. <sup>c</sup>Reference <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">29</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Routes Used for Preparation of Compounds <b>18a</b>–<b>d</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proposed mechanism of 1,3,4-aminoxadiazole degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/medium/jm-2016-01441n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Pharmacophore model 8, which gave the highest enrichment performance against the project compounds, was built from common features of superimposed compounds <b>4</b> (green sticks) and <b>18</b> (gray sticks). Pharmacophore features are indicated with circles: aromatic centroids and normal features orange cationic and hydrogen-bond donor features; projected points purple; hydrogen-bond acceptors cyan. (B) Enrichment performance of pharmacophore 8 against 418 project compounds, binned by activity (pIC<sub>50</sub>). The proportion of compounds detected by the model within each activity bin is colored green. The model matched 81% of compounds with pIC<sub>50</sub> > 6.5 and only 6% of compounds with pIC<sub>50</sub> ≤ 5.5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.6b01441/20170818/images/large/jm-2016-01441n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01441&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47544" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47544" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span> </span><span class="NLM_article-title">Antimalarial Drug Discovery: Recent Progress and Future Directions</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span><span class="refDoi"> DOI: 10.1016/B978-0-444-62652-3.00003-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2FB978-0-444-62652-3.00003-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=23384667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFGrsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=97-151&author=F.+Calder%C3%B3nauthor=D.+M.+Wilsonauthor=F.-J.+Gamo&title=Antimalarial+Drug+Discovery%3A+Recent+Progress+and+Future+Directions&doi=10.1016%2FB978-0-444-62652-3.00003-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug discovery: recent progress and future directions</span></div><div class="casAuthors">Calderon, Felix; Wilson, David M.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">97-151</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  This article discusses the recent developments and future perspectives on antimalarial chemotherapy, with a focus on the individual compds. and mechanisms rather than treatments as part of a combination product.  Antimalarial drugs with a complex mode of action and inhibiting defined mol. targets were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Nl668Y00BLVg90H21EOLACvtfcHk0ljgDeiYGLVz5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFGrsbc%253D&md5=48771e096c9f2096b95eb5d915a1e9e2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-62652-3.00003-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-444-62652-3.00003-X%26sid%3Dliteratum%253Aachs%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DGamo%26aufirst%3DF.-J.%26atitle%3DAntimalarial%2520Drug%2520Discovery%253A%2520Recent%2520Progress%2520and%2520Future%2520Directions%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D52%26spage%3D97%26epage%3D151%26doi%3D10.1016%2FB978-0-444-62652-3.00003-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>World Malaria Report 2016; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/malaria/publications/world-malaria-report-2016/en/" class="extLink">http://www.who.int/malaria/publications/world-malaria-report-2016/en/</a> (accessed February, 16, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Malaria+Report+2016%3B+World+Health+Organization%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fmalaria%2Fpublications%2Fworld-malaria-report-2016%2Fen%2F+%28accessed+February%2C+16%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Malaria%2520Report%25202016%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Sachs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaney, P.</span><span> </span><span class="NLM_article-title">The Economic and Social Burden of Malaria</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">685</span><span class="refDoi"> DOI: 10.1038/415680a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2F415680a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=11832956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=680-685&author=J.+Sachsauthor=P.+Malaney&title=The+Economic+and+Social+Burden+of+Malaria&doi=10.1038%2F415680a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The economic and social burden of malaria</span></div><div class="casAuthors">Sachs, Jeffrey; Malaney, Pia</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">415</span>
        (<span class="NLM_cas:issue">6872</span>),
    <span class="NLM_cas:pages">680-685</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Where malaria prospers most, human societies have prospered least.  The global distribution of per-capita gross domestic product shows a striking correlation between malaria and poverty, and malaria-endemic countries also have lower rates of economic growth.  There are multiple channels by which malaria impedes development, including effects on fertility, population growth, saving and investment, worker productivity, absenteeism, premature mortality and medical costs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJw0oyArOfc7Vg90H21EOLACvtfcHk0liF3vR_TA2V4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVCjtrY%253D&md5=0c755731170660d29535bc48425b494e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F415680a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F415680a%26sid%3Dliteratum%253Aachs%26aulast%3DSachs%26aufirst%3DJ.%26aulast%3DMalaney%26aufirst%3DP.%26atitle%3DThe%2520Economic%2520and%2520Social%2520Burden%2520of%2520Malaria%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D680%26epage%3D685%26doi%3D10.1038%2F415680a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span>Trends in Reported Malaria Incidence; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/en/" class="extLink">http://www.who.int/en/</a> (accessed Nov 19, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Trends+in+Reported+Malaria+Incidence%3B+World+Health+Organization%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fen%2F+%28accessed+Nov+19%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Reported%2520Malaria%2520Incidence%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ranson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">N’guessan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moiroux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nkuni, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbel, V.</span><span> </span><span class="NLM_article-title">Pyrethroid Resistance in African Anopheline Mosquitoes: What Are the Implications for Malaria Control?</span> <span class="citation_source-journal">Trends Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.pt.2010.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2Fj.pt.2010.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=20843745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=91-98&author=H.+Ransonauthor=R.+N%E2%80%99guessanauthor=J.+Linesauthor=N.+Moirouxauthor=Z.+Nkuniauthor=V.+Corbel&title=Pyrethroid+Resistance+in+African+Anopheline+Mosquitoes%3A+What+Are+the+Implications+for+Malaria+Control%3F&doi=10.1016%2Fj.pt.2010.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control?</span></div><div class="casAuthors">Ranson, Hilary; N'Guessan, Raphael; Lines, Jonathan; Moiroux, Nicolas; Nkuni, Zinga; Corbel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The use of pyrethroid insecticides in malaria vector control has increased dramatically in the past decade through the scale up of insecticide treated net distribution programs and indoor residual spraying campaigns.  Inevitably, the major malaria vectors have developed resistance to these insecticides and the resistance alleles are spreading at an exceptionally rapid rate throughout Africa.  Although substantial progress has been made on understanding the causes of pyrethroid resistance, remarkably few studies have focused on the epidemiol. impact of resistance on current malaria control activities.  As we move into the malaria eradication era, it is vital that the implications of insecticide resistance are understood and strategies to mitigate these effects are implemented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmOhvu-LCsBbVg90H21EOLACvtfcHk0liF3vR_TA2V4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yntbY%253D&md5=09bae65cf0bbef6db92d60e4125f8379</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2010.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2010.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DRanson%26aufirst%3DH.%26aulast%3DN%25E2%2580%2599guessan%26aufirst%3DR.%26aulast%3DLines%26aufirst%3DJ.%26aulast%3DMoiroux%26aufirst%3DN.%26aulast%3DNkuni%26aufirst%3DZ.%26aulast%3DCorbel%26aufirst%3DV.%26atitle%3DPyrethroid%2520Resistance%2520in%2520African%2520Anopheline%2520Mosquitoes%253A%2520What%2520Are%2520the%2520Implications%2520for%2520Malaria%2520Control%253F%26jtitle%3DTrends%2520Parasitol.%26date%3D2011%26volume%3D27%26spage%3D91%26epage%3D98%26doi%3D10.1016%2Fj.pt.2010.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Van den Berg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameneshewa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mnzava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hii, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dash, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ejov, M.</span><span> </span><span class="NLM_article-title">Global Trends in the Use of Insecticides to Control Vector-borne Diseases</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1289/ehp.1104340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1289%2Fehp.1104340" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=577-582&author=H.+Van+den+Bergauthor=M.+Zaimauthor=R.+S.+Yadavauthor=A.+Soaresauthor=B.+Ameneshewaauthor=A.+Mnzavaauthor=J.+Hiiauthor=A.+P.+Dashauthor=M.+Ejov&title=Global+Trends+in+the+Use+of+Insecticides+to+Control+Vector-borne+Diseases&doi=10.1289%2Fehp.1104340"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1289%2Fehp.1104340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1289%252Fehp.1104340%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bden%2BBerg%26aufirst%3DH.%26aulast%3DZaim%26aufirst%3DM.%26aulast%3DYadav%26aufirst%3DR.%2BS.%26aulast%3DSoares%26aufirst%3DA.%26aulast%3DAmeneshewa%26aufirst%3DB.%26aulast%3DMnzava%26aufirst%3DA.%26aulast%3DHii%26aufirst%3DJ.%26aulast%3DDash%26aufirst%3DA.%2BP.%26aulast%3DEjov%26aufirst%3DM.%26atitle%3DGlobal%2520Trends%2520in%2520the%2520Use%2520of%2520Insecticides%2520to%2520Control%2520Vector-borne%2520Diseases%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2012%26volume%3D120%26spage%3D577%26epage%3D582%26doi%3D10.1289%2Fehp.1104340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dondorp, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, N. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Socheat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Seidlein, L.</span><span> </span><span class="NLM_article-title">Artemisinin Resistance: Current Status and Scenarios for Containment</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">272</span><span class="NLM_x">–</span> <span class="NLM_lpage">280</span><span class="refDoi"> DOI: 10.1038/nrmicro2331</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnrmicro2331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=20208550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivVKjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=272-280&author=A.+M.+Dondorpauthor=S.+Yeungauthor=L.+Whiteauthor=C.+Nguonauthor=N.+P.+J.+Dayauthor=D.+Socheatauthor=L.+von+Seidlein&title=Artemisinin+Resistance%3A+Current+Status+and+Scenarios+for+Containment&doi=10.1038%2Fnrmicro2331"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin resistance: current status and scenarios for containment</span></div><div class="casAuthors">Dondorp, Arjen M.; Yeung, Shunmay; White, Lisa; Nguon, Chea; Day, Nicholas P. J.; Socheat, Duong; von Seidlein, Lorenz</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">272-280</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Artemisinin combination therapies are the first-line treatments for uncomplicated Plasmodium falciparum malaria in most malaria-endemic countries.  Recently, partial artemisinin-resistant P. falciparum malaria has emerged on the Cambodia-Thailand border.  Exposure of the parasite population to artemisinin monotherapies in subtherapeutic doses for over 30 years, and the availability of substandard artemisinins, have probably been the main driving force in the selection of the resistant phenotype in the region.  A multifaceted containment program has recently been launched, including early diagnosis and appropriate treatment, decreasing drug pressure, optimizing vector control, targeting the mobile population, strengthening management and surveillance systems, and operational research.  Math. modeling can be a useful tool to evaluate possible strategies for containment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonfWzrD-ixBLVg90H21EOLACvtfcHk0lg2chKu1M2ghQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivVKjsr0%253D&md5=b607e6a017568d0d6a71a0248d13724b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2331%26sid%3Dliteratum%253Aachs%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DL.%26aulast%3DNguon%26aufirst%3DC.%26aulast%3DDay%26aufirst%3DN.%2BP.%2BJ.%26aulast%3DSocheat%26aufirst%3DD.%26aulast%3Dvon%2BSeidlein%26aufirst%3DL.%26atitle%3DArtemisinin%2520Resistance%253A%2520Current%2520Status%2520and%2520Scenarios%2520for%2520Containment%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2010%26volume%3D8%26spage%3D272%26epage%3D280%26doi%3D10.1038%2Fnrmicro2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Straimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnädig, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amaratunga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duru, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramadani, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dacheux, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urnov, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercereau-Puijalon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benoit-Vical, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ménard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fidock, D. A.</span><span> </span><span class="NLM_article-title">Drug Resistance. K13-propeller Mutations Confer Artemisinin Resistance in Plasmodium Falciparum Clinical Isolates</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1126/science.1260867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1126%2Fscience.1260867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=25502314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=428-431&author=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=B.+Witkowskiauthor=C.+Amaratungaauthor=V.+Duruauthor=A.+P.+Ramadaniauthor=M.+Dacheuxauthor=N.+Khimauthor=L.+Zhangauthor=S.+Lamauthor=P.+D.+Gregoryauthor=F.+D.+Urnovauthor=O.+Mercereau-Puijalonauthor=F.+Benoit-Vicalauthor=R.+M.+Fairhurstauthor=D.+M%C3%A9nardauthor=D.+A.+Fidock&title=Drug+Resistance.+K13-propeller+Mutations+Confer+Artemisinin+Resistance+in+Plasmodium+Falciparum+Clinical+Isolates&doi=10.1126%2Fscience.1260867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates</span></div><div class="casAuthors">Straimer, Judith; Gnaedig, Nina F.; Witkowski, Benoit; Amaratunga, Chanaki; Duru, Valentine; Ramadani, Arba Pramundita; Dacheux, Melanie; Khim, Nimol; Zhang, Lei; Lam, Stephen; Gregory, Philip D.; Urnov, Fyodor D.; Mercereau-Puijalon, Odile; Benoit-Vical, Francoise; Fairhurst, Rick M.; Menard, Didier; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6220</span>),
    <span class="NLM_cas:pages">428-431</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The emergence of artemisinin resistance in Southeast Asia imperils efforts to reduce the global malaria burden.  We genetically modified the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival rates after drug exposure in vitro; these rates correlate with parasite clearance half-lives in artemisinin-treated patients.  With isolates from Cambodia, where resistance first emerged, survival rates decreased from 13 to 49% to 0.3 to 2.4% after the removal of K13 mutations.  Conversely, survival rates in wild-type parasites increased from ≤0.6% to 2 to 29% after the insertion of K13 mutations.  These mutations conferred elevated resistance to recent Cambodian isolates compared with that of ref. lines, suggesting a contemporary contribution of addnl. genetic factors.  Our data provide a conclusive rationale for worldwide K13-propeller sequencing to identify and eliminate artemisinin-resistant parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Ml-eUMKETLVg90H21EOLACvtfcHk0lg2chKu1M2ghQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVCiur4%253D&md5=5776238fb78428d16bcaed8d16fa73af</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1260867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1260867%26sid%3Dliteratum%253Aachs%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DRamadani%26aufirst%3DA.%2BP.%26aulast%3DDacheux%26aufirst%3DM.%26aulast%3DKhim%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DS.%26aulast%3DGregory%26aufirst%3DP.%2BD.%26aulast%3DUrnov%26aufirst%3DF.%2BD.%26aulast%3DMercereau-Puijalon%26aufirst%3DO.%26aulast%3DBenoit-Vical%26aufirst%3DF.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DDrug%2520Resistance.%2520K13-propeller%2520Mutations%2520Confer%2520Artemisinin%2520Resistance%2520in%2520Plasmodium%2520Falciparum%2520Clinical%2520Isolates%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D428%26epage%3D431%26doi%3D10.1126%2Fscience.1260867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">White, N. J.</span><span> </span><span class="NLM_article-title">Antimalarial Drug Resistance</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">1084</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span><span class="refDoi"> DOI: 10.1172/JCI21682</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1172%2FJCI21682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=15085184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1yisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2004&pages=1084-1092&author=N.+J.+White&title=Antimalarial+Drug+Resistance&doi=10.1172%2FJCI21682"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial drug resistance</span></div><div class="casAuthors">White, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1084-1092</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Malaria, the most prevalent and most pernicious parasitic disease of humans, is estd. to kill between one and two million people, mainly children, each year.  Resistance has emerged to all classes of antimalarial drugs except the artemisinins and is responsible for a recent increase in malaria-related mortality, particularly in Africa.  The de novo emergence of resistance can be prevented by the use of antimalarial drug combinations.  Artemisinin-deriv. combinations are particularly effective, since they act rapidly and are well tolerated and highly effective.  Widespread use of these drugs could roll back malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo66DKib7C1nLVg90H21EOLACvtfcHk0ljo4gPK-2WpLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1yisrc%253D&md5=5ebd8b2c447f183515238a9527d56121</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1172%2FJCI21682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI21682%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DAntimalarial%2520Drug%2520Resistance%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D113%26spage%3D1084%26epage%3D1092%26doi%3D10.1172%2FJCI21682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Farooq, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, R. C.</span><span> </span><span class="NLM_article-title">Drug Resistance in Malaria</span> <span class="citation_source-journal">J. Vector Borne Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=15672556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FksFSruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2004&pages=45-53&author=U.+Farooqauthor=R.+C.+Mahajan&title=Drug+Resistance+in+Malaria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance in malaria</span></div><div class="casAuthors">Farooq Umar; Mahajan R C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of vector borne diseases</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">45-53</span>
        ISSN:<span class="NLM_cas:issn">0972-9062</span>.
    </div><div class="casAbstract">Ever since the discovery of the first case of chloroquine resistance along the Thai-Combodian border in the late 1950s, Southeast Asia has played an important role as a focus for the development of drug resistance in Plasmodium falciparum.  Although the first case of quinine resistance had been reported much earlier from South America, the onset of chloroquine resistance marked the beginning of a new chapter in the history of malaria in Southeast Asia and by 1973 chloroquine finally had to be replaced by the combination of sulphadoxine and pyrimethamine (SP) as first line drug for the treatment of uncomplicated malaria in Thailand and more than 10 African countries have also switched their first line drug to SP.  In 1985, eventually SP was replaced by mefloquine.  The rapid development of resistance to this new drug leads to the introduction of artemisinin as a combination drug in the mid-1990s.  It is mandatory to mention here that therapeutic regimens for prevention and treatment of chloroquine-resistant P. falciparum are associated with higher costs and side-effects compared to chloroquine.  Additionally, some of these alternative treatments are associated with more side-effects, take longer time for cure and are more difficult to comply with than chloroquine.  Urgent efforts are needed to identify effective, affordable, alternative antimalarial regimens.  Molecular markers for antimalarial resistance have been identified, including pfmdr-1 and pfcrt polymorphisms associated with chloroquine resistance and dhfr and dhps polymorphisms associated with SP resistance.  Polymorphisms in pfmdr-1 may also be associated with resistance to chloroquine, mefloquine and artemisinin.  Use of such genetic information for the early detection of resistance foci and future monitoring of drug resistant malaria is a potentially useful epidemiological tool, in conjunction with the conventional in vitro and in vivo drug sensitivity assessments.  The purpose of this review is to describe the state of knowledge regarding drug resistant malaria and to outline the changing patterns of drug resistance including its determinants, current status in diverse geographical areas, molecular markers and their implications to limit the advent, spread and intensification of drug resistant malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmE7AgNfHRkKcY7HFp97qMfW6udTcc2eYyWI92Bmmbobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FksFSruw%253D%253D&md5=052b83e60c632150e7cc2ad7e7b94364</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarooq%26aufirst%3DU.%26aulast%3DMahajan%26aufirst%3DR.%2BC.%26atitle%3DDrug%2520Resistance%2520in%2520Malaria%26jtitle%3DJ.%2520Vector%2520Borne%2520Dis.%26date%3D2004%26volume%3D41%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Guiguemde, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diagana, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span> </span><span class="NLM_article-title">Global Phenotypic Screening for Antimalarials</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">116</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2Fj.chembiol.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=22284359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=116-129&author=W.+A.+Guiguemdeauthor=A.+A.+Shelatauthor=J.+F.+Garcia-Bustosauthor=T.+Diaganaauthor=F.+J.+Gamoauthor=R.+K.+Guy&title=Global+Phenotypic+Screening+for+Antimalarials&doi=10.1016%2Fj.chembiol.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Global Phenotypic Screening for Antimalarials</span></div><div class="casAuthors">Guiguemde, W. Armand; Shelat, Anang A.; Garcia-Bustos, Jose F.; Diagana, Thierry T.; Gamo, Francisco-Javier; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-129</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria, a devastating infectious disease caused by Plasmodium spp., leads to roughly 655,000 deaths per yr, mostly of African children.  To compd. the problem, drug resistance has emerged to all classical antimalarials and may be emerging for artemisinin-based combination therapies.  To address the need for new antimalarials with novel mechanisms, several groups carried out phenotypic screening campaigns to identify compds. inhibiting growth of the blood stages of Plasmodium falciparum.  In this review, we describe the characterization of these compds., explore currently ongoing strategies to develop lead mols., and endorse the concept of a "malaria box" of publicly accessible active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCn0XMDvpiA7Vg90H21EOLACvtfcHk0ljo4gPK-2WpLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CrsbY%253D&md5=56eacb3713c558ad449cc78eae8b7b14</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DGuiguemde%26aufirst%3DW.%2BA.%26aulast%3DShelat%26aufirst%3DA.%2BA.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DDiagana%26aufirst%3DT.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DGlobal%2520Phenotypic%2520Screening%2520for%2520Antimalarials%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D116%26epage%3D129%26doi%3D10.1016%2Fj.chembiol.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gardner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berriman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulsen, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzberg, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nene, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shallom, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiuoli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selengut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haft, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaidya, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlamb, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraunholz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadden, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanian, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carucci, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newbold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrell, B.</span><span> </span><span class="NLM_article-title">Genome Sequence of the Human Malaria Parasite Plasmodium Falciparum</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">419</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1038/nature01097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnature01097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=12368864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFais7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2002&pages=498-511&author=M.+J.+Gardnerauthor=N.+Hallauthor=E.+Fungauthor=O.+Whiteauthor=M.+Berrimanauthor=R.+W.+Hymanauthor=J.+M.+Carltonauthor=A.+Painauthor=K.+E.+Nelsonauthor=S.+Bowmanauthor=I.+T.+Paulsenauthor=K.+Jamesauthor=J.+A.+Eisenauthor=K.+Rutherfordauthor=S.+L.+Salzbergauthor=A.+Craigauthor=S.+Kyesauthor=M.+S.+Chanauthor=V.+Neneauthor=S.+J.+Shallomauthor=B.+Suhauthor=J.+Petersonauthor=S.+Angiuoliauthor=M.+Perteaauthor=J.+Allenauthor=J.+Selengutauthor=D.+Haftauthor=M.+W.+Matherauthor=A.+B.+Vaidyaauthor=D.+M.+Martinauthor=A.+H.+Fairlambauthor=M.+J.+Fraunholzauthor=D.+S.+Roosauthor=S.+A.+Ralphauthor=G.+I.+McFaddenauthor=L.+M.+Cummingsauthor=G.+M.+Subramanianauthor=C.+Mungallauthor=J.+C.+Venterauthor=D.+J.+Carucciauthor=S.+L.+Hoffmanauthor=C.+Newboldauthor=R.+W.+Davisauthor=C.+M.+Fraserauthor=B.+Barrell&title=Genome+Sequence+of+the+Human+Malaria+Parasite+Plasmodium+Falciparum&doi=10.1038%2Fnature01097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Genome sequence of the human malaria parasite Plasmodium falciparum</span></div><div class="casAuthors">Gardner, Malcolm J.; Hall, Neil; Fung, Eula; White, Owen; Berriman, Matthew; Hyman, Richard W.; Carlton, Jane M.; Pain, Arnab; Nelson, Karen E.; Bowman, Sharen; Paulsen, Ian T.; James, Keith; Eisen, Jonathan A.; Rutherford, Kim; Salzberg, Steven L.; Craig, Alister; Kyes, Sue; Chan, Man-Suen; Nene, Vishvanath; Shallom, Shamira J.; Suh, Bernard; Peterson, Jeremy; Angiuoli, Sam; Pertea, Mihaela; Allen, Jonathan; Selengut, Jeremy; Haft, Daniel; Mather, Michael W.; Vaidya, Akhil B.; Martin, David M. A.; Fairlamb, Alan H.; Fraunholz, Martin J.; Roos, David S.; Ralph, Stuart A.; McFadden, Geoffrey I.; Cummings, Leda M.; Subramanian, G. Mani; Mungall, Chris; Venter, J. Craig; Carucci, Daniel J.; Hoffman, Stephen L.; Newbold, Chris; Davis, Ronald W.; Fraser, Claire M.; Barrell, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">6906</span>),
    <span class="NLM_cas:pages">498-511</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The parasite Plasmodium falciparum is responsible for hundreds of millions of cases of malaria, and kills more than one million African children annually.  The genome sequence of P. falciparum clone 3D7 is reported.  The 23-megabase nuclear genome consists of 14 chromosomes, encodes about 5300 genes, and is the most (A + T)-rich genome sequenced to date.  Genes involved in antigenic variation are concd. in the subtelomeric regions of the chromosomes.  Compared to the genomes of free-living eukaryotic microbes, the genome of this intracellular parasite encodes fewer enzymes and transporters, but a large proportion of genes are devoted to immune evasion and host-parasite interactions.  Many nuclear-encoded proteins are targeted to the apicoplast, an organelle involved in fatty-acid and isoprenoid metab.  The genome sequence provides the foundation for future studies of this organism, and is being exploited in the search for new drugs and vaccines to fight malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWsAOvRnNBYLVg90H21EOLACvtfcHk0ljen3ViLF5Bhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFais7Y%253D&md5=d575af8bb4fef318660e0e6268f3f675</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnature01097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01097%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DM.%2BJ.%26aulast%3DHall%26aufirst%3DN.%26aulast%3DFung%26aufirst%3DE.%26aulast%3DWhite%26aufirst%3DO.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DHyman%26aufirst%3DR.%2BW.%26aulast%3DCarlton%26aufirst%3DJ.%2BM.%26aulast%3DPain%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DK.%2BE.%26aulast%3DBowman%26aufirst%3DS.%26aulast%3DPaulsen%26aufirst%3DI.%2BT.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DEisen%26aufirst%3DJ.%2BA.%26aulast%3DRutherford%26aufirst%3DK.%26aulast%3DSalzberg%26aufirst%3DS.%2BL.%26aulast%3DCraig%26aufirst%3DA.%26aulast%3DKyes%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DM.%2BS.%26aulast%3DNene%26aufirst%3DV.%26aulast%3DShallom%26aufirst%3DS.%2BJ.%26aulast%3DSuh%26aufirst%3DB.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DAngiuoli%26aufirst%3DS.%26aulast%3DPertea%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DSelengut%26aufirst%3DJ.%26aulast%3DHaft%26aufirst%3DD.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DMartin%26aufirst%3DD.%2BM.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFraunholz%26aufirst%3DM.%2BJ.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DMcFadden%26aufirst%3DG.%2BI.%26aulast%3DCummings%26aufirst%3DL.%2BM.%26aulast%3DSubramanian%26aufirst%3DG.%2BM.%26aulast%3DMungall%26aufirst%3DC.%26aulast%3DVenter%26aufirst%3DJ.%2BC.%26aulast%3DCarucci%26aufirst%3DD.%2BJ.%26aulast%3DHoffman%26aufirst%3DS.%2BL.%26aulast%3DNewbold%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DR.%2BW.%26aulast%3DFraser%26aufirst%3DC.%2BM.%26aulast%3DBarrell%26aufirst%3DB.%26atitle%3DGenome%2520Sequence%2520of%2520the%2520Human%2520Malaria%2520Parasite%2520Plasmodium%2520Falciparum%26jtitle%3DNature%26date%3D2002%26volume%3D419%26spage%3D498%26epage%3D511%26doi%3D10.1038%2Fnature01097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Guiguemde, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelat, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tripathi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharlow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazouni, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowble, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forquer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinley, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRisi, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riscoe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Voorhis, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, R. K.</span><span> </span><span class="NLM_article-title">Chemical Genetics of Plasmodium Falciparum</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span><span class="refDoi"> DOI: 10.1038/nature09099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnature09099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=20485428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1OjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=311-315&author=W.+A.+Guiguemdeauthor=A.+A.+Shelatauthor=D.+Bouckauthor=S.+Duffyauthor=G.+J.+Crowtherauthor=P.+H.+Davisauthor=D.+C.+Smithsonauthor=M.+Connellyauthor=J.+Clarkauthor=F.+Zhuauthor=M.+B.+Jimenez-Diazauthor=M.+S.+Martinezauthor=E.+B.+Wilsonauthor=A.+K.+Tripathiauthor=J.+Gutauthor=E.+R.+Sharlowauthor=I.+Bathurstauthor=F.+E.+Mazouniauthor=J.+W.+Fowbleauthor=I.+Forquerauthor=P.+L.+McGinleyauthor=S.+Castroauthor=I.+Angulo-Barturenauthor=S.+Ferrerauthor=P.+J.+Rosenthalauthor=J.+L.+DeRisiauthor=D.+J.+Sullivanauthor=J.+S.+Lazoauthor=D.+S.+Roosauthor=M.+K.+Riscoeauthor=M.+A.+Phillipsauthor=P.+K.+Rathodauthor=W.+C.+Van+Voorhisauthor=V.+M.+Averyauthor=R.+K.+Guy&title=Chemical+Genetics+of+Plasmodium+Falciparum&doi=10.1038%2Fnature09099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics of Plasmodium falciparum</span></div><div class="casAuthors">Guiguemde, W. Armand; Shelat, Anang A.; Bouck, David; Duffy, Sandra; Crowther, Gregory J.; Davis, Paul H.; Smithson, David C.; Connelly, Michele; Clark, Julie; Zhu, Fangyi; Jimenez-Diaz, Maria B.; Martinez, Maria S.; Wilson, Emily B.; Tripathi, Abhai K.; Gut, Jiri; Sharlow, Elizabeth R.; Bathurst, Ian; El Mazouni, Farah; Fowble, Joseph W.; Forquer, Isaac; McGinley, Paula L.; Castro, Steve; Angulo-Barturen, Inigo; Ferrer, Santiago; Rosenthal, Philip J.; De Risi, Joseph L.; Sullivan, David J., Jr.; Lazo, John S.; Roos, David S.; Riscoe, Michael K.; Phillips, Margaret A.; Rathod, Pradipsinh K.; Van Voorhis, Wesley C.; Avery, Vicky M.; Guy, R. Kiplin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">311-315</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malaria caused by Plasmodium falciparum is a disease that is responsible for 880,000 deaths per yr worldwide.  Vaccine development has proved difficult and resistance has emerged for most antimalarial drugs.  To discover new antimalarial chemotypes, we have used a phenotypic forward chem. genetic approach to assay 309,474 chems.  Here we disclose structures and biol. activity of the entire library-many of which showed potent in vitro activity against drug-resistant P. falciparum strains-and detailed profiling of 172 representative candidates.  A reverse chem. genetic study identified 19 new inhibitors of 4 validated drug targets and 15 novel binders among 61 malarial proteins.  Phylochemogenetic profiling in several organisms revealed similarities between Toxoplasma gondii and mammalian cell lines and dissimilarities between P. falciparum and related protozoans.  One exemplar compd. displayed efficacy in a murine model.  Our findings provide the scientific community with new starting points for malaria drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC5VVynAR2NLVg90H21EOLACvtfcHk0ljen3ViLF5Bhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1OjtL4%253D&md5=b1b838f5e43adeb4de019c3e41c33017</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature09099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09099%26sid%3Dliteratum%253Aachs%26aulast%3DGuiguemde%26aufirst%3DW.%2BA.%26aulast%3DShelat%26aufirst%3DA.%2BA.%26aulast%3DBouck%26aufirst%3DD.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DCrowther%26aufirst%3DG.%2BJ.%26aulast%3DDavis%26aufirst%3DP.%2BH.%26aulast%3DSmithson%26aufirst%3DD.%2BC.%26aulast%3DConnelly%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DMartinez%26aufirst%3DM.%2BS.%26aulast%3DWilson%26aufirst%3DE.%2BB.%26aulast%3DTripathi%26aufirst%3DA.%2BK.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DSharlow%26aufirst%3DE.%2BR.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DMazouni%26aufirst%3DF.%2BE.%26aulast%3DFowble%26aufirst%3DJ.%2BW.%26aulast%3DForquer%26aufirst%3DI.%26aulast%3DMcGinley%26aufirst%3DP.%2BL.%26aulast%3DCastro%26aufirst%3DS.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DDeRisi%26aufirst%3DJ.%2BL.%26aulast%3DSullivan%26aufirst%3DD.%2BJ.%26aulast%3DLazo%26aufirst%3DJ.%2BS.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26atitle%3DChemical%2520Genetics%2520of%2520Plasmodium%2520Falciparum%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D311%26epage%3D315%26doi%3D10.1038%2Fnature09099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Plouffe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzen, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">In Silico Activity Profiling Reveals the Mechanism of Action of Antimalarials Discovered in a High-throughput Screen</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">9059</span><span class="NLM_x">–</span> <span class="NLM_lpage">9064</span><span class="refDoi"> DOI: 10.1073/pnas.0802982105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1073%2Fpnas.0802982105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=18579783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=9059-9064&author=D.+Plouffeauthor=A.+Brinkerauthor=C.+McNamaraauthor=K.+Hensonauthor=N.+Katoauthor=K.+Kuhenauthor=A.+Nagleauthor=F.+Adrianauthor=J.+T.+Matzenauthor=P.+Andersonauthor=T.+G.+Namauthor=N.+S.+Grayauthor=A.+Chatterjeeauthor=J.+Janesauthor=S.+F.+Yanauthor=R.+Tragerauthor=J.+S.+Caldwellauthor=P.+G.+Schultzauthor=Y.+Zhouauthor=E.+A.+Winzeler&title=In+Silico+Activity+Profiling+Reveals+the+Mechanism+of+Action+of+Antimalarials+Discovered+in+a+High-throughput+Screen&doi=10.1073%2Fpnas.0802982105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen</span></div><div class="casAuthors">Plouffe, David; Brinker, Achim; McNamara, Case; Henson, Kerstin; Kato, Nobutaka; Kuhen, Kelli; Nagle, Advait; Adrian, Francisco; Matzen, Jason T.; Anderson, Paul; Nam, Tae-gyu; Gray, Nathanael S.; Chatterjee, Arnab; Janes, Jeff; Yan, S. Frank; Trager, Richard; Caldwell, Jeremy S.; Schultz, Peter G.; Zhou, Yingyao; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9059-9064</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The growing resistance to current first-line antimalarial drugs represents a major health challenge.  To facilitate the discovery of new antimalarials, we have implemented an efficient and robust high-throughput cell-based screen (1,536-well format) based on proliferation of Plasmodium falciparum (Pf) in erythrocytes.  From a screen of ≈ 1.7 million compds., we identified a diverse collection of ≈ 6,000 small mols. comprised of > 530 distinct scaffolds, all of which show potent antimalarial activity (< 1.25 μM).  Most known antimalarials were identified in this screen, thus validating our approach.  In addn., we identified many novel chem. scaffolds, which likely act through both known and novel pathways.  We further show that in some cases the mechanism of action of these antimalarials can be detd. by in silico compd. activity profiling.  This method uses large datasets from unrelated cellular and biochem. screens and the guilt-by-assocn. principle to predict which cellular pathway and/or protein target is being inhibited by select compds.  In addn., the screening method has the potential to provide the malaria community with many new starting points for the development of biol. probes and drugs with novel antiparasitic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL9PFy0SUhdbVg90H21EOLACvtfcHk0lh-N0nXIwHjcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVCiurw%253D&md5=bf14f093078c982e3604089588827166</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0802982105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0802982105%26sid%3Dliteratum%253Aachs%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DHenson%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DMatzen%26aufirst%3DJ.%2BT.%26aulast%3DAnderson%26aufirst%3DP.%26aulast%3DNam%26aufirst%3DT.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DJanes%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DS.%2BF.%26aulast%3DTrager%26aufirst%3DR.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DIn%2520Silico%2520Activity%2520Profiling%2520Reveals%2520the%2520Mechanism%2520of%2520Action%2520of%2520Antimalarials%2520Discovered%2520in%2520a%2520High-throughput%2520Screen%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D9059%26epage%3D9064%26doi%3D10.1073%2Fpnas.0802982105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Cozar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderwall, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peishoff, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardon, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Bustos, J. F.</span><span> </span><span class="NLM_article-title">Thousands of Chemical Starting Points for Antimalarial Lead Identification</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1038/nature09107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnature09107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=20485427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmt1Ois7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=305-312&author=F.+J.+Gamoauthor=L.+M.+Sanzauthor=J.+Vidalauthor=C.+de+Cozarauthor=E.+Alvarezauthor=J.+L.+Lavanderaauthor=D.+E.+Vanderwallauthor=D.+V.+S.+Greenauthor=V.+Kumarauthor=S.+Hasanauthor=J.+R.+Brownauthor=C.+E.+Peishoffauthor=L.+R.+Cardonauthor=J.+F.+Garcia-Bustos&title=Thousands+of+Chemical+Starting+Points+for+Antimalarial+Lead+Identification&doi=10.1038%2Fnature09107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Thousands of chemical starting points for antimalarial lead identification</span></div><div class="casAuthors">Gamo, Francisco-Javier; Sanz, Laura M.; Vidal, Jaume; de Cozar, Cristina; Alvarez, Emilio; Lavandera, Jose-Luis; Vanderwall, Dana E.; Green, Darren V. S.; Kumar, Vinod; Hasan, Samiul; Brown, James R.; Peishoff, Catherine E.; Cardon, Lon R.; Garcia-Bustos, Jose F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7296</span>),
    <span class="NLM_cas:pages">305-310</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Malaria is a devastating infection caused by protozoa of the genus Plasmodium.  Drug resistance is widespread, no new chem. class of antimalarials has been introduced into clin. practice since 1996 and there is a recent rise of parasite strains with reduced sensitivity to the newest drugs.  We screened nearly 2 million compds. in GlaxoSmithKline's chem. library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 μM concn.  More than 8,000 also showed potent activity against the multidrug resistant strain Dd2.  Most (82%) compds. originate from internal company projects and are new to the malaria community.  Analyses using historic assay data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host-pathogen interaction related targets.  Chem. structures and assocd. data are hereby made public to encourage addnl. drug lead identification efforts and further research into this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHijpWK_kBF7Vg90H21EOLACvtfcHk0lh-N0nXIwHjcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmt1Ois7k%253D&md5=a1fd8c0b89a5650ecba31f5456928b42</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature09107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09107%26sid%3Dliteratum%253Aachs%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3Dde%2BCozar%26aufirst%3DC.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DVanderwall%26aufirst%3DD.%2BE.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DHasan%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DPeishoff%26aufirst%3DC.%2BE.%26aulast%3DCardon%26aufirst%3DL.%2BR.%26aulast%3DGarcia-Bustos%26aufirst%3DJ.%2BF.%26atitle%3DThousands%2520of%2520Chemical%2520Starting%2520Points%2520for%2520Antimalarial%2520Lead%2520Identification%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D305%26epage%3D312%26doi%3D10.1038%2Fnature09107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span>ChEMBL-NTD; <span class="NLM_publisher-name">EMBL-EBI</span>: <span class="NLM_publisher-loc">Hinxton, Cambridgeshire, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2017</span><span class="NLM_x">; </span><a href="http://www.ebi.ac.uk/chemblntd" class="extLink">www.ebi.ac.uk/chemblntd</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ChEMBL-NTD%3B+EMBL-EBI%3A+Hinxton%2C+Cambridgeshire%2C+UK%2C+2017%3B+www.ebi.ac.uk%2Fchemblntd."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DChEMBL-NTD%26pub%3DEMBL-EBI%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueno, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coterón, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavandera, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiandor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J.</span><span> </span><span class="NLM_article-title">An Invitation to Open Innovation in malaria Drug Discovery: 47 Quality Starting Points from the TCAMS</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span><span class="refDoi"> DOI: 10.1021/ml200135p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200135p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtValsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=741-746&author=F.+Calder%C3%B3nauthor=D.+Barrosauthor=J.+M.+Buenoauthor=J.+M.+Coter%C3%B3nauthor=E.+Fern%C3%A1ndezauthor=F.+J.+Gamoauthor=J.+L.+Lavanderaauthor=M.+L.+Le%C3%B3nauthor=S.+J.+F.+Macdonaldauthor=A.+Malloauthor=P.+Manzanoauthor=E.+Porrasauthor=J.+M.+Fiandorauthor=J.+Castro&title=An+Invitation+to+Open+Innovation+in+malaria+Drug+Discovery%3A+47+Quality+Starting+Points+from+the+TCAMS&doi=10.1021%2Fml200135p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS</span></div><div class="casAuthors">Calderon, Felix; Barros, David; Bueno, Jose Maria; Coteron, Jose Miguel; Fernandez, Esther; Gamo, Francisco Javier; Lavandera, Jose Luis; Leon, Maria Luisa; MacDonald, Simon J. F.; Mallo, Araceli; Manzano, Pilar; Porras, Esther; Fiandor, Jose Maria; Castro, Julia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">741-746</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In 2010, GlaxoSmithKline published the structures of 13533 chem. starting points for antimalarial lead identification.  By using an agglomerative structural clustering technique followed by computational filters such as antimalarial activity, physicochem. properties, and dissimilarity to known antimalarial structures, we have identified 47 starting points for lead optimization.  Their structures are provided.  We invite potential collaborators to work with us to discover new clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5fqzf76wMHrVg90H21EOLACvtfcHk0ljcae1Cv7X-sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtValsLnI&md5=706374895ecc775c2c790c07e1195564</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fml200135p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200135p%26sid%3Dliteratum%253Aachs%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBueno%26aufirst%3DJ.%2BM.%26aulast%3DCoter%25C3%25B3n%26aufirst%3DJ.%2BM.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DLavandera%26aufirst%3DJ.%2BL.%26aulast%3DLe%25C3%25B3n%26aufirst%3DM.%2BL.%26aulast%3DMacdonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DMallo%26aufirst%3DA.%26aulast%3DManzano%26aufirst%3DP.%26aulast%3DPorras%26aufirst%3DE.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DCastro%26aufirst%3DJ.%26atitle%3DAn%2520Invitation%2520to%2520Open%2520Innovation%2520in%2520malaria%2520Drug%2520Discovery%253A%252047%2520Quality%2520Starting%2520Points%2520from%2520the%2520TCAMS%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D741%26epage%3D746%26doi%3D10.1021%2Fml200135p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rueda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellote, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Pichel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaparro, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Rosa, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, S. J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos Martínez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, E.</span><span> </span><span class="NLM_article-title">Cyclopropyl Carboxamides: A New Oral Antimalarial Series Derived from the Tres Cantos Anti-malarial Set (TCAMS)</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">840</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1021/ml2001517</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml2001517" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=840-844&author=L.+Ruedaauthor=I.+Castelloteauthor=J.+Castro-Pichelauthor=M.+J.+Chaparroauthor=J.+C.+de+la+Rosaauthor=A.+Garc%C3%ADa-Perezauthor=M.+Gordoauthor=M.+B.+Jimenez-D%C3%ADazauthor=A.+Kesslerauthor=S.+J.+F.+MacDonaldauthor=M.+Santos+Mart%C3%ADnezauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=E.+Fernandez&title=Cyclopropyl+Carboxamides%3A+A+New+Oral+Antimalarial+Series+Derived+from+the+Tres+Cantos+Anti-malarial+Set+%28TCAMS%29&doi=10.1021%2Fml2001517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml2001517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml2001517%26sid%3Dliteratum%253Aachs%26aulast%3DRueda%26aufirst%3DL.%26aulast%3DCastellote%26aufirst%3DI.%26aulast%3DCastro-Pichel%26aufirst%3DJ.%26aulast%3DChaparro%26aufirst%3DM.%2BJ.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DJ.%2BC.%26aulast%3DGarc%25C3%25ADa-Perez%26aufirst%3DA.%26aulast%3DGordo%26aufirst%3DM.%26aulast%3DJimenez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DMacDonald%26aufirst%3DS.%2BJ.%2BF.%26aulast%3DSantos%2BMart%25C3%25ADnez%26aufirst%3DM.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DFernandez%26aufirst%3DE.%26atitle%3DCyclopropyl%2520Carboxamides%253A%2520A%2520New%2520Oral%2520Antimalarial%2520Series%2520Derived%2520from%2520the%2520Tres%2520Cantos%2520Anti-malarial%2520Set%2520%2528TCAMS%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D840%26epage%3D844%26doi%3D10.1021%2Fml2001517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal-Mas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Rosa, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prats, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, E.</span><span> </span><span class="NLM_article-title">A Divergent SAR Study Allows Optimization of a Potent 5-HT<sub>2C</sub> Inhibitor to a Promising Antimalarial Scaffold</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1021/ml300008j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300008j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=373-377&author=F.+Calder%C3%B3nauthor=J.+Vidal-Masauthor=J.+Burrowsauthor=J.+C.+de+la+Rosaauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=T.+Muletauthor=S.+Pratsauthor=J.+Solanaauthor=M.+Wittyauthor=F.+J.+Gamoauthor=E.+Fernandez&title=A+Divergent+SAR+Study+Allows+Optimization+of+a+Potent+5-HT2C+Inhibitor+to+a+Promising+Antimalarial+Scaffold&doi=10.1021%2Fml300008j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml300008j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300008j%26sid%3Dliteratum%253Aachs%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DVidal-Mas%26aufirst%3DJ.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DJ.%2BC.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DPrats%26aufirst%3DS.%26aulast%3DSolana%26aufirst%3DJ.%26aulast%3DWitty%26aufirst%3DM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DFernandez%26aufirst%3DE.%26atitle%3DA%2520Divergent%2520SAR%2520Study%2520Allows%2520Optimization%2520of%2520a%2520Potent%25205-HT2C%2520Inhibitor%2520to%2520a%2520Promising%2520Antimalarial%2520Scaffold%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D373%26epage%3D377%26doi%3D10.1021%2Fml300008j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Chaparro, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueno, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colmenarejo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coterón, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de las Heras, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabarró, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafuente, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prats, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoval, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Villarejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderón, F.</span><span> </span><span class="NLM_article-title">Case Study of Small Molecules As Antimalarials: 2–Amino-1-phenylethanol (APE) Derivatives</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1021/ml500015r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500015r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=657-661&author=M.+J.+Chaparroauthor=J.+Vidalauthor=I.+Angulo-Barturenauthor=J.+M.+Buenoauthor=J.+Burrowsauthor=N.+Cammackauthor=P.+Casta%C3%B1edaauthor=G.+Colmenarejoauthor=J.+M.+Coter%C3%B3nauthor=L.+de+las+Herasauthor=E.+Fern%C3%A1ndezauthor=S.+Ferrerauthor=R.+Gabarr%C3%B3author=F.+J.+Gamoauthor=M.+Garc%C3%ADaauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=M.+J.+Lafuenteauthor=M.+L.+Le%C3%B3nauthor=M.+S.+Mart%C3%ADnezauthor=D.+Minickauthor=S.+Pratsauthor=M.+Puenteauthor=L.+Ruedaauthor=E.+Sandovalauthor=A.+Santos-Villarejoauthor=M.+Wittyauthor=F.+Calder%C3%B3n&title=Case+Study+of+Small+Molecules+As+Antimalarials%3A+2%E2%80%93Amino-1-phenylethanol+%28APE%29+Derivatives&doi=10.1021%2Fml500015r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml500015r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500015r%26sid%3Dliteratum%253Aachs%26aulast%3DChaparro%26aufirst%3DM.%2BJ.%26aulast%3DVidal%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DBueno%26aufirst%3DJ.%2BM.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DCasta%25C3%25B1eda%26aufirst%3DP.%26aulast%3DColmenarejo%26aufirst%3DG.%26aulast%3DCoter%25C3%25B3n%26aufirst%3DJ.%2BM.%26aulast%3Dde%2Blas%2BHeras%26aufirst%3DL.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DGabarr%25C3%25B3%26aufirst%3DR.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DM.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DLafuente%26aufirst%3DM.%2BJ.%26aulast%3DLe%25C3%25B3n%26aufirst%3DM.%2BL.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DMinick%26aufirst%3DD.%26aulast%3DPrats%26aufirst%3DS.%26aulast%3DPuente%26aufirst%3DM.%26aulast%3DRueda%26aufirst%3DL.%26aulast%3DSandoval%26aufirst%3DE.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DWitty%26aufirst%3DM.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26atitle%3DCase%2520Study%2520of%2520Small%2520Molecules%2520As%2520Antimalarials%253A%25202%25E2%2580%2593Amino-1-phenylethanol%2520%2528APE%2529%2520Derivatives%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D657%26epage%3D661%26doi%3D10.1021%2Fml500015r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Keurulainen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vahermo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puente-Felipe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandoval-Izquierdo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo-Fernández, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro-López, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas-Valentín, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de las Heras-Dueña, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leino, T. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siiskonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell-Pages, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda-Casado, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuru, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yli-Kauhaluoma, J.</span><span> </span><span class="NLM_article-title">A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: <i>N</i>–[3-[(Benzimidazol-2-yl)amino]propyl]amides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4573</span><span class="NLM_x">–</span> <span class="NLM_lpage">4580</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00114</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00114" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4573-4580&author=L.+Keurulainenauthor=M.+Vahermoauthor=M.+Puente-Felipeauthor=E.+Sandoval-Izquierdoauthor=B.+Crespo-Fern%C3%A1ndezauthor=L.+Guijarro-L%C3%B3pezauthor=L.+Huertas-Valent%C3%ADnauthor=L.+de+las+Heras-Due%C3%B1aauthor=T.+O.+Leinoauthor=A.+Siiskonenauthor=L.+Ballell-Pagesauthor=L.+M.+Sanzauthor=P.+Casta%C3%B1eda-Casadoauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=M.+S.+Mart%C3%ADnez-Mart%C3%ADnezauthor=S.+Vieraauthor=P.+Kiuruauthor=F.+Calder%C3%B3nauthor=J.+Yli-Kauhaluoma&title=A+Developability-Focused+Optimization+Approach+Allows+Identification+of+in+Vivo+Fast-Acting+Antimalarials%3A+N%E2%80%93%5B3-%5B%28Benzimidazol-2-yl%29amino%5Dpropyl%5Damides&doi=10.1021%2Facs.jmedchem.5b00114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00114%26sid%3Dliteratum%253Aachs%26aulast%3DKeurulainen%26aufirst%3DL.%26aulast%3DVahermo%26aufirst%3DM.%26aulast%3DPuente-Felipe%26aufirst%3DM.%26aulast%3DSandoval-Izquierdo%26aufirst%3DE.%26aulast%3DCrespo-Fern%25C3%25A1ndez%26aufirst%3DB.%26aulast%3DGuijarro-L%25C3%25B3pez%26aufirst%3DL.%26aulast%3DHuertas-Valent%25C3%25ADn%26aufirst%3DL.%26aulast%3Dde%2Blas%2BHeras-Due%25C3%25B1a%26aufirst%3DL.%26aulast%3DLeino%26aufirst%3DT.%2BO.%26aulast%3DSiiskonen%26aufirst%3DA.%26aulast%3DBallell-Pages%26aufirst%3DL.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCasta%25C3%25B1eda-Casado%26aufirst%3DP.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DViera%26aufirst%3DS.%26aulast%3DKiuru%26aufirst%3DP.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DYli-Kauhaluoma%26aufirst%3DJ.%26atitle%3DA%2520Developability-Focused%2520Optimization%2520Approach%2520Allows%2520Identification%2520of%2520in%2520Vivo%2520Fast-Acting%2520Antimalarials%253A%2520N%25E2%2580%2593%255B3-%255B%2528Benzimidazol-2-yl%2529amino%255Dpropyl%255Damides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4573%26epage%3D4580%26doi%3D10.1021%2Facs.jmedchem.5b00114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">McConville, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahamontes-Rosa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell-Pages, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Cózar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Díaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Mercado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos-Villarejo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigerio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washbourn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixon, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagini, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, P. M.</span><span> </span><span class="NLM_article-title">Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6448</span><span class="NLM_x">–</span> <span class="NLM_lpage">6455</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00434</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00434" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1CitbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6448-6455&author=M.+McConvilleauthor=J.+Fern%C3%A1ndezauthor=I.+Angulo-Barturenauthor=N.+Bahamontes-Rosaauthor=L.+Ballell-Pagesauthor=P.+Casta%C3%B1edaauthor=C.+de+C%C3%B3zarauthor=B.+Crespoauthor=L.+Guijarroauthor=M.+Jim%C3%A9nez-D%C3%ADazauthor=M.+S.+Mart%C3%ADnez-Mart%C3%ADnezauthor=J.+de+Mercadoauthor=A.+Santos-Villarejoauthor=L.+M.+Sanzauthor=M.+Frigerioauthor=G.+Washbournauthor=S.+A.+Wardauthor=G.+L.+Nixonauthor=G.+A.+Biaginiauthor=N.+G.+Berryauthor=M.+J.+Blackmanauthor=F.+Calder%C3%B3nauthor=P.+M.+O%E2%80%99Neill&title=Carbamoyl+Triazoles%2C+Known+Serine+Protease+Inhibitors%2C+Are+a+Potent+New+Class+of+Antimalarials&doi=10.1021%2Facs.jmedchem.5b00434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials</span></div><div class="casAuthors">McConville, Matthew; Fernandez, Jorge; Angulo-Barturen, Inigo; Bahamontes-Rosa, Noemi; Ballell-Pages, Lluis; Castaneda, Pablo; de Cozar, Cristina; Crespo, Benigno; Guijarro, Laura; Jimenez-Diaz, Maria Belen; Martinez-Martinez, Maria S.; de Mercado, Jaime; Santos-Villarejo, Angel; Sanz, Laura M.; Frigerio, Micol; Washbourn, Gina; Ward, Stephen A.; Nixon, Gemma L.; Biagini, Giancarlo A.; Berry, Neil G.; Blackman, Michael J.; Calderon, Felix; O'Neill, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6448-6455</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of the GSK corporate collection, some 1.9 million compds., against Plasmodium falciparum (Pf), revealed almost 14000 active hits that are now known as the Tres Cantos Antimalarial Set (TCAMS).  Follow-up work by Calderon et al. clustered and computationally filtered the TCAMS through a variety of criteria and reported 47 series contg. a total of 522 compds.  From this enhanced set, we identified the carbamoyl triazole TCMDC-134379, a known serine protease inhibitor, as an excellent starting point for SAR profiling.  Lead optimization of TCMDC-134379 led to several mols. with improved antimalarial potency, metabolic stabilities in mouse and human liver microsomes, along with acceptable cytotoxicity profiles.  Analog (I) displayed potent in vitro activity (IC50 = 10 nM) and oral activity in a SCID mouse model of Pf infection with an ED50 of 100 and ED90 of between 100 and 150 mg kg-1, resp.  The results presented encourage further investigations to identify the target of these highly active compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe5cb5tdfmTLVg90H21EOLACvtfcHk0lgUsY-A-EqBwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1CitbzI&md5=7b69cde5c4242d8ef8d906e77cad1e29</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00434%26sid%3Dliteratum%253Aachs%26aulast%3DMcConville%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DBahamontes-Rosa%26aufirst%3DN.%26aulast%3DBallell-Pages%26aufirst%3DL.%26aulast%3DCasta%25C3%25B1eda%26aufirst%3DP.%26aulast%3Dde%2BC%25C3%25B3zar%26aufirst%3DC.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DGuijarro%26aufirst%3DL.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3Dde%2BMercado%26aufirst%3DJ.%26aulast%3DSantos-Villarejo%26aufirst%3DA.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DFrigerio%26aufirst%3DM.%26aulast%3DWashbourn%26aufirst%3DG.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DNixon%26aufirst%3DG.%2BL.%26aulast%3DBiagini%26aufirst%3DG.%2BA.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DBlackman%26aufirst%3DM.%2BJ.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DCarbamoyl%2520Triazoles%252C%2520Known%2520Serine%2520Protease%2520Inhibitors%252C%2520Are%2520a%2520Potent%2520New%2520Class%2520of%2520Antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6448%26epage%3D6455%26doi%3D10.1021%2Facs.jmedchem.5b00434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Jiménez-Díaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibáñez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magán-Marchal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garuti, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortés-Gil, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraile, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderón, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shultz, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leroy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span> </span><span class="NLM_article-title">A New In Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e66967</span><span class="refDoi"> DOI: 10.1371/journal.pone.0066967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1371%2Fjournal.pone.0066967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=23825598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtV2qtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e66967&author=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=S.+Vieraauthor=J.+Ib%C3%A1%C3%B1ezauthor=T.+Muletauthor=N.+Mag%C3%A1n-Marchalauthor=H.+Garutiauthor=V.+G%C3%B3mezauthor=L.+Cort%C3%A9s-Gilauthor=A.+Mart%C3%ADnezauthor=S.+Ferrerauthor=M.+T.+Fraileauthor=F.+Calder%C3%B3nauthor=E.+Fern%C3%A1ndezauthor=L.+D.+Shultzauthor=D.+Leroyauthor=D.+M.+Wilsonauthor=J.+F.+Garc%C3%ADa-Bustosauthor=F.+J.+Gamoauthor=I.+Angulo-Barturen&title=A+New+In+Vivo+Screening+Paradigm+to+Accelerate+Antimalarial+Drug+Discovery&doi=10.1371%2Fjournal.pone.0066967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A new in vivo screening paradigm to accelerate antimalarial drug discovery</span></div><div class="casAuthors">Jimenez-Diaz, Maria Belen; Viera, Sara; Ibanez, Javier; Mulet, Teresa; Magan-Marchal, Noemi; Garuti, Helen; Gomez, Vanessa; Cortes-Gil, Lorena; Martiez, Antonio; Ferrer, Santiago; Fraile, Maria Teresa; Caldero, Felix; Fernandez, Esther; Shultz, Leonard D.; Leroy, Didier; Wilson, David M.; Garcia-Bustos, Jose Francisco; Gamo, Francisco Javier; Angulo-Barturen, Inigo</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e66967</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The emergence of resistance to available antimalarials requires the urgent development of new medicines.  The recent disclosure of several thousand compds. active in vitro against the erythrocyte stage of Plasmodium falciparum has been a major breakthrough, though converting these hits into new medicines challenges current strategies.  A new in vivo screening concept was evaluated as a strategy to increase the speed and efficiency of drug discovery projects in malaria.  The new in vivo screening concept was developed based on human disease parameters, i.e. parasitemia in the peripheral blood of patients on hospital admission and parasite redn. ratio (PRR), which were allometrically down-scaled into P. berghei-infected mice.  Mice with an initial parasitemia (P0) of 1.5% were treated orally for two consecutive days and parasitemia measured 24 h after the second dose.  The assay was optimized for detection of compds. able to stop parasite replication (PRR = 1) or induce parasite clearance (PRR >1) with statistical power >99% using only two mice per exptl. group.  In the P. berghei in vivo screening assay, the PRR of a set of eleven antimalarials with different mechanisms of action correlated with human-equiv. data.  Subsequently, 590 compds. from the Tres Cantos Antimalarial Set with activity in vitro against P. falciparum were tested at 50 mg/kg (orally) in an assay format that allowed the evaluation of hundreds of compds. per mo.  The rate of compds. with detectable efficacy was 11.2% and about one third of active compds. showed in vivo efficacy comparable with the most potent antimalarials used clin.  High-throughput, high-content in vivo screening could rapidly select new compds., dramatically speeding up the discovery of new antimalarial medicines.  A global multilateral collaborative project aimed at screening the significant chem. diversity within the antimalarial in vitro hits described in the literature is a feasible task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXKzdqs7h8k7Vg90H21EOLACvtfcHk0liY-BRPHKhz2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtV2qtbjJ&md5=35d24cc0f14f22be828f36714752ac78</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0066967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0066967%26sid%3Dliteratum%253Aachs%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DViera%26aufirst%3DS.%26aulast%3DIb%25C3%25A1%25C3%25B1ez%26aufirst%3DJ.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DMag%25C3%25A1n-Marchal%26aufirst%3DN.%26aulast%3DGaruti%26aufirst%3DH.%26aulast%3DG%25C3%25B3mez%26aufirst%3DV.%26aulast%3DCort%25C3%25A9s-Gil%26aufirst%3DL.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DFraile%26aufirst%3DM.%2BT.%26aulast%3DCalder%25C3%25B3n%26aufirst%3DF.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DE.%26aulast%3DShultz%26aufirst%3DL.%2BD.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DD.%2BM.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26atitle%3DA%2520New%2520In%2520Vivo%2520Screening%2520Paradigm%2520to%2520Accelerate%2520Antimalarial%2520Drug%2520Discovery%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De66967%26doi%3D10.1371%2Fjournal.pone.0066967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Boström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowright, A. T.</span><span> </span><span class="NLM_article-title">Oxadiazoles in Medicinal Chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1830</span><span class="refDoi"> DOI: 10.1021/jm2013248</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=A.+Llin%C3%A0sauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+Medicinal+Chemistry&doi=10.1021%2Fjm2013248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Oxadiazoles in medicinal chemistry</span></div><div class="casAuthors">Bostrom Jonas; Hogner Anders; Llinas Antonio; Wellner Eric; Plowright Alleyn T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1817-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms.  Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities.  The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection.  In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner.  Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers.  The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments).  To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO9RQiG9xFS2Zyxfu64m4ffW6udTcc2ebb-BqgmVdS4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1Oisw%253D%253D&md5=b934995431ced1be297e6f126262f3cb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830%26doi%3D10.1021%2Fjm2013248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Pace, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierro, P.</span><span> </span><span class="NLM_article-title">The New Era of 1,2,4-Oxadiazoles</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">4337</span><span class="NLM_x">–</span> <span class="NLM_lpage">4348</span><span class="refDoi"> DOI: 10.1039/b908937c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1039%2Fb908937c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=19830279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Gksb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=4337-4348&author=A.+Paceauthor=P.+Pierro&title=The+New+Era+of+1%2C2%2C4-Oxadiazoles&doi=10.1039%2Fb908937c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The new era of 1,2,4-oxadiazoles</span></div><div class="casAuthors">Pace, Andrea; Pierro, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4337-4348</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">This review covers the synthesis, the chem. and photochem. reactivity, and the use of 1,2,4-oxadiazoles in materials and as bioactive compds.  Further, the material in this survey includes some historical background, general features, state-of-the-art applications together with a crit. discussion about current limitations and suggestions for future developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS_Jcg58EXy7Vg90H21EOLACvtfcHk0lgKUJeHNqOqpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Gksb7E&md5=9314bd3fbc51b2e5bc1a6eafa44646a4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fb908937c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb908937c%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DA.%26aulast%3DPierro%26aufirst%3DP.%26atitle%3DThe%2520New%2520Era%2520of%25201%252C2%252C4-Oxadiazoles%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D4337%26epage%3D4348%26doi%3D10.1039%2Fb908937c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV AIDS Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5843</span><span class="NLM_x">–</span> <span class="NLM_lpage">5855</span><span class="refDoi"> DOI: 10.1021/jm800245z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+Raltegravir%2C+a+Potent%2C+Selective+Orally+Bioavailable+HIV-Integrase+Inhibitor+for+the+Treatment+of+HIV+AIDS+Infection&doi=10.1021%2Fjm800245z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Raltegravir%252C%2520a%2520Potent%252C%2520Selective%2520Orally%2520Bioavailable%2520HIV-Integrase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520HIV%2520AIDS%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5843%26epage%3D5855%26doi%3D10.1021%2Fjm800245z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zareef, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamboa De Dominguez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arfan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Synthesis and Antimalarial Activity of Novel Chiral and Achiral Benzenesulfonamides Bearing 1, 3, 4-Oxadiazole Moieties</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span><span class="refDoi"> DOI: 10.1080/14756360601114569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1080%2F14756360601114569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=17674812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslygtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=301-308&author=M.+Zareefauthor=R.+Iqbalauthor=N.+Gamboa+De+Dominguezauthor=J.+Rodriguesauthor=J.+H.+Zaidiauthor=M.+Arfanauthor=C.+T.+Supuran&title=Synthesis+and+Antimalarial+Activity+of+Novel+Chiral+and+Achiral+Benzenesulfonamides+Bearing+1%2C+3%2C+4-Oxadiazole+Moieties&doi=10.1080%2F14756360601114569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimalarial activity of novel chiral and achiral benzenesulfonamides bearing 1, 3, 4-oxadiazole moieties</span></div><div class="casAuthors">Zareef, Muhammad; Iqbal, Rashid; Gamboa de Dominguez, Neira; Rodrigues, Juan; Zaidi, Javid H.; Arfan, Muhammad; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">301-308</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of new benzenesulfonamides, most of which are chiral, incorporating 1, 3, 4-oxadiazole and amino acid moieties have been synthesized.  Some of these compds. were screened for antimalarial activity and also evaluated for their ability to inhibit hem polymn.  The electrophoretic anal. indicated that compd. I was effective in inhibiting the degrdn. of Hb.  The synthesized compds. were tested in mice infected with Plasmodium berghei.  These derivs. have the potential for the development of novel antimalarial lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ibmYXDuXaLVg90H21EOLACvtfcHk0lgKUJeHNqOqpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslygtLw%253D&md5=e24b51959645edd843f2f1cba7c66268</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F14756360601114569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360601114569%26sid%3Dliteratum%253Aachs%26aulast%3DZareef%26aufirst%3DM.%26aulast%3DIqbal%26aufirst%3DR.%26aulast%3DGamboa%2BDe%2BDominguez%26aufirst%3DN.%26aulast%3DRodrigues%26aufirst%3DJ.%26aulast%3DZaidi%26aufirst%3DJ.%2BH.%26aulast%3DArfan%26aufirst%3DM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DSynthesis%2520and%2520Antimalarial%2520Activity%2520of%2520Novel%2520Chiral%2520and%2520Achiral%2520Benzenesulfonamides%2520Bearing%25201%252C%25203%252C%25204-Oxadiazole%2520Moieties%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2007%26volume%3D22%26spage%3D301%26epage%3D308%26doi%3D10.1080%2F14756360601114569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Sanz, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De-Cozar, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llergo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Bustos, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span> </span><span class="NLM_article-title">P. falciparum in Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e30949</span><span class="refDoi"> DOI: 10.1371/journal.pone.0030949</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1371%2Fjournal.pone.0030949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=22383983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30949&author=L.+M.+Sanzauthor=B.+Crespoauthor=C.+De-Cozarauthor=X.+C.+Dingauthor=J.+L.+Llergoauthor=J.+N.+Burrowsauthor=J.+F.+Garc%C3%ADa-Bustosauthor=F.-J.+Gamo&title=P.+falciparum+in+Vitro+Killing+Rates+Allow+to+Discriminate+between+Different+Antimalarial+Mode-of-Action&doi=10.1371%2Fjournal.pone.0030949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action</span></div><div class="casAuthors">Sanz, Laura M.; Crespo, Benigno; De-Cozar, Cristina; Ding, Xavier C.; Llergo, Jose L.; Burrows, Jeremy N.; Garcia-Bustos, Jose F.; Gamo, Francisco-Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e30949</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chemotherapy is still the cornerstone for malaria control.  Developing drugs against Plasmodium parasites and monitoring their efficacy requires methods to accurately det. the parasite killing rate in response to treatment.  Commonly used techniques essentially measure metabolic activity as a proxy for parasite viability.  However, these approaches are susceptible to artifacts, as viability and metab. are two parameters that are coupled during the parasite life cycle but can be differentially affected in response to drug actions.  Moreover, traditional techniques do not allow to measure the speed-of-action of compds. on parasite viability, which is an essential efficacy determinant.  We present here a comprehensive methodol. to measure in vitro the direct effect of antimalarial compds. over the parasite viability, which is based on limiting serial diln. of treated parasites and re-growth monitoring.  This methodol. allows to precisely det. the killing rate of antimalarial compds., which can be quantified by the parasite redn. ratio and parasite clearance time, which are key mode-of-action parameters.  Importantly, we demonstrate that this technique readily permits to det. compd. killing activities that might be otherwise missed by traditional, metab.-based techniques.  The anal. of a large set of antimalarial drugs reveals that this viability-based assay allows to discriminate compds. based on their antimalarial mode-of-action.  This approach has been adapted to perform medium throughput screening, facilitating the identification of fast-acting antimalarial compds., which are crucially needed for the control and possibly the eradication of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlaUZufRfYxbVg90H21EOLACvtfcHk0lj9SpXPyXDAFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFynsLY%253D&md5=65d5d1a24dbe1811301ac5e684c886c5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030949%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DCrespo%26aufirst%3DB.%26aulast%3DDe-Cozar%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DLlergo%26aufirst%3DJ.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DGarc%25C3%25ADa-Bustos%26aufirst%3DJ.%2BF.%26aulast%3DGamo%26aufirst%3DF.-J.%26atitle%3DP.%2520falciparum%2520in%2520Vitro%2520Killing%2520Rates%2520Allow%2520to%2520Discriminate%2520between%2520Different%2520Antimalarial%2520Mode-of-Action%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30949%26doi%3D10.1371%2Fjournal.pone.0030949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Nassar, A-E F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarimont, C.</span><span> </span><span class="NLM_article-title">Improving the Decision-making Process in the Structural Modification of Drug Candidates: Enhancing Metabolic Stability</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1020</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span><span class="refDoi"> DOI: 10.1016/S1359-6446(04)03280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2FS1359-6446%2804%2903280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=15574318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1020-1028&author=A-E+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+Decision-making+Process+in+the+Structural+Modification+of+Drug+Candidates%3A+Enhancing+Metabolic+Stability&doi=10.1016%2FS1359-6446%2804%2903280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Kamel, Amin M.; Clarimont, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1020-1028</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.  The activity-exposure-toxicity relationship, which can be described as the rule of three', presents the single most difficult challenge in the design of drug candidates and their subsequent advancement to the development stage.  ADME studies are widely used in drug discovery to optimize the balance of properties necessary to convert lead candidates into drugs that are safe and effective for humans.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokn5ucRSES-rVg90H21EOLACvtfcHk0lgFS-fpD9wOXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL&md5=67a85a167b62f0ea4e9f43d25f3e0866</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903280-5%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA-E%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520Decision-making%2520Process%2520in%2520the%2520Structural%2520Modification%2520of%2520Drug%2520Candidates%253A%2520Enhancing%2520Metabolic%2520Stability%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1020%26epage%3D1028%26doi%3D10.1016%2FS1359-6446%2804%2903280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Dıaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulet, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regadera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez de las Heras, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gargallo-Viola, D.</span><span> </span><span class="NLM_article-title">A Murine Model of Falciparum-malaria by In Vivo Selection of Competent Strains in Non-myelodepleted Mice Engrafted with Humanerythrocytes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2252</span><span class="refDoi"> DOI: 10.1371/journal.pone.0002252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1371%2Fjournal.pone.0002252" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2252&author=I.+Angulo-Barturenauthor=M.+B.+Jimenez-D%C4%B1azauthor=T.+Muletauthor=J.+Rullasauthor=E.+Herrerosauthor=S.+Ferrerauthor=E.+Jim%C3%A9nezauthor=A.+Mendozaauthor=J.+Regaderaauthor=P.+J.+Rosenthalauthor=I.+Bathurstauthor=D.+L.+Pomplianoauthor=F.+G%C3%B3mez+de+las+Herasauthor=D.+Gargallo-Viola&title=A+Murine+Model+of+Falciparum-malaria+by+In+Vivo+Selection+of+Competent+Strains+in+Non-myelodepleted+Mice+Engrafted+with+Humanerythrocytes&doi=10.1371%2Fjournal.pone.0002252"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002252%26sid%3Dliteratum%253Aachs%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-D%25C4%25B1az%26aufirst%3DM.%2BB.%26aulast%3DMulet%26aufirst%3DT.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DJim%25C3%25A9nez%26aufirst%3DE.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DRegadera%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DG%25C3%25B3mez%2Bde%2Blas%2BHeras%26aufirst%3DF.%26aulast%3DGargallo-Viola%26aufirst%3DD.%26atitle%3DA%2520Murine%2520Model%2520of%2520Falciparum-malaria%2520by%2520In%2520Vivo%2520Selection%2520of%2520Competent%2520Strains%2520in%2520Non-myelodepleted%2520Mice%2520Engrafted%2520with%2520Humanerythrocytes%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2252%26doi%3D10.1371%2Fjournal.pone.0002252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Jakopin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolenc, M. S.</span><span> </span><span class="NLM_article-title">Recent Advances in the Synthesis of 1,2,4- and 1,3,4-Oxadiazoles</span> <span class="citation_source-journal">Curr. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span><span class="refDoi"> DOI: 10.2174/138527208784911860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.2174%2F138527208784911860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFWmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=850-898&author=Z.+Jakopinauthor=M.+S.+Dolenc&title=Recent+Advances+in+the+Synthesis+of+1%2C2%2C4-+and+1%2C3%2C4-Oxadiazoles&doi=10.2174%2F138527208784911860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the synthesis of 1,2,4- and 1,3,4-oxadiazoles</span></div><div class="casAuthors">Jakopin, Ziga; Dolenc, Marija Sollner</div><div class="citationInfo"><span class="NLM_cas:title">Current Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">850-898</span>CODEN:
                <span class="NLM_cas:coden">CORCFE</span>;
        ISSN:<span class="NLM_cas:issn">1385-2728</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The synthesis of peptidomimetics is an area of research that gained a lot of attention in recent years.  Peptidomimetics are compds. designed to mimic the natural peptide but retain its activity with increased stability and bioavailibility, as a result of the structural changes introduced into the parent mol.  The most frequent of these changes are peptide bond surrogates, which contribute to the hydrolytic resistance of peptidomimetics.  1,2,4- And 1,3,4-oxadiazoles are commonly employed as bioisosteric replacements of the amide bond thus constituting these heterocycles as an important structural motif for the pharmaceutical industry.  The article will therefore provide an insight into the synthetic methodologies leading to 1,2,4- and 1,3,4-oxadiazole formation to give the reader an appreciation of the field.  This review covered all recent developments achieved in the classical synthesis.  Addnl., it focuses on the emerging methodologies of microwave-assisted and solid phase synthesis, thus revealing the scope of influence that these methodologies have in the synthesis of 1,2,4- and 1,3,4-oxadiazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jpuRcYHHErVg90H21EOLACvtfcHk0lhJ31If7tAWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFWmtb0%253D&md5=769ce1aba50a18160228f6d3d4eedc4e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.2174%2F138527208784911860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138527208784911860%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3DZ.%26aulast%3DDolenc%26aufirst%3DM.%2BS.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Synthesis%2520of%25201%252C2%252C4-%2520and%25201%252C3%252C4-Oxadiazoles%26jtitle%3DCurr.%2520Org.%2520Chem.%26date%3D2008%26volume%3D12%26spage%3D850%26epage%3D898%26doi%3D10.2174%2F138527208784911860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Johnson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leet, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejwani, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.-Z.</span><span> </span><span class="NLM_article-title">Metabolism of 5-Isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-<i>N</i>-(2-methyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)pyrrolo[2,1-<i>f</i>][1,2,4]triazin-4-amine (BMS-645737): Identification of an Unusual <i>N</i>-Acetylglucosamine Conjugate in the Cynomolgus Monkey</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2475</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span><span class="refDoi"> DOI: 10.1124/dmd.108.022624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1124%2Fdmd.108.022624" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2475-2483&author=B.+M.+Johnsonauthor=A.+V.+Kamathauthor=J.+E.+Leetauthor=X.+Liuauthor=R.+S.+Bhideauthor=R.+W.+Tejwaniauthor=Y.+Zhangauthor=L.+Qianauthor=D.+D.+Weiauthor=L.+J.+Lombardoauthor=Y.-Z.+Shu&title=Metabolism+of+5-Isopropyl-6-%285-methyl-1%2C3%2C4-oxadiazol-2-yl%29-N-%282-methyl-1H-pyrrolo%5B2%2C3-b%5Dpyridin-5-yl%29pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-4-amine+%28BMS-645737%29%3A+Identification+of+an+Unusual+N-Acetylglucosamine+Conjugate+in+the+Cynomolgus+Monkey&doi=10.1124%2Fdmd.108.022624"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.022624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.022624%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26aulast%3DKamath%26aufirst%3DA.%2BV.%26aulast%3DLeet%26aufirst%3DJ.%2BE.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26aulast%3DTejwani%26aufirst%3DR.%2BW.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DD.%2BD.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DShu%26aufirst%3DY.-Z.%26atitle%3DMetabolism%2520of%25205-Isopropyl-6-%25285-methyl-1%252C3%252C4-oxadiazol-2-yl%2529-N-%25282-methyl-1H-pyrrolo%255B2%252C3-b%255Dpyridin-5-yl%2529pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-4-amine%2520%2528BMS-645737%2529%253A%2520Identification%2520of%2520an%2520Unusual%2520N-Acetylglucosamine%2520Conjugate%2520in%2520the%2520Cynomolgus%2520Monkey%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2475%26epage%3D2483%26doi%3D10.1124%2Fdmd.108.022624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberhard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastuck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boesche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouwmeester, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuster, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span> </span><span class="NLM_article-title">Quantitative Chemical Proteomics Reveals Mechanisms of Action of Clinical ABL Kinase Inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1038/nbt1328</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnbt1328" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=17721511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWksLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=1035-1044&author=M.+Bantscheffauthor=D.+Eberhardauthor=Y.+Abrahamauthor=S.+Bastuckauthor=M.+Boescheauthor=S.+Hobsonauthor=T.+Mathiesonauthor=J.+Perrinauthor=M.+Raidaauthor=C.+Rauauthor=V.+Readerauthor=G.+Sweetmanauthor=A.+Bauerauthor=T.+Bouwmeesterauthor=C.+Hopfauthor=U.+Kruseauthor=G.+Neubauerauthor=N.+Ramsdenauthor=J.+Rickauthor=B.+Kusterauthor=G.+Drewes&title=Quantitative+Chemical+Proteomics+Reveals+Mechanisms+of+Action+of+Clinical+ABL+Kinase+Inhibitors&doi=10.1038%2Fnbt1328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors</span></div><div class="casAuthors">Bantscheff, Marcus; Eberhard, Dirk; Abraham, Yann; Bastuck, Sonja; Boesche, Markus; Hobson, Scott; Mathieson, Toby; Perrin, Jessica; Raida, Manfred; Rau, Christina; Reader, Valerie; Sweetman, Gavain; Bauer, Andreas; Bouwmeester, Tewis; Hopf, Carsten; Kruse, Ulrich; Neubauer, Gitte; Ramsden, Nigel; Rick, Jens; Kuster, Bernhard; Drewes, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1035-1044</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The authors describe a chem. proteomics approach to profile the interaction of small mols. with hundreds of endogenously expressed protein kinases and purine-binding proteins.  This subproteome is captured by immobilized nonselective kinase inhibitors (kinobeads), and the bound proteins are quantified in parallel by mass spectrometry using isobaric tags for relative and abs. quantification (iTRAQ).  By measuring the competition with the affinity matrix, the authors assess the binding of drugs to their targets in cell lysates and in cells.  By mapping drug-induced changes in the phosphorylation state of the captured proteome, the authors also analyze signaling pathways downstream of target kinases.  Quant. profiling of the drugs imatinib (Gleevec), dasatinib (Sprycel) and bosutinib in K562 cells confirms known targets including ABL and SRC family kinases and identifies the receptor tyrosine kinase DDR1 and the oxidoreductase NQO2 as novel targets of imatinib.  The data suggest that the approach is a valuable tool for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsC3OpIuhl8LVg90H21EOLACvtfcHk0lhJ31If7tAWeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWksLvF&md5=ed20d4684a8a6733aba24ca64602bae8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnbt1328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1328%26sid%3Dliteratum%253Aachs%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DEberhard%26aufirst%3DD.%26aulast%3DAbraham%26aufirst%3DY.%26aulast%3DBastuck%26aufirst%3DS.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DHobson%26aufirst%3DS.%26aulast%3DMathieson%26aufirst%3DT.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRaida%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DReader%26aufirst%3DV.%26aulast%3DSweetman%26aufirst%3DG.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DKruse%26aufirst%3DU.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DRick%26aufirst%3DJ.%26aulast%3DKuster%26aufirst%3DB.%26aulast%3DDrewes%26aufirst%3DG.%26atitle%3DQuantitative%2520Chemical%2520Proteomics%2520Reveals%2520Mechanisms%2520of%2520Action%2520of%2520Clinical%2520ABL%2520Kinase%2520Inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D1035%26epage%3D1044%26doi%3D10.1038%2Fnbt1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bergamini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doce, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leggate, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plavec, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rharbaoui, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rausch, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span> </span><span class="NLM_article-title">A Selective Inhibitor Reveals PI3Kγ Dependence of T(H)17 Cell Differentiation</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">576</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1038/nchembio.957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1038%2Fnchembio.957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=22544264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Gqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=576-582&author=G.+Bergaminiauthor=K.+Bellauthor=S.+Shimamuraauthor=T.+Wernerauthor=A.+Cansfieldauthor=K.+M%C3%BCllerauthor=J.+Perrinauthor=C.+Rauauthor=K.+Ellardauthor=C.+Hopfauthor=C.+Doceauthor=D.+Leggateauthor=R.+Manganoauthor=T.+Mathiesonauthor=A.+O%E2%80%99Mahonyauthor=I.+Plavecauthor=F.+Rharbaouiauthor=F.+Reinhardauthor=M.+M.+Savitskiauthor=N.+Ramsdenauthor=E.+Hirschauthor=G.+Drewesauthor=O.+Rauschauthor=M.+Bantscheffauthor=G.+Neubauer&title=A+Selective+Inhibitor+Reveals+PI3K%CE%B3+Dependence+of+T%28H%2917+Cell+Differentiation&doi=10.1038%2Fnchembio.957"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation</span></div><div class="casAuthors">Bergamini, Giovanna; Bell, Kathryn; Shimamura, Satoko; Werner, Thilo; Cansfield, Andrew; Mueller, Katrin; Perrin, Jessica; Rau, Christina; Ellard, Katie; Hopf, Carsten; Doce, Carola; Leggate, Daniel; Mangano, Raffaella; Mathieson, Toby; O'Mahony, Alison; Plavec, Ivan; Rharbaoui, Faiza; Reinhard, Friedrich; Savitski, Mikhail M.; Ramsden, Nigel; Hirsch, Emilio; Drewes, Gerard; Rausch, Oliver; Bantscheff, Marcus; Neubauer, Gitte</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">576-582</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We devised a high-throughput chemoproteomics method that enabled multiplexed screening of 16,000 compds. against native protein and lipid kinases in cell exts.  Optimization of one chem. series resulted in CZC24832, which is to our knowledge the first selective inhibitor of phosphoinositide 3-kinase γ (PI3Kγ) with efficacy in in vitro and in vivo models of inflammation.  Extensive target- and cell-based profiling of CZC24832 revealed regulation of interleukin-17-producing T helper cell (TH17) differentiation by PI3Kγ, thus reinforcing selective inhibition of PI3Kγ as a potential treatment for inflammatory and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqinUn8kLqw_LVg90H21EOLACvtfcHk0lhjI3zz0kNqvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Gqt7c%253D&md5=0141d8596ee10d4d796de57fb87a2c19</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.957%26sid%3Dliteratum%253Aachs%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DShimamura%26aufirst%3DS.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DCansfield%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DEllard%26aufirst%3DK.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DDoce%26aufirst%3DC.%26aulast%3DLeggate%26aufirst%3DD.%26aulast%3DMangano%26aufirst%3DR.%26aulast%3DMathieson%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DPlavec%26aufirst%3DI.%26aulast%3DRharbaoui%26aufirst%3DF.%26aulast%3DReinhard%26aufirst%3DF.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DRausch%26aufirst%3DO.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DNeubauer%26aufirst%3DG.%26atitle%3DA%2520Selective%2520Inhibitor%2520Reveals%2520PI3K%25CE%25B3%2520Dependence%2520of%2520T%2528H%252917%2520Cell%2520Differentiation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D8%26spage%3D576%26epage%3D582%26doi%3D10.1038%2Fnchembio.957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wolber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendix, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Molecule-pharmacophore Superpositioning and Pattern Matching in Computational Drug Design</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1016/j.drudis.2007.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=10.1016%2Fj.drudis.2007.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=18190860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVWhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=23-29&author=G.+Wolberauthor=T.+Seidelauthor=F.+Bendixauthor=T.+Langer&title=Molecule-pharmacophore+Superpositioning+and+Pattern+Matching+in+Computational+Drug+Design&doi=10.1016%2Fj.drudis.2007.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Molecule-pharmacophore superpositioning and pattern matching in computational drug design</span></div><div class="casAuthors">Wolber, Gerhard; Seidel, Thomas; Bendix, Fabian; Langer, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Three-dimensional (3D) pharmacophore modeling is a technique for describing the interaction of a small mol. ligand with a macromol. target.  Since chem. features in a pharmacophore model are well known and highly transparent for medicinal chemists, these models are intuitively understandable and have been increasingly successful in computational drug discovery in the past few years.  The performance and applicability of pharmacophore modeling depends on two main factors: the definition and placement of pharmacophoric features and the alignment techniques used to overlay 3D pharmacophore models and small mols.  An overview of key technologies and latest developments in the area of 3D pharmacophores is given and provides insight into different approaches as implemented by the 3D pharmacophore modeling packages like Catalyst, MOE, Phase and LigandScout.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf1WZmfDtNXLVg90H21EOLACvtfcHk0lhjI3zz0kNqvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVWhtA%253D%253D&md5=ce232a83e23dac545e35b600de6aeb33</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2007.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2007.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DWolber%26aufirst%3DG.%26aulast%3DSeidel%26aufirst%3DT.%26aulast%3DBendix%26aufirst%3DF.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DMolecule-pharmacophore%2520Superpositioning%2520and%2520Pattern%2520Matching%2520in%2520Computational%2520Drug%2520Design%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D23%26epage%3D29%26doi%3D10.1016%2Fj.drudis.2007.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01441">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27040"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01441">10.1021/acs.jmedchem.6b01441</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Description of the pharmacophore modeling; protocols for cell drug susceptibility studies; assessment of in vitro frequency of spontaneous resistance and characterization of resistant mutants; in vivo efficacy in <i>P. falciparum</i> mouse model; hERG inhibition determination and cell cytotoxicity assays; tolerability studies; PK studies methodology; intrinsic clearance determination; FaSSIF solubility determination and ChromlogD protocol; IC<sub>50</sub> standard deviation and controls; PRR figures for compounds <b>2</b> and <b>14</b>; in vivo controls (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_001.pdf">jm6b01441_si_001.pdf (966.4 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01441/suppl_file/jm6b01441_si_002.csv">jm6b01441_si_002.csv (1.37 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01441&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-16%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01441%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01441" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679906c278372308","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
